THE INTERPLAY BETWEEN HOST DEFENSES AND SYSTEMIC PATHOGENS IN PROMOTING DISEASES OF COMPANION ANIMALS by S. Meazzi
 
 
 
UNIVERSITÀ DEGLI STUDI DI MILANO 
 
SCUOLA DI DOTTORATO IN SCIENZE VETERINARIE E DELL’ALLEVAMENTO 
(XXXII CICLO) 
DIPARTIMENTO DI MEDICINA VETERINARIA 
 
 
 
THE INTERPLAY BETWEEN HOST DEFENSES AND 
SYSTEMIC PATHOGENS IN PROMOTING DISEASES OF 
COMPANION ANIMALS 
 
 
 
 
 
SARA MEAZZI 
R11566         
  
 
 
 
TUTOR: Prof.ssa Alessia Giordano 
COORDINATORE: Prof.ssa Valeria Grieco 
 
 
 
 
 
 
 
 
A.A. 2018-2019 
 
1 
 
SCIENTIFIC BACKGROUND ................................................................................................................ 4 
GUT MICROBIOTA ............................................................................................................................... 5 
METHODS FOR THE INVESTIGATION OF GUT MICROBIOTA ................................................ 5 
HUMAN GUT MICROBIOTA ........................................................................................................... 7 
MICROBIOTA AND DYSBIOSIS ..................................................................................................... 9 
GUT MICROBIOTA IN VETERINARY MEDICINE ..................................................................... 12 
FELINE INFECTIOUS PERITONITIS ................................................................................................. 14 
EPIDEMIOLOGY AND ETIOLOGY ............................................................................................... 14 
PATHOGENESIS .............................................................................................................................. 15 
CLINICAL SIGNS AND PATHOLOGICAL FINDINGS ................................................................ 17 
DIAGNOSIS ...................................................................................................................................... 17 
Paraoxonase-1 ................................................................................................................... 20 
CANINE LEISHMANIASIS ................................................................................................................. 22 
EPIDEMIOLOGY AND ETIOLOGY ............................................................................................... 22 
PATHOGENESIS .............................................................................................................................. 23 
CLINICAL SIGNS AND PATHOLOGICAL FINDINGS ................................................................ 24 
DIAGNOSIS ...................................................................................................................................... 26 
AIMS OF THE PhD PROJECT ............................................................................................................. 30 
AIMS OF THE PhD PROJECT ............................................................................................................. 31 
SPECIFIC AIMS .................................................................................................................................... 31 
DESCRIPTION OF THE STUDIES (I – VI) ......................................................................................... 34 
I. FELINE GUT MICROBIOTA COMPOSITION IN ASSOCIATION WITH FELINE 
CORONAVIRUS INFECTION ............................................................................................................. 35 
MATERIALS AND METHODS ....................................................................................................... 35 
Animals/Caseload .............................................................................................................. 35 
Sample collection .............................................................................................................. 35 
Screening Analyses ........................................................................................................... 36 
Microbiota Analyses ......................................................................................................... 38 
Statistical Analysis ............................................................................................................ 39 
RESULTS ........................................................................................................................................... 40 
Screening analyses ............................................................................................................ 40 
Microbiota analyses ........................................................................................................... 41 
DISCUSSION .................................................................................................................................... 45 
II.  REFERENCE INTERVALS FOR PARAOXONASE 1 (PON-1) ACTIVITY IN A HEALTHY 
FELINE POPULATION ........................................................................................................................ 48 
MATERIAL AND METHODS ......................................................................................................... 48 
Animals/Caseload .............................................................................................................. 48 
Measurement of PON-1 activity ....................................................................................... 48 
Statistical Analysis ............................................................................................................ 49 
RESULTS ........................................................................................................................................... 50 
2 
 
DISCUSSION .................................................................................................................................... 52 
III.  ROLE OF PARAOXONASE-1 (PON-1) AS A DIAGNOSTIC MARKER FOR FELINE 
INFECTIOUS PERITONITIS ............................................................................................................... 54 
MATERIALS AND METHODS ....................................................................................................... 54 
Animals/Caseload .............................................................................................................. 54 
Measurement of PON-1 activity ....................................................................................... 55 
Statistical Analysis ............................................................................................................ 55 
RESULTS ........................................................................................................................................... 56 
Difference in PON-1 activity among HEALTHY, FIP and NON FIP .............................. 57 
Comparison between suspected FIP and confirmed FIP ................................................... 58 
Comparison between cats with wet FIP and cats with dry FIP ......................................... 60 
Comparison among NON FIP subgroups.......................................................................... 61 
Diagnostic performance of PON-1 .................................................................................... 62 
DISCUSSION .................................................................................................................................... 63 
IV.  DIAGNOSTIC PERFORMANCE OF RT-PCR COMPARED TO 
IMMUNOHISTOCHEMISTRY FOR THE DIAGNOSIS OF FELINE INFECTIOUS PERITONITIS
 68 
MATERIAL AND METHODS ......................................................................................................... 68 
Animals/Caseload .............................................................................................................. 68 
Tissues sampling ............................................................................................................... 69 
Histology and immunohistochemistry .............................................................................. 70 
FCoV RT-nPCR ................................................................................................................ 71 
Analyses of results ............................................................................................................ 71 
RESULTS ........................................................................................................................................... 72 
Histology ........................................................................................................................... 74 
Immunohistochemistry ...................................................................................................... 75 
RT-PCR ............................................................................................................................. 76 
Agreement among histology, immunohistochemistry and PCR ....................................... 76 
Diagnostic accuracy of immunohistochemistry and RT-PCR .......................................... 79 
DISCUSSION .................................................................................................................................... 80 
V. CANINE GUT MICROBIOTA COMPOSITION IN ASSOCIATION WITH LEISHMANIA 
INFANTUM ........................................................................................................................................... 85 
MATERIALS AND METHODS ....................................................................................................... 85 
Animals/Caseload .............................................................................................................. 85 
Sample collection .............................................................................................................. 86 
Screening analyses ............................................................................................................ 86 
Microbiota analyses ........................................................................................................... 87 
Statistical Analyses ........................................................................................................... 89 
RESULTS ........................................................................................................................................... 90 
3 
 
Screening analyses ............................................................................................................ 90 
Microbiota analysis ........................................................................................................... 92 
DISCUSSION .................................................................................................................................... 98 
VI. CORRELATION BETWEEN CANINE GUT MICROBIOTA COMPOSITION AND 
LEUKOCYTES CLASSES ASSESSED THROUGH FLOW CYTOMETRY IN ASSOCIATION 
WITH LEISHMANIA INFANTUM INFECTION .............................................................................. 101 
MATERIALS AND METHODS ..................................................................................................... 101 
Animal/Caseload and Microbiota Analyses .................................................................... 101 
Flow Cytometry Analyses ............................................................................................... 101 
Statistical Analysis .......................................................................................................... 103 
RESULTS ......................................................................................................................................... 103 
Comparison of percentages of leukocytes classes among three groups .......................... 104 
Comparison of the absolute number of leukocytes classes among three groups ............ 107 
Correlation between microbiota phyla and leukocyte classes ......................................... 109 
DISCUSSION .................................................................................................................................. 110 
CONCLUSIONS ..................................................................................................................................... 112 
REFERENCES ..................................................................................................................................... 116 
PUBLICATIONS ................................................................................................................................. 132 
INTERNATIONAL PEER REVIEWED PAPERS ......................................................................... 132 
ABSTRACTS ................................................................................................................................... 132 
ORAL PRESENTATION ................................................................................................................ 133 
CO-SUPERVISION OF DEGREE THESIS .................................................................................... 133 
  
4 
 
 
 
 
 
SCIENTIFIC BACKGROUND 
  
5 
 
GUT MICROBIOTA 
The intestinal microbiota is the consortium of all living microorganisms that inhabit the 
gastrointestinal (GI) tract. The whole amount of genes of microbiota is known as the 
“microbiome”, which is far more larger than the human genome (Adak et Khan, 2019). The insight 
into the complexity of the intestinal microbiota and its intimate relationship with the host has 
spurred researchers to better understand the importance of a balanced microbial ecosystem for the 
regulation of host health and immunity (Suchodolski, 2016). Indeed, microbiota plays different 
roles contributing to the digestion and energy harvest from feed, producing metabolites pivotal for 
enterocytes nutrition, acting as a physical barrier against pathogens and shaping and interact with 
the immune system (Neish, 2009). 
 
METHODS FOR THE INVESTIGATION OF GUT MICROBIOTA 
There are two main methods that could be used to study microbiota, that are culture-dependent 
and culture-independent methods.  
Culture-dependent methods were firstly introduced in 1881 by Robert Koch, which was the father 
of the plating technique used to culture and identify microorganism. These methods are still largely 
used in microbiology; however, they detect only 30-50% of the totality of bacteria. There are two 
main issue: the first is related to the bacteria properties, indeed several bacteria requires specific 
environment condition to grow. On the other hand, the growth of predominant bacteria could mask 
the isolation of the less abundant one (Adak et Khan, 2019; Sarangi et al., 2019).  
Culture-independent methods include both sequencing and non-sequencing methods. The first 
ones relies on Sanger sequencing of the 16S rRNA (firstly introduced in 1970 by Carl Woese and 
colleagues) also known as “first generation sequencing”. This new insight allows to investigate 
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intestinal microbiota exploiting the conserved sequence of the hypervariable region V1-V9 in the 
small ribosomal subunit 16S rRNA (Figure 1). Since these techniques do not require bacterial 
culture, they allow to identify those microorganisms that do not grow well, besides the culturable 
ones. 
 
Figure 1. 16S ribosomal RNA gene showing the nine hypervariable regions (in brown colour) and constant regions 
(in blue) (Sarangi et al., 2019) 
The non-sequencing method rely on the identification of the hypervariable region too, which is 
highlighted through the use of electrophoresis based on fragment length or based on the presence 
of a specific nucleotide sequence (FISH-flow). However, these methods lack in resolution, because 
the differences are too small to be correctly identified. Moreover, the less abundant bacteria are 
generally missed (Sarangi et al., 2019). For these reasons, they have been replaced by sequencing 
techniques. Sequencing methods provide a reliable picture of the relative abundance of each 
bacterial group (Sarangi et al., 2019). Sanger was the first sequencing technique, but it was limited 
to the sequencing of one DNA strand at a time, so it was very expensive and time consuming 
(Costa et Weese, 2019).  Several techniques had been proposed during the years and in 2005 a 
high throughput sequencing technique was developed. This was also called next generation of 
sequencing (NGS) and relies on a bridge amplification that produced cluster of clonal populations 
which, thanks to fluorescent labelled deoxyribonucleotide, could be in turn identified (Metzker, 
2005; Nie et al., 2019). NGS technology provide an enormous amount of data that needs dedicated 
computational software tools to be analyzed (Sarangi et al., 2019). They are in continuous 
evolution and become more and more accurate during the years. Nowadays, the most used are 
Illumina MiSeq (250-300 base length reads, lower output) and Illumina HiSeq (150 base lengh 
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reads, higher output) (Sarangi et al., 2019). However, even PCR has some limitations: the detected 
genome could come from dead bacteria, moreover, due to the extreme sensitivity, it is extremely 
prone to error and contamination in clinical setting (Adak et Khan, 2019).  
Intestinal microbiota composition could be assessed on different specimens, for example tissue 
biopsies or stool. The first one gives a reliable picture of microbiota composition in association 
with the histologic appearance of the mucosal layer; however, it requires an endoscopic procedure, 
which is invasive and require, for small animals, general anaesthesia. Faecal sample, on the other 
hand, is more representative of the distal gut, but it is very easy to obtain. All the sample should 
be collected and stored in the same way and, ideally, processed simultaneously by the same 
laboratory, in order to decrease any batch effect (Sarangi et al., 2019).  
Independently on the type of study performed, the evaluation of microbiota usually starts with the 
assessment of alpha and beta diversity. Alpha diversity is an evaluation of the diversity into a 
single sample and it is usually represented through rarefaction curves, which express richness and 
diversity. Microbiota with more diverse communities will have a greater slope at the beginning of 
the curve, because for every sequence read, a new “microorganism” (Operational Taxonomic Unit) 
is found. Conversely, beta diversity is referred to the comparison between community or groups 
(Costa et Weese, 2019).  
 
HUMAN GUT MICROBIOTA 
The gastrointestinal tract is divided both functionally and anatomically in several compartment 
(stomach, small and large intestine) with different microenvironmental conditions that reflects in 
differences in the microbiota composition (Adak et Khan, 2019). Nevertheless, healthy human gut 
microbiota is composed by seven main phyla: Firmicutes, Bacteroidetes, Actinobacteria, 
Fusobacteria, Proteobacteria, Verrucomicrobia and Cyanobacteria (Bäckhed et al., 2005). 
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Bacteroidetes and Firmicutes together constitute over 90% of the total population (The Human 
Microbiome Project Consortium, 2012; Marchesi et al., 2016). Gut microbiota explains different 
roles in the human body. Firstly, a metabolic role, indeed large intestine microbiota, especially 
bacteria belonging to Firmicutes and Bacteroidetes phyla, own a large variety of genes encoding 
for the use of different polysaccharides as a source of energy (e.g. lignin or other oligosaccharides). 
The fermentation of dietary fibers results in the release of gas, small chain fatty acid (SCFAs), 
some organic acids (lactate and succinate) and alchools (methanol and ethanol) (Adak et Khan, 
2019). Specifically, SCFAs are absorbed in the colon and meet about 10% of caloric demand in 
people (McNeil, 1984). Bacteria influence also the protein catabolism into peptides and amino-
acids. Moreover, it seems that the sources of dietary protein could shape the microbiota 
composition (e.g. beef meat increase the population of Bacteroides and Clostridia, while pea and 
whey proteins enhance the growth of Bifidobacterium and Lactobacillus, suppressing the 
pathogenic Bacteroides fragilis and Clostridium perfringens) (Hentges et al., 1977; Swiatecka et 
al., 2011). For what concerns the lipid metabolism, a high-fat diet seems to induce microbial 
dysbiosis (with a decrease in Bacteroidetes and an increase in Firmicutes and Proteobacteria), to 
enhance adiposity and to sustain a low-grade inflammation in the adipose tissue (Murphy et al., 
2015). Although it is known that there is a correlation between gut microbiota and host health 
status, it is still unclear if dysbiosis could be a cause or an effect (Nie et al., 2019). 
Moreover, there is a relationship between gut microbiota and immunity. Indeed, the immune 
system is not fully developed at birth and appropriate microbial stimulation in early life has a 
strong effect on the immune system maturation. This has been demonstrated on sterile mice which 
showed a compromised intestinal and systemic immune system (Round et Mazmanian, 2009; Lee 
et Mazmanian, 2010; Kamada et al., 2013). In humans, cesarean born seems to have a greater 
chance to develop immune disorders in early life compared with those born naturally. The same is 
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reported also for infants treated with antibiotics (Bokulich et al., 2016; Kristensen et Henriksen, 
2016). In both these situations, a simpler microbiota composition has been found.  
It seems that gut microbiota could influence at different levels the defenses in the gastrointestinal 
tract. For example, it has been demonstrated that the intestinal mucous layer of two mice colonies 
with different bacterial composition are quite different too in terms of penetrability to bacteria, 
indicating that the intestinal microbiota plays a role in the formation of the mucous layer 
(Jakobsson et al., 2015). Moreover, bacteria gut colonization enhances the mucosa immunity 
tolerance by inducing the generation of regulatory T cells (Treg) through specific metabolites or 
structural components. This mechanism is the basis of the symbiotic relationship between bacteria 
and host (Nie et al., 2019). 
 
MICROBIOTA AND DYSBIOSIS 
Due to the relationship with innate immunity and the ability to trigger Treg and T helper (Th) 
lymphocytes (Gosalbes et a., 2011), it seems that gut microbiota could also play a role in the 
development of autoimmune diseases.  
For example, during Inflammatory Bowel Disease (IBD), especially Crohn’s disease, the presence 
of a complicated genetic background causes an abnormal immune response and a damaged 
intestinal epithelial barrier. It seems that, both in mice and people, there is an expansion of IgA-
coated bacteria with a positive correlation with the colitis-causing capability (Palme et al., 2014; 
De Souza et al., 2017).  
The relationship between the host immune response and the microbiota occurs not only in the 
intestine, but it seems to extend also to other organs (Nie et al., 2019) (Figure 2) 
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Figure 2. Schematic representation of the systematic immune effect of intestinal microbiota (Nie et al., 2019) 
The role of gut microbiota has been studied also in other autoimmune disorder such as type 1 
diabetes (Wen et al., 2008), multiple sclerosis, arthritis and in other metabolic disorders in which 
obesity could be a predisposing factor (cardiovascular disease, type 2 diabetes). In all these studies 
significant differences in the gut microbiota composition have been found with respect of the 
healthy control (Nie et al., 2019).  
For example, children affected by type 1 diabetes, showed a lower Firmicutes/Bacteroidetes ratio, 
concurrently with an increase in Prevotella genera, a higher representation of Clostridum and a 
lower abundance of Lactobacillus and Bifidobacterium (Murri et al., 2013). It is also possible to 
observe in microbiota composition some early signs promoting the development of type 1 diabetes, 
before the actual production of autoantibodies, particularly with the expansion of pro-
inflammatory microorganisms (Alkanani et al., 2015).  
The relationship between obesity and gut microbiota has been of great interest. Several studies 
confirmed the presence of an altered microbiota composition of obese subject compared to the 
lean one (both in mice and in people), with a higher Firmicutes/Bacteroidetes ratio and a simpler 
11 
 
microbiota composition (Ley et al., 2006; Turnbaugh et al., 2009). Moreover, with fecal 
transplantation, it has been demonstrated that the obese phenotype associated with a concurrent 
peculiar metabolism, could be transferred from an obese mouse to a germ-free mouse, through 
fecal microbiota transplantation (Nie et al., 2019).  
Finally, gut microbiota seems to be also involved in carcinogenesis, particularly in colorectal 
cancer and liver cancer in people. Indeed, colorectal cancer patients show a higher abundance of 
B. fragilis and other opportunistic pathogens, while butyrate-producer bacteria are reduced (Wang 
et al., 2012). These changes seem to be present before the precancerous lesions progress to invasive 
cancer (Dejea et al., 2018).  
The use of microbiota analyses in the diagnosis of a disease is still controversial, because it requires 
a sampling in a specific site (according to the location of the lesion) being stool sampling, even 
though not invasive, not always providing the best results (Nie et al., 2019). Some changes in the 
intestinal microbiota could occur before the onset of tissue damage or clinical signs of a disease, 
but to obtain this information there is a need for longitudinal monitoring of genetically predisposed 
population (for example as for type 1 diabetes) (Kostic et al., 2015). Moreover, alterations in gut 
microbiota are not taxonomically uniform and could be influenced by diet or other environmental 
factors (Nie et al., 2019). So, to date, changes in gut microbiota composition are mostly indicators 
of an unhealthy state, more than a specific disease (Duvallet et al., 2017).  
Several studies investigate the exact relationship between immune response to viral systemic 
diseases and microbiota. For example, type I interferon (IFN) response is demonstrated to be 
decreased in antibiotic-treated mice, both locally and at distal non-gastrointestinal site. 
Specifically, the expression of IFN and other pro-inflammatory cytokines such as TNF-α and IL-
6 is decreased, as well as the ability of macrophages and dendritic cells to respond to IFN-γ, 
lipopolysaccharides (LPS) or different virus infections (Ito et al., 1976; Abt et al., 2012). 
12 
 
Moreover, the decrease in type I IFN response is associated with an increase in virus titers and/or 
enhanced susceptibility of mice to lethal infection (Winkler et Thackray, 2019). Finally, the 
commensal microbiota plays a pivotal role in the development of secondary lymphoid tissues and 
the differentiation, maturation and function of CD4+ and CD8+ T lymphocytes, Treg, Th17 cells 
and B lymphocytes (Winkler et Thackray, 2019), even though the exact mechanism is still not 
clear.   
The importance of microbiota for the host is highlighted by altered immune responses that have 
been recorded in several studies carried out on germ-free mice: in the absence of commensal 
bacteria both systemic and gut-associated lymphoid tissues (GALT) were less developed. 
Moreover, these subjects had a reduced number of T and B lymphocytes and a dysregulation of 
Th1/Th2 balance. These studies clearly indicate an important reciprocal regulation between 
intestinal microbiota and T cell development (Williams et al., 2006; Round et Mazmanian, 2009; 
Lopes et al., 2016).  
 
GUT MICROBIOTA IN VETERINARY MEDICINE 
Due to the increasing interest in gut microbiota in human medicine, the number of veterinary 
studies focused on the microbiota analyses in pets has dramatically increase.  
Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria are the most represented phyla 
(99% of all the gut microbiota) both in dogs and cats (Handl et al., 2011).  
Consistent changing in diet has been demonstrated to play a pivotal role in the microbiota 
composition of dogs. Specifically, there is a significant difference between commercial diets, 
enriched in fibers and carbohydrates, and BARF (Biologically Appropriate Raw Food), typically 
containing more animal proteins and fat: dogs fed with commercial diets usually show a lower 
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abundance of Bacteroidetes and Fusobacteria and a higher proportion of Firmicutes (Schmidt et 
al., 2018; Alessandri et al., 2019).  
Most of the veterinary literature investigates variations of gut microbiota in association with 
dysbiosis (with different underlying causes). The word dysbiosis is referred to an alteration in the 
composition and/or in richness of the intestinal microbiota (Suchodolski, 2016) and it has been 
associated with various gastrointestinal disorders (e.g. acute diarrhea, IBD) (Suchodolski et al., 
2012a; Zheng et al., 2018) but also with an inflammatory status in general. More specifically, it 
seems that during IBD, both dogs and people showed a decrease in relative abundance of 
Fusobacteria; while during episodes of acute diarrhea there is an increase in Proteobacteria and a 
decrease in Bacteroidetes (specifically those members producing SCFA, important for intestinal 
health) and Firmicutes both in small intestine and fecal sample. This demonstrate that despite the 
differences in the microbial composition in the different GI tract, dysbiosis in the small intestine 
could still be identified in fecal samples that actually were considered as an appropriate reflection 
of the distal intestinal tract (Suchodolski et al., 2012b).   
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FELINE INFECTIOUS PERITONITIS  
 
EPIDEMIOLOGY AND ETIOLOGY 
Feline infectious peritonitis is a severe and usually fatal disease that affects mostly young cats, 
especially those that live in a multi-cat environment. It has been observed firstly in the late 1950s 
and the causative agent is a Coronavirus (Pedersen, 2009). It is an enveloped, positive, single 
strand RNA virus and its genome consist of 11 open reading frames (ORFs) encoding for both 
structural and non-structural proteins, together with some accessory proteins. The first group 
include four protein: spike (S), nucleocapsid (N), membrane (M) and envelope (E), while the latter 
is related with viral replicase (Kipar et Meli, 2014). Among all these proteins, S protein, arranged 
in peplomers, plays a pivotal role in entering target host cells (Bosch et al., 2003). Due to its RNA 
genome, as other Coronaviruses, it is prone to high error rates during its replication, with the 
consequent formation of different quasispecies. Feline Coronavirus (FCoV) exists in two 
antigenically different serotype: type I, ubiquitous and difficult to grow in cell culture, and type II, 
which is a recombination of type I with canine Coronavirus (CCoV), mostly diffused in Asia and 
that grow easily in cell cultures (Pedersen et al., 1984; Herrewegh et al., 1998). Moreover, both 
serotypes could occur in two different pathotypes or biotypes: feline enteric coronavirus (FECV) 
and feline infectious peritonitis virus (FIPV), that can not be distinguished each other 
serologically, nor morphologically (Kipar and Meli, 2014). Even though both of them could spread 
systemically through monocyte-associated viremia, only FIPV is capable to cause FIP (Kipar et 
al., 2006a).  
Despite the extremely high prevalence of FCoV infection (over 90% in multi-cat environments 
such as shelters), FIP morbidity is low (about 5%) (Pedersen, 2009; Drechsler et al., 2011). FIP 
affect most frequently young cats (younger than 2 years). Some purebreds (Abyssinian, Bengals, 
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Birmans, Himalayans, Ragdoll and Rex cats) and male intact cats seems to have a higher 
predisposition (Pesteanu-Somogyi et al., 2006) to the infection. After a fecal-oral transmission, 
FCoV firstly replicates inside the enterocytes, so cats could become shedders for the virus for a 
long time (persistent carriers represented by 13% of cats), or be re-infected with the same or a 
different strain of the virus itself, even in absence of any clinical signs (Addie et Jarrett, 2001; 
Kipar et Meli, 2014). 
 
PATHOGENESIS 
Even if not completely clear, it seems that FIP relies on the presence of a systemic infection with 
the virulent pathotype of FCoV (FIPV) associated with both viral replication inside blood 
monocyte/macrophages and an activation of these cells. Cats show individual differences in 
monocyte susceptibility to infection, highlighting that host factors play a role in the infection too 
(Kipar et Meli, 2014). Even though both FECV and FIPV could replicate inside blood monocytes, 
the viral load is usually higher during FIPV infection (Kipar et al., 2006a). It has been suggested 
that blood monocytes could be the site in which FECV to FIPV mutation occurs, allowing a viral 
adaptation to replication in monocyte/macrophages. The presence of FIPV infection induce a 
generalized monocytes/macrophages activation, that, in turn, produce several pro inflammatory 
cytokines (TNFα and IL-1β), adhesion molecules (CD18) and enzymes (metalloproteinase-9) that 
allows the interaction with endothelial cells, causing a granulomatous phlebitis, which is the 
typical lesion of FIP (Kipar et Meli, 2014). Several attempts had been made to investigate the role 
of host immunity in the development of FIP. FCoV infection, regardless of the pathotype, starts 
with a humoral response and the consequent increases in the antibody titer against the virus (Vogel 
et al., 2010). For what concerns specifically FIPV infection, it is thought that the cell mediated 
immunity is protective, while antibodies, even in presence of high titers, are not enough to 
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eliminate the virus (Kipar et Meli, 2014). Indeed, through a still not clear mechanism, FIPV 
inhibits the complement-mediated lysis of infected monocyte, even in presence of viral antigen on 
their surface (Cornelissen et al., 2009). For what concerns lymphocyte populations, while healthy 
FCoV-infected cats show a lymphoid follicular hyperplasia, FIP affected cats are usually 
lymphopenic both in blood and in lymphoid organs, with a decrease in circulating CD4+ and CD8+ 
T-cells and a depletion in natural killer cells, that causes a reduced ability to contain the 
inflammatory process (de Groot-Mijnes et al., 2005; Vermeulen et al., 2013). An experimental 
study evaluated the role of cytokines in FIP infection and results show that IL-10, which decreases 
macrophage activation and increases cytotoxic immune response, limits the viral infection. On the 
other hand, a lack of IL-12 decreases the efficacy of a protective immunity, allowing monocyte 
activation and the development of the clinical disease (Kipar et al., 2006b). The 
immunopathogenic mechanism underlying the development of FIP it is thought to be an immune-
complexes mediated type III hypersensitivity, even if FIP does not show all the typical features of 
an immune mediated vasculitis (such as the involvement of arteries and the main presence of 
neutrophils) (Pedersen et Boyle, 1980; Kipar et al., 2005).  
The immune response has a pivotal role not only in the protection against FIP, but also in the 
development of different clinical presentations. Indeed, a strong humoral response lead to the 
effusive form of the disease, due to the huge amount of circulating immune complexes, while a 
weak non-protective cell mediated immunity is usually associated with a non-effusive presentation 
(Pedersen, 2009).  
Finally, environmental factors and particularly stressors, such as overcrowding or surgery, seems 
to play a role as a trigger for the disease (Tasker, 2018).  
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CLINICAL SIGNS AND PATHOLOGICAL FINDINGS 
Clinical features of FIP could be very variable due to both the form (effusive or not) and to the 
target organs, but all of them are caused by a vasculopathy (Tasker, 2018). In most of the cases, 
there is an overlap between effusive (wet) and non-effusive (dry) forms (Pedersen, 2009; Kipar et 
Meli, 2014). Fever unresponsive to treatments, anorexia, weight loss and jaundice are some of the 
most common, even if very unspecific, clinical signs (Addie et al., 2009). In the wet form, clinical 
signs are strictly dependent on the effusion site: abdominal enlargement, dyspnoea, lethargy or, 
rarely, scrotal enlargement (with effusions respectively in abdomen, thorax, pericardium or 
scrotum). Generally, the effusive form has a rapid and fatal progression. Pyogranulomatous 
lesions, typical of the dry form, could affect different organs leading possibly to: nephromegaly, 
diarrhoea or vomiting, lymph node enlargement, uveitis or neurological signs (Addie et al, 2009). 
The clinical course of the non-effusive form could last for several weeks or months (Pedersen, 
2009).  
During the necropsy, the main feature of FIP is a fibrinous-granulomatous serositis. Sometimes 
granulomas can be so small that only histological examination could identify them. 
 
DIAGNOSIS 
Obtaining a definitive diagnosis of FIP is quite a challenge and could be achieved only through 
the evidence of the coronavirus highlighted with immunohistochemistry (IHC), inside the typical 
histopathological lesions on biopsies (Pedersen 2014; Kipar et Meli, 2014; Tasker 2018).  
However, in the absence of a definitive diagnosis, it is still possible to obtain a high index of 
suspicion of FIP. As already state above, signalment and clinical observation is the starting point 
of a FIP suspicion.  
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Haematology is usually unspecific and the most common findings are lymphopenia (49.5 – 77%) 
with neutrophilia (39 – 57%) and a mild normocytic to microcytic normochromic anaemia (37 – 
54%) (Riemer et al., 2016). However, it should be kept in mind that some atypical presentation 
may occur (for example in association with immune-mediated haemolytic anaemia) (Norris et al., 
2005). 
Clinical biochemistry may show some abnormalities that could support FIP suspicion even if none 
of them is sufficiently specific for the disease. For example, hyperglobulinemia (89% of cases) 
and hypoalbuminemia (near to 65%), together with an overall hyperproteinaemia (which however 
not always occurs) (Riemer et al., 2016). To evaluate the globulin classes, a serum protein 
electrophoresis is needed: usually there is an increase in α2 and γ-globulins, even though in the 
last few years the typical pattern became less common (Stranieri et al., 2017a). In literature is 
reported that an albumin:globulin ratio lower than 0.4 is very suggestive of FIP (Tasker et al., 
2018). Other common biochemical findings are represented by hyperbilirubinemia (21 - 36%), 
without a significant increase of hepatic enzymes.  
Alpha-1-acid glycoprotein (AGP) is a positive acute phase protein which significantly increases 
in cats affect by FIP. If values higher than 0.5 mg/mL are not specific for FIP, an AGP higher than 
1.5 mg/mL is quite accurate for the disease (Duthie et al., 1997; Giori et al., 2011; Hazuchova et 
al., 2017). Depending on pre-test probability, higher value could be needed to “confirm” the 
disease, especially in cats with a low pre-test probability (Paltrinieri et al., 2007). Two years ago, 
the only validated kit for determining the serum concentration of AGP was retired from commerce. 
The role of other feline acute phase protein as diagnostic marker for FIP, such as serum amyloid 
A, has been investigated, but resulted non sufficiently specific. For this reason, new biomarkers 
such as paraoxonase-1 have been investigated for diagnostic purposes (see below). 
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For what concerns serology, even though it seems that FIP affected cats usually had higher 
antibody anti-FCoV titers, there is still some overlapping with non-affected cats. So, serology is 
of limited use in clinical practice for the diagnosis of FIP. Moreover, healthy cats living in multi-
cat environment may have high antibody titers and, on the other hand, 10% of FIP affected cats 
are seronegative (Addie et al., 2009) due to the presence of immune-complexes that lower the 
concentration of circulating antibodies. These results further decrease its usefulness. 
In the wet form of the disease, the analyses of effusion is very helpful. FIP effusion is usually 
yellow, clear, viscous and protein rich ([total protein] > 33 g/L). Albumin to globulin ratio, 
electrophoretic profile and AGP concentration are similar to those of the serum. The cellular 
component is generally, but not always, scarce and represented mainly by macrophages, non-
degenerated neutrophils and a low number of lymphocytes. Cytological examination highlights 
the presence of a typical eosinophilic granular proteinaceous background (Tasker, 2018). Some 
test could identify the coronavirus inside the sample effusion, such as PCR or 
immunocytochemistry, even though it is not possible to differentiate between enteric and FIP virus 
(Felten et al., 2017a, 2017b). Finally, on effusion samples, the Rivalta’s test could be performed. 
This is a rapid and inexpensive test which is not specific for FIP but resulted generally positive 
during this disease. A drop of effusion is added to a solution of distilled water and acetic acid: a 
positive result is obtained when the drop does not dissolve inside the solution, but, conversely, 
could be clearly identify as a firm clot, and it is helpful to differentiate a transudate from an exudate 
(Fischer et al., 2013). Particularly in FIP effusions, this is due to the high concentration of high 
molecular weight proteins which clot in contact with the acetic acid. Rivalta’s test provides a 
qualitative finding, but a quantitative result, based on the same principle, could be obtained 
evaluating the Δ total nucleated cells (ΔTNC) using the automated haematology analyser Sysmex 
XT-2000iV. Specifically, a value of ΔTNC higher than 1.7 strongly enhances the probability to 
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diagnose FIP and the specificity maximizes with values higher than 2.5 (Giordano et al., 2015; 
Stranieri et al., 2017b).  
In cats presenting neurological signs, an evaluation of cerebrospinal fluid (CSF) could reveal an 
increase in the protein content (>0.3 g/L from cisternal puncture samples and >0.46 from lumbar 
sample) and/or in cell count (8x106 cells/L), even though sometimes it could be unremarkable. 
When present, cells are mainly represented by neutrophils and macrophages. Nevertheless, CSF 
may be useful for PCR evaluation, with some limitation here below reported (Crawford et al., 
2017).  
RT-PCR is used to identify FCoV but it is not specific for FIPV (neither are the PCR targeting the 
specific mutation of the Spike gene, since it is just a marker of systemic diffusion of the 
coronavirus and not specific for the identification of FIPV). PCR could be performed on any kind 
of specimens, including blood, tissues, effusions, CSF or aqueous humour. Tissue samples should 
not be stored in formalin, since it degrades RNA, decreasing PCR sensitivity (Tasker, 2018).  
On tissue biopsies it is possible to perform histopathology in order to find the typical lesions. 
Moreover, on the same sample, it is advisable to perform an immunostaining 
(immunohistochemistry – IHC) using anti-FCoV antibodies, in order to confirm the diagnosis 
(Tasker, 2018). Immunostaining could be performed, as immunocytochemistry, also on effusions 
(sensitivity 57 -100%) or CSF (Ives et al., 2013; Felten et al., 2017a). 
 
Paraoxonase-1  
Paraoxonase-1 (PON-1) belongs to a group of enzymes (paraoxonases) capable to metabolize the 
organophosphate paraoxon. PON-1 is a glycoprotein, synthetized by liver, that circulates in the 
blood stream associated with HDL particles, specifically the apolipoprotein-1 (Furlong et al., 
2016; Shunmoogam et al., 2018). During inflammation, especially when associated with a marked 
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oxidative stress, the HDL particles loses the apolipoprotein-1 and many associated enzymes, 
including PON-1, that are replaced by serum amyloid A and ceruloplasmin (Khovidhunkit et al., 
2004). Moreover, liver production of PON-1 during inflammation is inhibited. For this reasons, 
PON-1 acts as a negative acute phase reactant, with PON-1 activity decreasing during strong 
inflammation in people and in several animal species (Giordano et al., 2013; Rossi et al., 2013). 
Cats seem to be more prone than other species to the oxidative stress damage. A recent work  has 
demonstrated the intimate relationship between inflammation and oxidative stress during FIP 
(Tecles et al., 2015). Further studies are required to investigate the role of PON-1 as a biomarker 
for FIP diagnosis.   
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CANINE LEISHMANIASIS 
 
EPIDEMIOLOGY AND ETIOLOGY 
Canine leishmaniasis is a systemic infectious zoonotic disease of dogs. It is caused by a protozoan 
named Leishmania and the most common species is Leishmania infantum (or, in the New World, 
Leishmania chagasi) (Paltrinieri et al., 2016). The canine species represents the definitive host for 
the parasite. It is transmitted by a phlebotomine sand fly, which acts as a vector, even though the 
transmission could be also transplacentar, transfusional and sexual (with a marginal 
epidemiological role) (Saridomichelakis, 2009). The disease distribution worldwide is influenced 
by the presence of this particular vector (Maroli et al., 2013). The parasite could be present in two 
different forms: amastigote (without a proper flagellum) and promastigote (with the flagellum). 
Specifically, females of sand fly ingest the amastigote form during the blood meal on infected 
dogs. The parasite repeatedly divides and the promastigotes mobile forms are subsequently 
inoculated in the host skin during the following blood meal. Here, the promastigotes are 
phagocytized by macrophages and then turn again into the amastigote form. The shift from 
amastigote to promastigote takes from 4 to 20 days, depending on Leishmania and vector species 
(Saridomichelakis, 2009). The vector is ubiquitous in most of the tropical, subtropical and 
Mediterranean regions and several species are involved in Leishmania transmission (in Italy the 
most common one is Phlebotomus perniciosus) (Ready, 2013). During the last year, due to an 
increase in the climate change the area of vector diffusion is changing (Ready, 2008). Moreover, 
the spread of the disease is enhanced by the animal movements and this also explain the reported 
cases of canine leishmaniasis in United Kingdom or United States, which are still not considered 
as endemic (Di Muccio et al., 2015).  
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PATHOGENESIS 
The development of the disease depends both on the protozoan features and the host immunity 
response (Paltrinieri et al., 2016). During the blood meal, the sandfly inoculates the promastigotes 
into the skin, where, due to the small vessel rupture, there is a draw of macrophages, neutrophils, 
dendritic cells and fibroblasts (de Menezes et al., 2016). Neutrophils act with their proteolytic 
enzymes and oxygen reactive species (ROS) and even though most of the promastigotes survive, 
the presence of neutrophils and their cytokine secretions, helps in recruiting more specialized 
immune cells such as macrophages, lymphocytes or dendritic cells. Parasites are then phagocytized 
into a parasitophorous vacuole by macrophages, where they can resist to the phagolysosomal 
digestion due to a defective production of nitric oxide (Brandonisio et al., 1996; Vouldoukis et al., 
1996) and survive inside these cells, spreading the infection (Engwerda et al., 2004). Depending 
on several factors, as reminded above, parasites may be eliminated directly in the skin (self-limited 
infection), may remain located in the skin and lymph nodes (asymptomatic infection) or they could 
spread systemically (both symptomatic or asymptomatic infection) depending on the resistance of 
the host (Saridomichelakis, 2014).  
The macrophages have also a pivotal role in presenting the parasite antigens to T cells through the 
major histocompatibility complex molecules. The activation of a cell-mediated immunity is 
mandatory for an efficient defence against Leishmania infection (Baneth, 2005). For this reason, 
T cell subsets have a crucial role in the host susceptibility (Saridomichelakis, 2009). In most of 
the studies CD4+ T helper lymphocytes in peripheral blood are decreased in susceptible dogs, as 
well as CD8+ T cells (even if there are some exception) (Pinelli et al., 1994; Pinelli et al., 1995; 
Reis et al., 2006). T helper cells could be classified into two classes depending upon the specific 
cytokines they secrete in response to antigenic stimulation. Th1 cells primarily produce interferon 
(IFN)- and interleukin (IL)-2, whereas Th2 cells produce IL-4, IL-5, IL-6, IL-10, and IL-13. For 
a long time, it has been thought that Th1 response would be protective, while Th2 activation is 
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correlated with susceptibility (Locksley et al, 1987) to canine leishmaniasis. However, this is not 
completely true, since it seems that both Th1 and Th2 responses are present in an infected dog, 
even though the former seems to be predominant in resistant dogs (Saridomichelakis, 2014). For 
what concerns the cytokine profiles, IL-2 and IFN-γ have been linked with resistance and Th-1 
profile (even though some results are controversial (Manna et al., 2006; Correa et al., 2007). On 
the other hand, IL-4 and IL-6 seem to be associated with a Th-2 profile (Santos-Gomes et al., 2002; 
de Lima et al., 2007). The total number of B lymphocyte in peripheral blood of susceptible dogs 
may be increased or normal due to the migration into target organs (Saridomichelakis, 2014). The 
activation of B lymphocytes is not protective against the parasite and results in an overproduction 
of immunoglobulins, generally IgG (Marinez-Moreno et al., 1993; Almeida et al., 2015; Cardoso 
et al., 2007). The antibody titer is usually positively associated with the presence and severity of 
clinical signs (da Costa et al., 2007). Indeed, the presence of antibodies causes the formation of 
immune-complexes that deposit in different sites and, in turn, enhance the inflammation with the 
complement activation, which is the real responsible for the clinical signs (Lopez et al., 1996).  
 
CLINICAL SIGNS AND PATHOLOGICAL FINDINGS 
Clinical signs of canine leishmaniasis could be quite heterogeneous based on the targeted organs. 
It is a chronic disease and the most common clinical features are cutaneous lesion, lymph nodes 
enlargement, anorexia, muscular atrophy, polyuria, polydipsia, ocular lesion, epistaxis, 
onycogryphosis, lameness, diarrhoea and vomiting (Solano-Gallego 2009; Koutinas et Koutinas, 
2014). However, as previously reminded, dogs infected may also present as asymptomatic.  
Skin lesions are very common and could be observed alone or together with other clinical signs. 
Moreover, they could present in a different range of patterns: most frequently there is an exfoliative 
dermatitis with the presence of dry white scales and dry coat, associated with periocular, ear or 
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nasal planum alopecia and sometimes erythema and hypopigmentation (Koutinas et Koutinas, 
2014). Histologically, it is possible to observe hyperkeratosis and follicular keratosis. On the bony 
prominences and foot pads it is not rare to observe an ulcerative dermatitis secondary to the local 
inflammatory process associated with vasculitis. Uncommon is the nodular, pustular or papular 
dermatitis. All these findings could be associated with secondary bacterial infection (piodermitis) 
mostly caused by Staphylococcus (Ciaramella et al., 1997; Saridomichelakis et Koutinas, 2014). 
Ocular lesions, usually signs of the systemic diffusion of the parasites, include several different 
presentations such as conjunctivitis, kerato- conjunctivitis sicca, blepharitis and uveitis (Di Pietro 
et al., 2016). Enlarged lymph nodes are not warm or painful and histologically it is possible to see 
a reactive lymphoid hyperplasia with macrophages containing amastigotes (Ciaramella et al., 
1997; Mylonakis et al., 2005). Polyuria and polydipsia are generally correlated with a severe renal 
damage, generally a glomerulonephritis due to immune-complexes deposition that could evolve in 
a tubular damage (Zatelli et al., 2003). The renal damage could be associated with proteinuria and 
since this is the first cause of death in dogs affected by leishmaniasis, it is mandatory to perform a 
correct staging according to IRIS guidelines (International Renal Interest Society Canine 
Guidelines, 2013). The musculo-skeletal system could be affected both for the deposition of 
immune-complexes and for the catabolic nature of this disease. Temporal muscle could be atrophic 
and there could also appear lethargy, asthenia and lameness. Common are also the polyarthritis 
that could be erosive or not and should be investigated with imaging (Ciaramella et al., 1997). 
The typical histopathological pattern is the presence of a granulomatous-pyogranulomatous 
inflammation associated with vasculitis. (Paltrinieri et al., 2016) 
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DIAGNOSIS 
There are several clinico-pathological abnormalities that could support the suspicion for 
Leishmania infection (Paltrinieri et al., 2016). Alterations in the complete blood cell count are 
usually unspecific, but the most common findings are anaemia and neutrophilia (that could be 
marked in case of secondary bacterial infection) (Nicolato et al., 2013), sometimes associated with 
lymphopenia or lymphocytosis. Anaemia is typically mild to moderate normocytic normochromic, 
related to the chronicity of the disease, even though there could be other underlying mechanisms 
such as, a reduced erythropoietin production due to renal failure, or a haemolytic component 
(Ciaramella et al., 1997; Nicolato et al., 2013). Finally, mild to moderate thrombocytopenia is 
quite frequent in dogs with leishmaniasis, even if in case of marked thrombocytopenia is advisable 
to exclude the presence of other concurrent vector-borne diseases (Paltrinieri et al., 2016). The 
finding od amastigotes in the peripheral blood smear is very uncommon (<0.5%) (Giudice et 
Passantino, 2011). For what concern the serum biochemical evaluation, since the kidney is one of 
the most frequently affected organs, it is very common to find increased creatinine and urea (or 
BUN), as well as phosphorous, while serum albumin, in case of a severe protein-losing 
nephropathy, could be lower than the range of normality. Moreover, albumin could decrease also 
due to its role as a negative acute phase protein, which tend to decrease during inflammation.  
Biomarkers of hepatobiliary and pancreatic dysfunction could be increased, as well as CK (creatine 
kinase) and LDH (lactate dehydrogenase) enzymes related with the musculoskeletal system 
(Paltrinieri et al., 2016). Urinalysis is necessary to complete the renal function evaluation, as 
suggested by the IRIS guidelines (IRIS Canine Guidelines, 2013). In case of loss of renal function, 
urine specific gravity (USG) tends to decrease; the presence of glucose in urine without concurrent 
hyperglycaemia in serum, it is considered as a marker of tubular damage. Finally, it is necessary 
to assess the presence of proteinuria, since it is considered as a risk factor for the progression of 
nephropathy, possibly using a urine creatinine-to-protein ratio (UPC), more than just the dipstick 
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estimate, because UPC allows a quantification of the damage and it is also useful for the therapy 
monitoring (Jacob et al., 2005). Using SDS-page or SDS-age (Sodium dodecyl sulphate - 
polyacrylamide and agarose gel electrophoresis, respectively) it is also possible to evaluate the 
weight of proteins in the ultrafiltrate in order to state if the damage is mainly glomerular, tubular, 
or if it is a mixed form (Schultze et Jensen, 1998). Serum total proteins could be normal or 
increased, but generally there is a decrease in albumin, as already mentioned previously, associated 
with an increase in the concentration of globulins, resulting in a decreased albumin/globulin ratio. 
A serum protein electrophoresis is needed to investigate the different globulin fractions: generally, 
an increase in α2 and γ-globulins is observed, with a polyclonal arrangement. In these fractions 
migrate both acute phase proteins (α2-globulins) and immunoglobulin (γ-globulins). Occasionally, 
a peak in the β2 region could be observed, due to the presence of IgM and some acute phase 
proteins. The Leishmania induced gammopathy is usually polyclonal, although, rarely, 
monoclonal peaks have been described (Font et al., 1994). Finally, positive acute phase proteins 
(APPs) such as C reactive protein (CRP), haptoglobin (Hp), ceruloplasmin (Cp), serum amyloid 
A (SAA) and ferritin have been shown to increase in diseased dogs (Martinez-Subiela et al., 2002). 
On the other hand, albumin, transferrin and paraoxonase-1 (PON-1) decrease, since they are 
negative acute phase proteins (Ibba et al., 2015). Modifications in APPs concentration is not 
diagnostic but could be very useful as a monitoring tool for treatments and as prognostic factor 
(Rossi et al., 2014a).  
To confirm the diagnosis of leishmaniasis, both direct and indirect tests could be used (Paltrinieri 
et al., 2016). Direct tests are those that clearly identify the parasite, such as PCR and cytology. The 
most used PCR methods are conventional, nested and real-time (Reis et al., 2013). The last one is 
the only one that could give some quantitative information and, since it run in a closed system, it 
is less prone to contamination. Sensitivity and specificity may change according to the method and 
the target DNA sequence. PCR could be performed on any tissue or fluid; it could be run also on 
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peripheral blood and even though the sensitivity is lower, it is a less invasive sampling than tissue 
biopsies (Almeida et al., 2013). It should not be forgot that the presence of the parasite is related 
only with an infection and not with the clinical signs of the disease. Hence, the diagnosis should 
be supported by the presence of clinical signs or clinico-pathological abnormalities. Cytology is a 
simple and less expensive analyses that should always be performed at least in case of skin lesions, 
lymph nodes enlargement or the atypical presence of nodular lesions. The same evaluation could 
be performed also on fluid specimens such as joint fluids, effusions, CSF or on bone marrow 
smears. The detection of the amastigotes, both inside the macrophages cytoplasm or free on the 
background, associated with the clinical signs, is an evidence of the disease. The typical 
cytological pattern associated is characterized by macrophages and neutrophils, with a lower 
degree of lymphocytes and plasma cells (Paltrinieri et al., 2016).  
On the other hand, some indirect tests are available, highlighting the contact between the host and 
the parasite thanks to the presence of specific anti-Leishmania antibodies (Paltrinieri et al., 2016). 
The most commonly used techniques are based on immunofluorescence (IFAT), enzyme-linked 
immunosorbent assay (ELISA) and immunochromatography (ICT) (Solano-Gallego et al., 2014). 
The last one is the base for any rapid assay which are diffused for the in-clinic use, but it and 
provide only a qualitative result. Nevertheless, the specificity of rapid test is usually quite good, 
whereas the sensitivity is usually low (30-70%). The other assays give, on the contrary, a 
quantitative information. IFAT is considered as the reference method for anti-Leishmania serology 
in dogs and it has both sensitivity and specificity near to 100%, except for analyses done in some 
area of the new world where it may cross-react with Trypanosoma cruzii, giving some false 
positive results. However, IFAT is operator-dependent, so it is advisable to always monitor the 
patient in the same laboratory. ELISA, on the other hand, is easier to standardize since the results 
are read by a spectrophotometer and it is characterized by a good specificity and sensitivity too. 
Antibody titers are considered as high when they are four-fold higher than the laboratory threshold. 
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A lower value should be interpreted carefully in light of the clinical signs or of the presence of a 
possible vaccination that could sometimes interfere with the test. It should be remembered that the 
median time for seroconversion is around 5 months in natural conditions (Solano-Gallego et al., 
2014; Paltrinieri et al., 2016).   
Based on clinical signs and clinic-pathological data, dogs should be classified as (Paltrinieri et al., 
2016): 
- Exposed: clinically unremarkable, low-titer positive serology, but negative by PCR and/or 
cytology 
- Infected: clinically unremarkable, with normal haemato-chemistry, but a positive PCR 
and/or cytology  
- Sick: infected with clinical signs or clinic-pathological abnormalities  
- Severely sick: with severe chronic condition such as proteinuric nephropathy, chronic renal 
failure or other concurrent diseases. 
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AIMS OF THE PhD PROJECT 
The general aim of this thesis was to investigate the presence of possible correlation between gut 
microbiota and the presence of systemic infectious disease in dog and cats. Since it is known that 
microbiota could influence the development and shape the immunity system, in some cases the 
immunity status was evaluated too. The development of the diseases investigated along this project 
(feline infectious peritonitis and canine leishmaniasis in cats and dogs respectively) is known to 
be strictly correlated with the type of immune response mounted by the host, as described in the 
sections above. Moreover, for what concerns FIP, standing the difficulties in diagnosing the 
disease in vivo the performances of a new biomarker have been evaluated, as well as the correlation 
between different diagnostic techniques on tissues, in order to ease the enrolment and the 
appropriate grouping of cats in future studies. Specific aims and steps of the PhD project are listed 
here below. 
 
SPECIFIC AIMS 
I.  To compare the fecal microbiota composition, evaluated through next generation 
sequencing (NGS), of FCoV negative clinically healthy cats with that of FCoV positive clinically 
healthy cats and of cats with FIP. It is known that gut microbiota could shape the immune response 
and the development of feline infectious peritonitis has for sure a huge component in the host 
immune response. The availability of information on this topic would give new insight on the 
microbiota-immunity relationship and possibly on the mechanisms of susceptibility or resistance 
to the disease. 
II.  To determine the reference intervals of the paraoxonase-1 (PON-1) activity on a healthy 
feline population using a paraoxon-based method. This method was already validated in cats and 
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the presence of an established reference interval would allow any further hypothesis on its role as 
a biomarker for specific diseases.  
III.  To evaluate the potential of PON-1 as a diagnostic biomarker of FIP in a group of cats 
showing clinical signs consistent with the disease and enrolled regardless of the final diagnosis. 
Since oxidative stress has a pivotal role for the development of FIPV infection, so lower values of 
PON-1 activity in serum was expected in FIP affected cats.  Since in vivo diagnosis of FIP is still 
quite challenging, the availability of a marker supporting the clinical suspicion could be useful for 
future researches on this disease as well as for clinical purposes. 
IV. To evaluate the agreement among histology, immunohistochemistry and RT-PCR on 
different organs for the diagnosis of feline infectious peritonitis. The use of RT-PCR instead of 
histology and immunohistochemistry on biopsies would ease the organs investigation for the 
presence of the virus and possibly the in vivo diagnosis of this disease. As for PON-1, the 
availability of reliable in vivo assays will be useful for both clinical and research settings.  
V.   To compare the fecal microbiota composition evaluated through next generation 
sequencing (NGS) of healthy dogs with that of clinically healthy dogs exposed to Leishmania and 
of dogs with clinical leishmaniasis. The presence of clinical signs of leishmaniasis depends mostly 
on the host immune response. Microbiota seems to have a role in shaping the immune system. 
Results of this study would provide new insights on the microbiota-immunity relationship and 
eventually on the possible susceptibility to clinical leishmaniasis in dogs. 
VI.  To evaluate the leukocyte population, using flow cytometry, in peripheral blood of healthy 
dogs, clinically healthy dogs exposed to Leishmania and dogs with clinical leishmaniasis. 
Moreover, to correlate the results with the fecal microbiota composition evaluated through next 
generation sequencing (NGS) in order to evaluate the presence of possible significant association 
between microbiota composition and the immunity asset. The concurrent evaluation of immunity 
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and microbiota could highlight relationship that would help in better define possible aspects of 
susceptibility for clinical leishmaniasis. 
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DESCRIPTION OF THE STUDIES (I – VI) 
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I. FELINE GUT MICROBIOTA COMPOSITION IN 
ASSOCIATION WITH FELINE CORONAVIRUS INFECTION 
 
MATERIALS AND METHODS 
Animals/Caseload 
Twenty-one cats, submitted for clinical examinations to both the Veterinary Teaching Hospital of 
our University and to private practitioners, were recruited.  
The inclusion criteria applied after the screening analyses, in order to reduce possible confounding 
factors, were: (1) Private owned cats living indoor. (2) No administration of antibiotics in the 
previous sixty days. (3) Negative serology for feline immunodeficiency virus (FIV) and feline 
leukemia virus (FeLV). (4) Age ≤2.5 years. (5) Availability of fresh feces (6) Absence of clinical 
signs (for inclusion in the groups of clinically healthy FCoV positive or negative cats)  or presence 
of clinical signs such as effusions or neurological signs and clinicopathological abnormalities 
consistent with FIP (Stranieri et al., 2018), followed by a post-mortem confirmation of diagnosis 
(for the inclusion in FIP group). (7) Fed with a similar diet based on dry and canned commercial 
food.  
 
Sample collection 
At admission, 2 mL of whole blood was collected from each cat by venipuncture of the jugular 
vein: 1 mL was transferred into an EDTA tube and 1 mL into a plain tube (Venoject, Terumo Italia 
Srl, Rome, Italy). When effusion was present, it was sampled by ultrasound-guided drainage and 
stored in EDTA tubes. According to the standard operating procedures of our laboratory whole 
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blood and effusion were analyzed within 12-18 hours from the sampling. From each animal, a 
fresh fecal sample (at least 15 g) was collected and immediately stored, frozen at -20°.  
The FIP cats, due to the severe course of the disease, were humanly euthanized, after owner’s 
consent. A complete necropsy followed by routine histology and immunohistochemistry and RT-
PCR for Feline Coronavirus was performed. Immunohistochemistry and RT-PCR were performed 
on tissue biopsies from liver, spleen, mesenteric lymph node, intestine, kidney and lung and, in 
cats with neurological signs also on brain and cerebellum, in order to confirm the clinical suspicion 
of FIP. In one case, since the owner declined the necropsy, the diagnosis of FIP was confirmed 
using immunocytochemistry on the effusion sample. The samples had been collected for 
diagnostic purposes by referring veterinarians according to standard veterinary procedures. 
Therefore, according to the decision of the Ethical Committee of the University of Milan, residual 
aliquots of samples or tissues collected under informed consent of the owners can be used for 
research purposes without any additional formal request of authorization to the Ethical Committee 
(EC decision 29 Oct 2012, renewed with the protocol n° 02-2016). 
 
Screening Analyses 
The purpose of clinicopathological tests was to confirm the absence of subclinical changes in 
healthy cats and to evaluate the clinical status of those affected by FIP. A complete blood cell 
count was performed on whole blood in EDTA using the Sysmex XT-2000iV hematology laser 
analyzer (Sysmex Corporation, Kobe, Japan), along with a blood smear evaluation. Serum samples 
were obtained by centrifugation (3750 rpm x 5min) of blood collected in plain tubes and used to 
run a panel of routine biochemical tests (including urea, creatinine, total bilirubin, total protein, 
albumin, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase) with an 
automated spectrophotometer (RX Daytona, Randox Laboratories, Crumlin, United Kingdom), 
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using reagents provided by the manufacturer. A rapid serological test for FIV and FeLV was 
performed on serum with a lateral flow ELISA kit (SNAP FIV/FeLV Combo Test, IDEXX 
Veterinary Diagnostic, Hoofddorp, Netherlands). 
Additional laboratory tests were performed for cats suspected of FIP, to further support the clinical 
diagnosis of the disease (Pedersen, 2014a; Tasker, 2018). Specifically, serum protein 
electrophoresis was performed on agarose gel using the automated analyzer Hydrasis (Sebia Italia, 
Bagno a Ripoli, Florence, Italy) and the specific manufacturer’s reagents (Hydragel 7/15 β1–β2, 
Sebia Italia), as previously reported (Stranieri et al., 2017). Based on the total protein 
concentration, measured with the biuret method, and on the percentages of the electrophoretic 
fractions, the concentration (g/L) of each electrophoretic fraction was calculated. Moreover, feline 
α-1-acid-glycoprotein (AGP) was measured on serum using a radial immunodiffusion (SRID) kit 
(Tridelta Development Ltd, Maynooth, Kildare, Ireland), following the manufacturer's instructions 
(Duthie et al., 1997; Paltrinieri et al., 2007; Hazuchova et al., 2017). When present, effusion was 
analyzed by measuring total protein concentration with a refractometer, and cell counts using the 
Sysmex XT-2000iV hematology laser analyzer mentioned above. A cytologic evaluation was also 
performed. Particular attention was given to ΔTNCC due to its high diagnostic accuracy for FIP-
related effusion (Giordano et al., 2015; Stranieri et al., 2017b). In two cases, due to the severe 
health conditions, it was not possible to perform an adequate blood sample for the screening 
analyses. However, a complete necropsy followed by tissue biopsies was performed in order to 
confirm the suspicion for FIP.  
For molecular testing, each frozen fecal specimen was diluted in 400 µL of PBS. The mixture was 
vortexed, incubated at 40 °C for 5 minutes and then centrifuged (5500 rpm × 4 min). The 
supernatant was transferred into a new sterile Eppendorf tube, incubated at 95 °C for 5 minutes 
and then centrifuged (11000 rpm x 1 min). RNA was extracted from the supernatant using a kit 
for viral RNA extraction (NucleoSpin® RNA Virus, Macherey-Nagel, Düren, Germany), 
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following manifacturer’s instructions. Amplification of a 177bp fragment of the conserved 3’ 
untranslated region (3’ UTR) using a nested RT-PCR was performed as previously described 
(Herrewegh et al., 1995). FCoV RNA was used as positive control and RNase-free water as 
negative control. RT-PCR amplicons were visualized under an ultraviolet transilluminator 
following electrophoresis through a 2% agarose, ethidium bromide stained gel. Based on the 
presence or absence of amplicons, samples were considered as positive or negative for FCoV, 
respectively. 
For immunohistochemistry, the biopsy samples were fixed in 10% isosmotic formalin. The 
samples were processed as already described in other studies (Zini et al., 2018). The primary 
antibody, manually added by an operator, was a mice monoclonal antibody against FCoV (clone 
FIPV3-70 Serotec, Oxfork UK). The immunocytochemistry was performed only on one sample 
using a similar procedure, except for the antigen unmasking step. 
 
Microbiota Analyses 
Microbiota analyses were outsourced to an external laboratory. Investigation of microbial 
communities (Metabarcoding analyses) in each frozen fecal sample was performed by amplicon 
sequencing of a hypervariable genomic region (V3-V4 region 16SrRNA gene amplification) using 
an NGS approach on Illumina Platform. Total DNA was extracted from each fecal sample using a 
commercial kit (QIAamp DNA Stool Mini Kit, QIAGEN S.r.l. Milan, Italy).The quality of the 
genomic DNA was verified using a 2200 TapeStation DNA Screen Tape device (Agilent, Santa 
Clara, CA, USA) and an ND-1000 spectrophotometer (NanoDrop, Wilmington, DE) and its 
concentration ascertained using a Qubit assay (Life Technologies). The DNA was normalized to 
5 ng/uL and then 2.5 uL was used for PCR amplification. Indexed NGS libraries were evaluated 
with the D1000 screen Tape (Agilent Tape Station 2200) and then quantified with ABI9700 qPCR 
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instrument using the KAPA Library Quantification Kit in triplicates, according to the 
manufacture’s protocol (Kapa Biosystems, Woburn, MA, USA). Five uL of the pooled library at 
a final concentration of 4 nM were used for sequencing using Illumina Miseq with a 250 Paired 
end-read sequencing module.  
 
Statistical Analysis 
Pre-processing steps were performed and the raw reads quality of the extracted sequences were 
checked (using FastQC v0.11.2). Reads were trimmed with Phred scale quality threshold of 19 
(which represent the probability of an incorrect base call) allowing the reads to be truncated after 
base quality drops below 18 (Phred scale). Reads IDs were edited 
(multiple_split_libraries_fastq.py, Qiime script) in order to be compatible for the following QIIME 
pipeline scripts. The 97% clustered Qiime formatted Greengenes v.13.8 reference database was 
used. Before the statistical analyses, alpha rarefaction and beta diversity were evaluated. Alpha 
rarefaction was an evaluation of within-sample diversity by species richness. A graphical alpha-
rarefaction plot has been created using Qiime pipeline. Beta diversity is an estimation of between-
sample diversity by microbial profile. A graphical representation has been calculated using Bray 
Curtis Qiime beta-diversity pipeline.  
Finally, statistical analyses were performed with "R" statistical software (R v3.2; packages edgeR 
v3.10.5, Robinson M.D., 2010 and Phyloseq v1.14.0. McMurdie et Holmes, 2013). Samples were 
assigned to groups relying on samples’ metadata and the Taxonomy table (genus level) was 
normalized. For each group of samples, a statistical analysis was performed using the edgeR 
ExactTest function, to generate a list of statistically relevant taxonomies that are differentially 
present among the conditions. Exact test specifications for differential expression between two 
groups of taxonomy tables was performed. It implements the exact test proposed by Robinson and 
40 
 
Smyth (Robinson et Smyth, 2008) for a difference in mean between two groups of random 
variables following a negative binomial distribution. 
Finally, comparison of different phyla, classes and orders relative abundance among groups, was 
performed using Analyse-it for Microsoft Excel. Specifically, a Kruskall-Wallis test was 
performed, followed, when statistically relevant results were found, by a Wilcoxon Mann-Whitney 
test, for the comparison between two groups. Statistical significance was set at P < 0.05  
 
RESULTS 
Screening analyses 
Based on the results of the screening analyses, after the application of inclusion criteria, 15 cats 
were selected and classified as follows: five healthy negative for FCoV PCR on feces (H group), 
five healthy positive for FCoV PCR on feces (COR group) and five affected by FIP, confirmed by 
post-mortem analyses (FIP group). Of the 15 animals enrolled, eight were female and seven were 
male. Breeds were quite variable, even though the domestic shorthair was the most represented 
(six cats), followed by two ragdolls, an exotic, a holy birman, a nowegian forest, a bobtail, a maine 
coon, a Scottish fold and a sphynx. Hematology and biochemistry, together with the clinical 
examination, were unremarkable for all the clinically healthy cats, regardless the FCoV positivity, 
while cats of the FIP group showed changes consistent with the disease (Table 1.1). 
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ID Hematology Biochemistry SPE AGP ΔTNCC IHC 
1F na  na  na   Na Na + 
2F Na Na na  na  Na + 
3F 
Microcytic 
hypochromic 
anemia 
↑total protein,  
↑bilirubin 
↓Albumin, ↑α2, β1, β2, 
γ globlulin 
4.86 21.0 + 
4F Mild leukopenia 
Mild 
azotemia,  
↑ALT 
↑ γ globulin 0.54 Na + 
5F Nr 
Mild 
azotemia,  
↑total protein,  
↑ALT 
↑bilirubin 
↓Albumin, ↑β2, γ 
globlulin 
2.0 7.70 +(ICC) 
Table 1.1. Clinicopathological abnormalities of cats belonging to the FIP group. Cats 1F and 2F were humanly 
euthanized in an external clinic due to the severe clinical conditions and subsequently referred to the University for 
necropsy. For this reason, no information regarding routine hematology and biochemistry were available for these 
animals. ID = identification number; SPE = serum protein electrophoresis; AGP = alpha-1-acid glycoprotein; ΔTNCC 
= delta total nucleated cell count; IHC = FIPV immunohistochemistry; nr = not relevant; na = not available; ALT = 
alanine aminotranferase; ICC = FIPV immunocytochemistry 
 
Microbiota analyses 
A total of 3,231,916 sequences, with an average of 215,461 sequences/sample (median 219,276, 
range 195,516.5 – 235,660.5) were of adequate quality and were subsequently analyzed. The 
alpha-diversity rarefaction curves did not reach a proper plateau for almost all the samples (Figure 
1.1). This means that the sequencing depth was enough to identify only the most abundant bacteria 
for each sample, excluding the rarest ones.  
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Figure 1.1. Alpha rarefaction for the entire caseload. Each sample is represented in a different colour. 
 
The evaluation of beta-diversity showed that the samples were not grouped perfectly by category. 
However, the COR group seemed to have a hybrid microbial composition, between the microbial 
composition of the H and the FIP groups (Figure 1.2).  
 
Figure 1.2. Beta diversity. Principal coordinates analyses of weighted distances. Proportions of variance explained 
by each principal coordinate axis is denoted in the corresponding axis label. In red cats belonging to healthy 
Coronavirus positive group (COR), in blue cats affected by FIP (FIP) and in orange healthy cats, negative for 
Coronavirus (H). 
According to the statistical analyses there were no taxa significantly linked to the different 
conditions (zero differential taxa found for FIP vs H, FIP vs COR, COR vs H.). However, it was 
possible in some cases, to identify specific pattern between groups or for single animals. Eleven 
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different phyla were identified, even if the majority was represented by six of them (Figure 1.3). 
Firmicutes was the main represented phylum, followed by Bacteroidetes, Actinobacteria and 
Proteobacteria. Nevertheless, COR group showed a major abundance of Firmicutes and minor of 
Bacteroidetes, compared to the other groups. This was also confirmed by the 
Bacteroidetes:Firmicutes ratio (0.9 in H group, 0.5 in FIP group and 0.1 in COR group; P = 0.13. 
If we compare COR group to H and FIP group taken together, the P value gets closer to the 
significance level p = 0.055). Even though the phylum relative abundance were not significantly 
different among the three groups, Bacteroides and Firmicutes were close to the significance level 
(P =0.13 and 0.08 respectively). 
 
Figure 1.3. Relative abundance of the predominant phyla in the fecal microbiota in the three groups (y-axis). Group 
of FIP affected cats (n =5), healthy coronavirus negative (n =5) and positive (n =5) on x-axis. Each colour 
corresponds to different phylum. 
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In the FIP group three cats shared a similar microbiota composition, while cat 1F showed a 
completely different composition and cat 2F showed a lower number of diverse phyla (Figure 
1.4).  
 
Figure 1.4. Relative abundance of the predominant phyla for each subject in the fecal microbiota. FIP affected cats 
(n =5), healthy coronavirus negative (n =5) and positive (n =5). Each colour corresponds to different phylum. 
The same pattern could also be observed in relative class abundance (Table 1.2). COR group had 
a major proportion of Erysipelothrichi and Clostridia and lower Bacteroidia with respect of the 
other two groups (P =0.05; 0.10 and 0.13 respectively). Again, cat 1F showed a completely 
different pattern of microbiota composition and cat 2F had a lower number of different classes 
(Figure 1.5). The same trend was observed also in relative order abundance. For family and genus, 
the great amount of data made impossible to observe any evident pattern. Lactobacillus presence 
was quite variable in healthy cats. However, in FIP group, they were present only in one cat (4F) 
which had a dry form of FIP. 
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Class (%) FIP (n =5)   COR (n =5)   H (n =5) 
Actinobacteria 0.0024   0.0007   0.0900 
Coriobacteriia 0.1024   0.0908   0.0624 
Bacteroidia 0.2948   0.1221   0.3795 
Bacilli 0.0002   0.0303   0.0105 
Clostridia 0.4988   0.5244   0.3677 
Erysipelotrichi 0.0055   0.1630   0.0367 
Fusobacteriia 0.0108   0.0018   0.0021 
Betaproteobacteria 0.0020   0.0017   0.0055 
Deltaproteobacteria 0.0014   0.0011   0.0006 
Epsilonproteobacteria 0.0011   0.0023   0.0061 
Gammaproteobacteria 0.0218   0.0135   0.0082 
Table 1.2. Median relative abundance of the most common classes in the fecal microbiota. 
 
Figure 1.5. Relative abundance of the predominant classes for each subject in the fecal microbiota. FIP affected cats 
(n =5), healthy coronavirus negative (n =5) and positive (n =5). Each colour corresponds to different class. 
 
DISCUSSION 
Until recently, traditional bacterial culture was commonly used to identify gut microbial 
population, but it is now recognized that the vast majority of intestinal microorganisms cannot be 
cultured using standard plating techniques (Suchodolski, 2016). In the last few years molecular 
methods, mostly targeting the small subunit ribosomal RNA gene (16S rRNA), have been used for 
identification of bacterial microbiota. This gene is ubiquitously present in all bacteria and archaea 
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and contains both conserved and variable sequence regions, enabling researchers to distinguish 
organisms at different phylogenetic levels. However, microbiota evaluation is tricky both in the 
execution and in the interpretation of results, and the use of next generation sequencing technique 
is quite expensive. For this reason, several studies involved a low number of animals (Desai et al., 
2009; Płoneczka-Janeczko et al., 2017; Schmid et al., 2018).  
This is the first study about the gut microbiota composition in cats with feline coronaviruses. Alpha 
rarefaction and beta diversity analyses are the most common and historically relevant statistics for 
metagenome studies aimed to determine easily and visually the presence of groups between 
samples. The alpha rarefaction aims to demonstrate that enough reads were sequenced for each 
sample for the main taxa identification. The beta diversity graphically represents the distance 
between microbiological communities from each sample. No differences in the fecal microbiota 
were observed among three groups (H, COR and FIP). However, despite the low number of 
animals, in several cases, P values were close to statistical significance. The analyses of a higher 
number of animals is needed to confirm the impact of systemic infection on the intestinal 
microbiota, as previously reported in people (Goedert, 2016). Moreover, the peculiar enteric 
tropism of FCoV could explain these results. Whether is the microbiota influenced by FCoV 
presence, or if certain animals with peculiar microbiota composition are predisposed to FCoV 
infection is unclear. In literature, only two studies investigated the correlation between coronaviral 
diseases and gut microbiota, specifically in swine transmissible gastro-enteritis caused by the 
Transmissible Gastro Enteritis virus (TGEV) (Koh et al., 2015; Liu et al., 2015). However, the 
results were not comparable with our findings because of the different pathogenic role of FCoV 
compared to TGEV, as FECV infection is usually asymptomatic, and because of the different diet 
and bacterial phylotypes observed in swine compared to cats.  
In contrast to what previously reported in cats (Weese et al., 2015), our caseload showed a low 
abundance of Proteobacteria. In humans, increase in Proteobacteria relative abundance is usually 
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associated with “dysbiosis” and gastrointestinal symptoms, such as, for example, diarrhea 
(Kaakoush et al., 2012; Suchodolski et al., 2012b; Shin et al., 2015). In our study, none of the cats 
had gastrointestinal disorders and this could explain the Proteobacteria lower abundance, together 
with the individual variability. Interestingly, in human a low Bacteroidetes to Firmicutes ratio in 
considered another marker od dysbiosis (Shin et al., 2015). In our study, the COR group showed 
a lower Bacteroidetes to Firmicutes ratio compared to the others. This could be related to the 
peculiar FCoV enteric tropism (stronger than in FIP cats), even if none of the animals showed 
signs of gastrointestinal disorders. This findings in COR group, could be a hint for an alteration in 
microbiota stability, even in absence of overt clinical signs.  
In the FIP group, two of the five cats enrolled showed a completely different microbiota 
composition compared to the others. Specifically, cat 2F showed a lower number of diverse phyla. 
Despite the possible individual variability, such a lack in microbiota diversity in the gut microbiota 
diversity has previously been reported in people treated with antibiotic (Modi et al., 2014). In our 
caseload, as this was an exclusion criterion, this low abundance may be associated with other 
variables (e.g. diet).  
Lactobacillus seem to have a probiotic activity, however, elevated concentration had been reported 
in systemic disorders, such as type II diabetes in people, thus making unclear their protective role 
(Sato et al., 2014). In the FIP group, Lactobacillus was only found in cat 4F, affected by a dry 
form of FIP. The meaning of this finding it is unclear. Besides, few studies have investigated this 
genus in cats, so it could be interesting to evaluate its presence in a larger number of animals, both 
healthy and diseased.  
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II.  REFERENCE INTERVALS FOR PARAOXONASE 1 (PON-1) 
ACTIVITY IN A HEALTHY FELINE POPULATION  
 
MATERIAL AND METHODS 
Animals/Caseload 
Serum samples were collected from client-owned cats admitted at our Institution for routine visits 
or for diagnostic purposes. Cats were considered clinically healthy based on the lack of clinical or 
laboratory abnormalities as determined by physical examination and a routine panel of laboratory 
tests (complete blood cell counts, spectrophotometric evaluation of creatinine, urea, glucose, 
alanine aminotransferase, alkaline phosphatase and total protein). Cats that had recent history of 
diseases or of pathophysiological conditions potentially affecting blood results (pregnancy, 
lactation, infections, etc.) or that received any medication or surgical treatments were excluded. 
Blood was collected from the cephalic or jugular vein and immediately transferred to plain tubes 
to obtain serum by centrifugation (2500g for 15 minutes). Serum samples were processed 
immediately, as described in following sections. Since blood was collected for diagnostic purposes 
and the owners signed an informed consent that authorizes the use of leftover sera for research 
purposes (after the diagnostic procedures), according to the regulations of our Institution (EC 
decision 02-2016) a formal approval from the Ethical Committee was not required.  
 
Measurement of PON-1 activity 
Serum PON-1 activity was measured using an automated spectrophotometer (Cobas Mira, Roche 
Diagnostic, Basel, Switzerland) using paraoxon (an organophosphate) as substrate to ensure that 
only PON-1 and no other enzymes were measured. The assay has been previously validated in 
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dogs (Rossi et al., 2014a) adapting the enzymatic method proposed by Feingold and colleagues 
(Feingold et al., 1998). The reaction buffer was prepared using glycine buffer (0.05 mM, pH 10.5) 
containing 1 mM of paraoxon-ethyl as a substrate (purity > 90%, Sigma-Aldrich, Missouri, USA) 
and 1 mM of CaCl2. The reaction was initiated with 6 µL of sample, 89 µL of distilled water, and 
100 µL of reaction buffer, at 37 °C. The rate of hydrolysis of paraoxon to p-nitrophenol was 
measured by monitoring the increase in absorbance at 504 nm using a molar extinction coefficient 
of 18,050 L/mol/cm-1. PON-1 activity was expressed as U/mL i.e. 1 nmol of p-nitrophenol formed 
per minute under the assay conditions. The same method was already validated also in cats (Rossi 
et al., 2014b). A single measurement of PON-1 activity was done. Results were used to determine 
the reference intervals according to the ASVCP guidelines (Friedrichs et al., 2012). 
 
Statistical Analysis 
Reference intervals were determined using an Excel (Excel; Microsoft Corp., USA) spreadsheet 
with the Reference Value Advisor (version 2.0) (Geffrè et al., 2011) that performs computations 
according to the IFCC-CLSI recommendations as suggested by the ASVCP guidelines (Friedrichs 
et al., 2012). Descriptive statistics, tests of normality according to the Anderson-Darling method 
with histograms and Q-Q plots, and Box-Cox transformation were calculated. Both the Dixon-
Reed and Tukey tests were used to identify outliers. Following the ASVCP guidelines, outliers 
that were considered “suspicious” by the software were retained. Conversely, far outliers were 
removed from the analyses. RIs were calculated using a nonparametric bootstrap method that also 
calculated the 90% CI of RIs. Results recorded in male vs female cats were compared to each other 
with a Mann-Whitney U test (using Analyse-it software Ltd, Leeds, UK), to assess whether it 
would be advisable to establish separate RIs for the partitioned groups. The possible age-related 
differences were investigated by linear regression using the Reference Value Advisor (version 2.0) 
macroinstructions mentioned above.   
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RESULTS 
A total of 71 cats were enrolled to establish the reference interval. Information about sex was 
available for 69 out of 71: 43 were male and 24 were female. For what concern the age: 25 cats 
were younger than 1 year, for 13 cats the age ranged between 1 and 2 years, while 33 cats were 
older than 2 years (up to 13 years old) (Table 2.1).  
Cats n° Breed Gender Age   Cats n° Breed Gender Age 
1 SPHYNX F 4 MM   36 RAGDOLL F 2,5 YY 
2 DSH M 3 YY   37 RAGDOLL M 4 YY 
3 MAINE COON MN 1 YY   38 RAGDOLL F 3 YY 
4 RAGDOLL M 8 MM   39 RAGDOLL M 8 YY 
5 RAGDOLL F 1 YY   40 RAGDOLL F 5 YY 
6  Nd nd  6 MM   41 RAGDOLL FS 1 YY 
7 DSH F 9 MM   42 RAGDOLL MN 2 YY 
8 DSH MN 7 YY   43 RAGDOLL F 10 YY 
9 MAINE COON M 4 YY   44 DSH M 1 YY 
10 DSH FS 2 YY   45 DSH FS 1 YY 
11 DSH MN 7 YY   46 DSH MN 1 YY 
12 DSH FS 8 YY   47 DSH FS 2 YY 
13 DSH MN 8 YY   48 DSH MN 3 YY 
14 DSH MN 4 YY   49 DSH MN 6 YY 
15 DSH MN 2 YY   50 DSH MN 1 YY 
16 DSH MN 8.8 YY   51 DSH MN 9 YY 
17 PERSIAN M 1,5 YY   52 DSH FS 2 YY 
18 RAGDOLL M 8 YY   53 DSH MN 1 YY 
19 DSH  MN 5 YY   54 MAINE COON M 7 YY 
20 RAGDOLL F 1 YY   55 DSH FS 1 YY 
21 RAGDOLL F 6 YY   56 SIBERIAN MN 3 YY 
22 RAGDOLL M 1,5 YY   57 DSH FS 1 YY 
23 RAGDOLL M 3 YY   58 DSH FS 8 YY 
24 RAGDOLL MN 7 YY   59 DSH M 1 YY 
25 RAGDOLL M 8 MM   60 DSH M 7 YY 
26 RAGDOLL F 9 YY   61 DSH M 1 YY 
27 RAGDOLL F 1,5 YY   62 DSH MN 13 YY 
28 RAGDOLL MN 7,5 YY   63 BSH M 4 MM 
29 RAGDOLL F 1,5 YY   64 SPHYNX M 2 YY 
30 RAGDOLL F 1 YY   65 DSH M 10 MM 
31 RAGDOLL MN 8 YY   66 DSH MN 8 MM 
32 RAGDOLL F 1 YY   67 SPHYNX M 2 YY 
33 RAGDOLL F 6 YY   68 DSH M 1 YY 
34 RAGDOLL F 2 YY   69 DSH M 10 YY 
35 RAGDOLL M 2,5 YY   70 nd  F 6 MM 
          71  nd nd  6 MM 
Table 2.1. Signalment of the cats enrolled for the establishment of reference interval of PON-1 activity. DSH: 
domestic shorthair; BSH: british shorthair; M: male; MN: male neutered; F: female; FS: female spayed; MM: months; 
YY: years 
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The reference interval determined in clinically healthy cats spans from 57.8 to 153.7 U/mL. Details 
about the determination of reference interval and about data distribution are reported in Table 2.2 
and summarized in Figure 2.1 in accordance with the ASVCP guidelines (Friedrichs et al., 2012).  
  Mean ± S.D. Median Min – Max Outlier 
Limitmin RI 
(90% CI) 
Limitmax RI 
(90% CI) 
Distr. Method 
PON-1 
U/mL 
(n =70) 
91,4 ± 23,0 86,8 
46,6 – 
174,1 
2 (S) 
1 (R) 
57,8  
(46,6 - 64,7) 
153,7  
(132,3 - 174,1) 
NG NP 
Table 2.2. Reference interval of Paraoxonase activity in a healthy cats population. PON-1: paraoxonasi-1; S.D.: 
standard deviation; RI: reference interval; CI: confidence interval; Distr.: distribution, NG: non gaussian, NP: non 
parametric 
 
Figure 2.1. Data distribution for the reference interval of the paraoxonase-1 activity in a healthy cat population (n = 
70). 
 
No significant age-related difference in PON-1 activity was revealed by linear regression analyses 
(P =0.822). Conversely, PON-1 activity was significantly higher in male than in female cats (P 
=0.025) (Table 2.3).  
PON-1 
U/mL 
Mean ± S.D. Median Min – Max Outlier 
Limitmin (RI) 
(90% CI) 
Limitmax (RI) 
(90% CI) 
Distr. Method 
F (n = 26) 84,6 ± 17,5 81,4 62 – 147,8 1 ( S ) 
62,9 
(59,5 67,6) 
137,7 
(110,2 - 210,9) 
NG NP 
M (n = 42) 96,3 ± 24,3 91,3 61,1 – 174,1 1 ( S ) 
61,3 
(61,1 - 66,3) 
171,6 
(136,6 - 174,1) 
NG NP 
Table 2.3. Reference interval of Paraoxonase activity in a healthy cats population, divided by gender. PON-1: 
paraoxonasi-1; F: female; M: male; S.D.: standard deviation; RI: reference interval; CI: confidence interval; Distr.: 
distribution, NG: non gaussian, NP: non parametric 
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However, the reference intervals calculated separately on male and female cats were largely 
overlapping to each other (61.3-171.6 U/mL in male, 62.9-137.7 U/mL in female) and, more 
importantly, the lower reference limit of male cats was very similar to that of female. 
 
DISCUSSION 
PON-1 hydrolyses a broad range of substrates, including esters, lactones, organophosphates, lipid 
peroxides and estrogen esters (Mackness et Mackness, 2015). Due to the lack of a “natural” 
substrate for PON-1, non-physiological substrates are used to measure PON-1 activity: paraoxon 
(paraoxonase activity), non-phosphorus arylesters (arylesterase activity) or lactones (lactonase 
activity) (Camps et al., 2009). The use of paraoxon as substrate was based on technical reasons as 
well as on previous publications. Phenylacetate (PA), p-nitrophenyl acetate (pNA) and 5-thiobutil 
butyrolactone (TBBL) have been previously validated in cats. However, despite paraoxon is more 
toxic than other substrates, it offers some advantages: the use of phenylacetate or TBBL is time 
consuming, since it can only be performed using manual methods or 96-well microplates and ultra-
violet wavelength; on the other hand, even though the measurement with p-nitrophenyl acetate can 
be automated, results in healthy cats are very low (median 3.45 U/mL) and it may be difficult to 
appreciate the decreased values expected for a negative APP such as PON-1 (Tecles et al., 2015).  
Paraoxon-based method provides results higher than other substrates, so it may be more useful in 
practice.  
Interestingly, reference intervals for PON-1 activity recorded in this study were lower than those 
reported for dogs (Rossi et al., 2014a) and humans (Tomas et al., 2000) and similar to those of 
cattle (Giordano et al., 2013) or horses (Ruggerone et al., 2018). The peculiar lipoprotein 
metabolism may explain the low PON-1 activity of cattle; however, it is surprising a similar 
finding in cats, metabolically more similar to dogs. The lack of significant age-related differences 
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seems to contrast with what reported in cattle (Giordano et al., 2013) and people (Furlong et al., 
2016). Nevertheless, these latter studies were focused on PON-1 activity in newborns, in which 
the biosynthetic ability of the liver is still incomplete. In the current study the youngest animals 
were already weaned and can be considered as “young adults”, with a PON-1 activity not 
significantly different from adults, as either in people or in horses (Furlong et al., 2016; Ruggerone 
et al., 2018). It is therefore possible that also newborn cats (not included in this study) may have a 
significantly lower PON-1 activity compared with adults. Conversely, the higher PON-1 activity 
recorded in male cats, contrasts with what reported in dogs, on which no significant sex-related 
differences were found (Rossi et al., 2014a), or in mice, cattle or horses, on which PON-1 activity 
is higher in females than in males (Bin al et al., 2003; Giordano et al., 2013; Ruggerone et al., 
2018). The sex-related differences recorded in this study may suggest that different RIs should be 
used in male or female cats. However, the two RIs were largely overlapping and, more important, 
the lower reference limit, which in practice may correspond to the clinical decision limit, was very 
similar, with a difference quantitatively lower than the intrinsic imprecision of the method. 
Therefore, although the decision to use or not separate reference intervals should depend on 
statistical approaches (Harris et Boyd, 1990; Lathi et al., 2004), the current guidelines for the 
establishment of de novo reference intervals admit the use of non-statistical approaches based on 
practical considerations (Friedrichs et al., 2012). From this perspective, it would not be advisable 
to differentiate the RIs of male vs female cats, since it would likely not affect the clinical decisions. 
Many of the cats used to set out the reference interval belong to Ragdoll breed. It is unknown if 
this could have somehow influence out results, even if it is unlikely, since they does not seems to 
have different PON-1 activity compared to other breeds.    
  
54 
 
III.  ROLE OF PARAOXONASE-1 (PON-1) AS A DIAGNOSTIC 
MARKER FOR FELINE INFECTIOUS PERITONITIS  
 
MATERIALS AND METHODS 
Animals/Caseload  
All the animals included in this study were submitted for routine or diagnostic clinical 
examinations to the Veterinary Teaching Hospital of our Institution or to private practitioners. 
Both clinically healthy cats and cats with clinical signs consistent with FIP (regardless of the final 
diagnosis e.g. FIP or diseases other than FIP) were recruited.  
Inclusion criteria for the clinically healthy cats included as a control group (HEALTHY) were the 
absence of any clinical signs or laboratory abnormalities consistent with disease or inflammation 
(e.g. leukocytosis, hyperprotidemia), in order to exclude any possible subclinical illness which 
could influence PON-1 activity. For sick cats the inclusion criteria were the presence of one or 
more clinical signs consistent with FIP, namely: effusions, hyperthermia, anorexia, weight loss, 
depression, jaundice, neurological or ocular affection.  
The entire caseload had results of complete blood cell count and a biochemistry panel (including 
spectrophotometric evaluation of creatinine, urea, total protein, alanine aminotransferase, alkaline 
phosphatase, glucose at least) which should result inside the reference intervals for healthy cats. 
Sick cats had a definitive diagnosis of feline infectious peritonitis (FIP group) or disease other than 
FIP (NON FIP group) and were further grouped accordingly. In order to increase the number of 
FIP affected animals, cats with a strong suspicion for FIP were included as long as they have been 
humanly euthanized and had signalment, laboratory analyses and clinical signs consistent with the 
disease. For the sick cats, different analyses had been performed, depending on the clinician 
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request (e.g. electrophoresis, effusion analyses, ΔTNCC evaluation, effusion cytology, abdominal 
or cardiac ultrasound). After the diagnostic procedures, serum leftover (at least 150 µL) was 
transferred into a plain 1,5 mL Eppendorf tube and then frozen at -20°C. 
The samples had been collected for diagnostic purposes by referring veterinarians according to 
standard veterinary procedures with a signed owner’s consent. Therefore, according to the 
regulations of our institution, a formal approval of the Institutional Ethical Committee was not 
required (EC decision 29 Oct 2012, renewed with the protocol n° 02-2016). 
 
Measurement of PON-1 activity 
PON-1 activity was measured using a paraoxon based method, already described in Study II (see 
above)  
 
Statistical Analysis 
Statistical analysis were performed using Analyse-it for Microsoft Excel (Analyse-it Software Ltd, 
Leeds, United Kingdom). Statistical significance was set at P <0.05. Specifically, differences in 
PON-1 activity among groups were evaluated using Kruskall-Wallis test, followed, when 
statistically relevant results were found, by a Wilxocon Mann-Whitney test.  
Then, cats in the FIP group were further divided in a group of confirmed FIP (with IHC positive 
results) cats and a group of cats with suspected FIP (cats with clinical signs or laboratory data 
strongly consistent with the disease, but lack of a definitive diagnosis by IHC). Then, they were 
further divided based on the clinical form of the disease in dry and wet FIP affected cats. The same 
statistical tests, namely the Kruskal-Wallis test, followed by a Wilcoxon Mann-Whitney test, were 
performed to compare PON-1 activity among these subgroups and NON FIP and HEALTHY 
groups. The same analyses were performed to compare NON FIP subgroups (divided based on the 
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underlying disease in neoplasia, chylothorax, cardiopathy, infectious or other) with FIP and 
HEALTHY groups.  
Finally, in order to evaluate the diagnostic power of PON-1 activity in discriminating FIP affected 
cats, a receiver operating characteristic curve (ROC) was built. The area under the curve (AUC) 
was calculated in order to evaluate the difference from the no-discrimination line. The ROC curve 
was used to determine clinically relevant threshold.  
 
RESULTS 
Firstly, 191 cats were enrolled in the study. After the application of the inclusion criteria, 159 cats 
were finally selected (32 cases were excluded from the study due to the lack of a definitive 
diagnosis, or to the absence of laboratory analyses). Among the included cats, 59 were female and 
90 were male (in 10 cats the gender was not reported by the referring veterinarian). The most 
represented breed was the domestic shorthair (n =91). Age ranged from 3 months to 19 years old, 
with a median of 3 years of age. These animals were further divided into three groups. 
The HEALTHY group included 71 cats (43 male, 24 female, two unknown) (see study II). All the 
animals had a normal physical examination and the absence of any laboratory abnormalities 
consistent with inflammation or disease.  
The NON FIP group included 54 cats (26 female, 20 male, 8 unknown). 8 cats were younger than 
2 years, 20 cats were aged between 2 and 10 years and 19 were older than 10 years. Effusion was 
present in 47 cats (19 peritoneal, 30 thoracic, 6 pericardial. 8 cats had bicavitary effusion). The 
remaining 7 cats had hyperthermia and lethargy (n = 4), neurological or ocular signs (n = 3). Most 
of the cats had a definitive diagnosis of neoplasia, followed by cardiogenic effusion, chylothorax, 
septic effusion, infectious diseases, immune-mediated haemolytic anaemia (IMHA), diabetes, 
intestinal occlusion, traumatism or hepatic lipidosis. Based on the definitive diagnosis, six 
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subgroups had been further compared: INFECTIVE (n = 4), NEOPLASIA (n = 21), 
CARDIOPATHY (n = 7), CHYLOTHORAX (n = 5), SEPTIC (n = 7) and OTHER (n = 10). 
The FIP group was composed by 34 cats (12 female, 19 male, 3 unknown). 23 cats were younger 
than 1 year; nevertheless, 6 cats were adults (5 unknown). In 27 cats, effusions were present (21 
peritoneal, 8 pleural, 2 pericardial. 4 cats showed bi or multi-cavitary effusion). 7 cats were 
affected by a dry form of the disease with neurological or ocular signs (4) or more unspecific signs 
such as hyperthermia, jaundice, lethargy, vomiting (3). In 19 cases, the definitive diagnosis was 
achieved through IHC on post-mortem biopsies. In the remaining 15 cases a strong suspicion for 
FIP was achieved due to signalment (young cats), clinical signs (such as fever, jaundice, ocular 
signs) and laboratory abnormalities (hyperprotidemia, typical electrophoretic pattern, effusion 
cytology, TNC with SysmexXT-2000iV), together with the severe clinical course of the disease 
that always ended with the spontaneous death or human euthanasia.  
 
Difference in PON-1 activity among HEALTHY, FIP and NON FIP 
PON-1 activity was significantly different among the three groups (P <0.0001). Specifically, PON-
1 activity was significantly lower in FIP cats than in HEALTHY and NON FIP cats (P <0.0001 in 
both cases). Cats belonging to NON FIP group had values of PON-1 activity significantly lower 
than the HEALTHY group (P <0.0001). (Table 3.1 and Figure 3.1)  
Group Median IQR I-III Min – Max 90%CI 
FIP (n = 34) 26,55 16,56 – 44,67 5,40 – 78,20 18,70 to 37,85 
NON FIP (n = 54) 57,9 35,52 – 74,47 3,80 – 122,60 50,70 to 63,10 
HEALTHY (n = 71) 87,5 74,52 – 103,02 46,60 – 215,50 83,10 to 91,50 
Table 3.1. Value of PON-1 activity (U/mL) in cats belonging to group FIP, NON FIP and HEALTHY. For each group 
median, interquartil range, maximum and minimun value an 90% confidence interval has been reported.  
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Figure 3.1. Comparison of the value of PON-1 (paraoxonase 1) among the groups FIP, NON FIP and HEALTHY. In 
light blue are reported the reference interval of PON-1 for healthy cats.  
 
Comparison between suspected FIP and confirmed FIP 
The SUSPECTED FIP subgroup was composed by cats with signalment, clinical signs and/or 
laboratory data consistent with the FIP (Table 3.2). The values recorded in the SUSPECTED FIP 
subgroup were not significantly different from the confirmed FIP subgroup (P =0.61). Conversely, 
both subgroups maintain significantly lower results compared with NON FIP and HEALTHY 
groups (P <0.0001). (Table 3.3 and Figure 3.2a - b) 
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ID BREED SEX AGE CLINICAL SIGNS LABORATORY DATA 
126 DSH MN 1 YY Abdominal effusion 
Anaemia, leucocytosis, lymphopenia, hypoalbuminemia, 
>α2; ΔTNC = 7,4; AGP = 5,81; cytology consistent; Ab 
anti-FCoV 1:1800; PCR on effusion + 
127 DSH MN 1 YY Thoracic effusion 
Anaemia, lymphopenia, hyperprotidemia, 
hypoalbuminemia, >β1, γ; ΔTNC = 49.6; AGP = 1,45; 
cytology consistent 
128 DSH MN 4 YY 
Abdominal effusion, 
jaundice 
Lymphopenia, thrombocytopenia, azotaemia, 
hypercreatininemia, hyperbilirubinemia, hypocalcaemia, > 
ALP, hypoalbuminemia, >γ; ΔTNC = 21.22; cytology: 
acellular 
129 DSH M 1 YY Thoracic effusion 
Leukopenia, lymphopenia, neutropenia, thrombocytopenia, 
hypoalbuminemia,; ΔTNC = 3.1 
130 HB FS 
11 
MM 
Pericardial effusion, 
lethagy, anorexia 
Mild azotaemia, hyperbilirubinemia, hyperprotidemia, , > 
ALT, hypoalbuminemia, >β2, γ; ΔTNC = 7.7; AGP = 2; 
cytology consistent; ICC on effusion + 
131       Abdominal effusion ΔTNC = 21,8; PCR on effusion + 
132 DSH F 9 YY 
Thoracic and 
abdominal effusion  
ΔTNC = 29,8; necroscopy consistent 
134 DSH M 
6 
MM 
Abdominal effusion, 
neurological signs 
Anaemia, monocytosis, > AST, hyperprotidemia, 
hyperphosphatemia, hypoalbuminemia, >γ; cytology 
consistent; Ab anti-FCoV 1:1800; PCR on CSF + 
135 DSH F 
8 
MM 
Abdominal effusion, 
anorexia, fever  
Anaemia, eosinopenia, thrombocytopenia, , > AST, 
hyperbilirubinemia, hyperlipemia, azotaemia, 
hyperphosphatemia, hypoalbuminemia; ΔTNC = 25; 
cytology consistent; PCR on effusion + 
136 EX  F 
4 
MM 
Abdominal effusion 
Anaemia, eosinopenia, hyperlipemia, < ALT, ALP, 
hypoalbuminemia; cytology consistent; PCR on effusion + 
137 DSH MN   
Tri-cavitary effusion, 
neurological signs, 
jaundice 
Anaemia, leucocytosis, lymphopenia, thrombocytopenia, 
hyperprotidemia, hypoalbuminemia, >β1; ΔTNC = 12; 
cytology consistent; necroscopy consistent 
138 DSH MN   Abdominal effusion 
Leucocytosis, lymphopenia, azotaemia, >β1; ΔTNC = 0.98; 
necroscopy consistent 
139 SCO  M 
6 
MM 
Abdominal effusion, 
fever 
Anaemia, eosinopenia, hyperbilirubinemia, 
hypoalbuminemia; ΔTNC = 1.58; cytology consistent 
140 SPH MN 
8 
MM 
Abdominal effusion, 
fever 
Anaemia, leucocytosis, lymphopenia, hypoalbuminemia, 
>α2, β1 e γ; ΔTNC = 109.72; cytology consistent 
141 BSH MN 1 YY Abdominal effusion 
Anaemia, lymphopenia, hyperprotidemia, 
hyperbilirubinemia, hyperlipemia, hypoalbuminemia, >γ; 
necroscopy consistent 
Table 3.2. Signalment, clinical signs and laboratory data of the cats belonging to the SUSPECTED FIP subgroup. 
DSH: domestic shorthair, HB: holy birman cat, EX: exotic, SCO: scottish fold, SPH: sphinx, BSH: british shorthair, 
F: female, FS: female spayed, M: male, MN: male neutered, YY: years, MM: months 
 
Group Median IQR I-III Min – Max 90%CI 
CONFIRMED FIP (n = 19) 25,700 15,60 - 47,42 6,30 - 78,20 16,10 to 44,50 
SUSPECTED FIP (n = 15) 30,60 19,67 - 41,93 5,40 - 68,10 19,10 to 42,20 
Table 3.3. Value of PON-1 activity (U/mL) in cats belonging to subgroup CONFIRMED FIP and SUSPECTED FIP. 
For each group median, interquartil range, maximum and minimun value an 90% confidence interval has been 
reported.  
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Figure 3.2a. Comparison of the value of PON-1 (paraoxonase 1) between the subgroup of CONFIRMED and 
SUPECTED FIP. (left) 3.2b. Comparison of the value of PON-1 (paraoxonase 1) among the subgroup of 
CONFIRMED, SUPECTED FIP, NON FIP and HEALTHY. In light blue are reported the reference interval of PON-
1 for healthy cats. (right) 
 
Comparison between cats with wet FIP and cats with dry FIP 
The cats with wet FIP had a lower PON-1 activity compared with cats with dry FIP (P = 0.035). 
Even though, cats with the wet form still maintained lower values of PON-1 compared to NON 
FIP and HEALTHY group (P <0.0001), whereas cats with the dry form of FIP showed 
significantly lower PON-1 compared with the HEALTHY group (P =0.0003), but not statistically 
lower compared to NON FIP group (P = 0.44). However, the power of this analyses could be 
strongly affected by the scarce number of dry FIP cases. (Table 3.4 and Figure 3.3a - b)  
Group Median IQR I-III Min – Max 90%CI 
DRY FIP (n = 7) 48,00 32,77 - 72,30 15,10 - 78,20 15,10 to 78,20 
WET FIP (n = 27) 23,20 16,183 – 39,950 5,40 – 71,50 17,40 to 34,60 
Table 3.4. Value of PON-1 activity (U/mL) in cats belonging to subgroup DRY and WET FIP. For each group median, 
interquartile range, maximum and minimum value an 90% confidence interval has been reported.  
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Figure 3.3a. Comparison of the value of PON-1 (paraoxonase 1) between the subgroup of DRY and WET FIP (left). 
3.3b. Comparison of the value of PON-1 (paraoxonase 1) among the subgroup of DRY, WET FIP, NON FIP and 
HEALTHY. In light blue are reported the reference interval of PON-1 for healthy cats.  
 
Comparison among NON FIP subgroups 
The NON FIP group, as reported above, has been divided into 6 subgroups based on the definitive 
diagnosis:  neoplasia, septic, cardiopathy, chylothorax, infective or other. The comparison of PON-
1 activity among groups did not result in any significant differences.  
In all the subgroups PON-1 resulted significantly lower than HEALTHY group (P <0.0001), 
except for chylothorax (P =0.066). Similarly, all the subgroups except for the septic one (P =0.88) 
showed a higher value of PON-1 compared with FIP group (P <0.0001). (Table 3.5 and Figure 
3.4) 
Group Median IQR I-III Min – Max 90%CI 
OTHER (n = 10) 57,450 41,32 - 74,92 24,90 - 105,40 26,20 to 80,60 
CARDIOPATHY (n = 7) 73,800 40,45 - 82,43 35,60 - 84,80 35,60 to 84,80 
CHYLOTHORAX (n = 5) 69,900 49,33 - 88,30 34,60 - 102,00 34,60 to 102,00 
INFECTIVE (n = 4) 64,100 56,30 - 75,31 51,40 - 82,60 0 to 0 
NEOPLASIA (n = 21) 54,700 31,80 - 63,27 25,30 - 118,60 38,30 to 61,80 
SEPTIC (n = 7) 31,800 10,12 - 73,62 3,80 - 122,60 3,80 to 122,60 
Table 3.5. Value of PON-1 activity (U/mL) in cats belonging to subgroup OTHER, CARDIOPATHY, 
CHYLOTHORAX, INFECTIVE, NEOPLASIA and SEPTIC. For each group median, interquartile range, maximum 
and minimum value an 90% confidence interval has been reported. 
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Figure 3.4. Comparison of the value of PON-1 (paraoxonase 1) among the group FIP, the subgroup OTHER, 
CARDIOPATHY, CHYLOTHORAX, INFECTIVE, NEOPLASIA, SEPTIC and the HEALTHY group. In light blue 
are reported the reference interval of PON-1 for healthy cats.  
 
Diagnostic performance of PON-1 
The analyses of ROC curve highlighted a statistical difference from the no-discrimination line (P 
=0.02) with an AUC equal to 88.7% (CI 95% = 0.83 to 0.94). Based on the ROC curve, the 
threshold that maximizes the diagnostic power of the test providing equal sensitivity and 
specificity corresponds to a PON-1 value activity of 51,40 U/mL (Se and Sp = 82%). However, 
depending on the clinical setting, it was possible to select a cut off threshold that maximized the 
specificity, in order to decrease the number of false positive results. In this study, this threshold is 
equal to a PON-1 value of 24,90 U/mL (positive Likelihood Ratio - LR+ = 18.38; Sp = 97.6%; Se 
= 44.1%). (Figure 3.5) 
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Figure 3.5. ROC curve of the values of PON-1 activity. The central line represents the no-discrimination line. In this 
case, NON FIP cats included both NON FIP and HEALTHY group.  
 
DISCUSSION 
PON-1 acts as a negative acute phase reactant in cats, similarly to other species (Giordano et al., 
2013; Rossi et al., 2014). From this perspective, the results obtained from the comparison of the 
three groups was not surprising, especially due to the strong inflammatory response and oxidative 
stress that mounts in FIP cats (Regan et al., 2009; Tecles et al., 2015). Generally, during an 
inflammatory response, several mediators, including pro-inflammatory cytokines such as TNF-α 
and IL-1β, are produced (Montorfano et al., 2014). These, in turn, induce cellular oxidative 
processes that end in the production of reactive oxygen species (ROS). Moreover, ROS are also 
produced by leukocytes, specifically neutrophils and macrophages. So, the cellular damage caused 
by these reactive molecules go along with an inflammatory process, that recruited and induce 
activation of leukocytes. Due to the intimate relationship between oxidative stress and 
inflammation, it is easy to imagine its role in cats affected by FIP (Tecles et al., 2015). It has been 
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shown how, during this disease, the pro-inflammatory cytokines increase the releasing of the bone 
marrow neutrophils reservoir and decrease their apoptotic rate (Paltrinieri et al., 2008; Takano et 
al., 2009). That, in turn, enhance the oxidative stress, through the release of strong oxidant 
components. A previous study, based on a different substrate for the paraoxonase activity 
assessment and on a lower number of cats, had already highlighted how PON-1 may decrease in 
FIP affected cats (Tecles et al., 2015). This may happen both due to its role as a negative acute 
phase reactant and to an enzymatic consumption for its antioxidant properties. Indeed, PON-1 has 
a tendency to decrease significantly in those inflammatory processes that involve also a strong 
oxidative response. So, a low value of PON-1 activity was expected in FIP affected cats. In NON 
FIP group, PON-1 activity resulted to be higher compared to FIP cats, but still lower than in healthy 
cats. This result may depend on the high number of cats with a definitive diagnosis of neoplasia. 
It is interesting to note that one of the anti-tumoral mechanisms is represented by the macrophages 
production of ROS. Moreover, in some neoplasia, such as human renal carcinoma, are the 
neoplastic cells themselves that produce ROS, to enhance their survival (Toyokuni et al., 1995). 
These assumptions lead to the conclusion that the inflammatory microenvironment created by 
different neoplasia, could affect also the oxidative stress of the entire organism. Another 
hypothesis is that the decrease of PON-1 during neoplastic cachexia could be related both with a 
decrease of HDL particles (that usually bind PON-1) or with a hepatic lipidosis, that lead to a 
PON-1 production decrease. However, it is unlikely that neoplasia, especially when confined to a 
single organ, could cause the same systemic effect of a strong inflammation such as FIP.  
A possible limitation of the study is that FIP was confirmed by post-mortem analyses only in some 
cases included in the FIP group. On one hand, however, FIP was the most likely diagnosis on all 
the cats belonging to this group, based on clinical and laboratory findings. On the other hand, 
PON-1 activity did not significantly differ in cats with confirmed FIP compared with cats on which 
FIP was highly probable based on in vivo findings. Moreover, both subgroups, maintained a PON-
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1 activity level lower than both NON FIP and H groups. This could be a further support to the 
suspected diagnosis in those cats in which IHC was not performed. The suspicion of FIP was 
release after the cats died (both for natural causes or euthanasia) and was supported by signalment, 
history, clinical signs and laboratory results. All the cats belonging to the suspected FIP subgroup 
presented an effusive form of the disease. None of the findings could confirm the diagnosis alone. 
However, the presence of several data consistent with FIP increased the diagnostic suspicion, as 
already reported in literature (Stranieri et al., 2018).  
In the effusive form of FIP PON-1 activity resulted to be lower with respect of the non-effusive 
form. This result is consistent with the major inflammatory component of the effusive FIP. Indeed, 
in the non-effusive form a partially protective immune response causes, through the cell mediated 
immunity, the destruction of infected monocytes and, in turn, a lower viral spread (Pedersen, 
2014b). For this reason, usually the granulomas are more localized. Conversely, in the effusive 
form, pyogranulomas tend to be more disseminated. Moreover, the presence of neutrophils in the 
granulomas itself, it is typical of the effusive form (Pedersen, 2014b). Since it is known that 
neutrophils and macrophages are the major producer of ROS, it is possible to conclude that in the 
effusive form, a strong inflammation go together with marked oxidative stress, leading to an 
evident decrease in PON-1 activity. The localization of the granulomas could also influence the 
different results obtained in PON-1 measurement. As an example, one cat showed a value of PON-
1 that falls inside the reference interval for healthy cats. In this particular case, the virus associated 
with the typical lesions had been found microscopically only in the cerebellum, which was also 
the only organ with histological lesions in this cat. The strict localization associated with the 
presence of the haemato-encephalic barrier could lead to a decrease in the strength and efficacy of 
the immune response (Pedersen, 2009). The same hypothesis could also explain the lack of 
significant differences between dry FIP subgroup and NON FIP group in which the oxidative 
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component was not so pivotal. However, this are only speculations, that need an increased number 
of cases to be confirmed.  
The comparison among different NON FIP subgroups resulted in the absence of significant 
differences. This outcome could be influenced by the different (and in some cases scarce) sample 
size of the subgroups.  Comparing the different subgroups with the H group, all of them showed a 
lower level of PON-1 activity except for the CHYLOTHORAX subgroup. This result could be 
explained by the low systemic inflammation caused by the presence of this type of effusion, but 
results should be interpreted cautiously due to the low number of cats in this subgroup (only 5 
cases). The comparison between the NON FIP subgroups and FIP group resulted in higher value 
of PON-1 for all the subgroup except for the SEPSIS one. This was composed by 7 cats: 6 of them 
presented effusion, while one presented a septic spondylitis, complicated by toxoplasmosis and 
FeLV infection. This could justify the extremely low value of PON-1 in this latter cat. The 
presence of septic effusion could determine a strong inflammation, due to the high level of 
inflammatory cells, associated with strong oxidative stress (Draganov et al., 2010). On the other 
hand, since it is a localized problem, it is not always cause of severe systemic repercussion. 
Specifically, three cases presented anaemia due to the presence of inflammatory processes, 
possibly related with the action of the oxidative stress on erythrocytes (Ottenjann et al., 2006). 
Anaemia could be considered as a sign of systemic repercussion of a localized problem and could 
explain the low value of PON-1. In one case, the extremely low value on PON-1 could be related 
with the presence of Nocardia in the effusion. It is known that Nocardia causes a severe mixed 
unspecific serositis, similar to those observed in FIP (Hayward, 1968). Finally, in one case anaemia 
was not present, maybe due to a low systemic impact or an initial phase of the disease. As a result, 
the value of PON-1 was sensibly higher. This relationship between anaemia and PON-1 activity 
has already been reported in human medicine (Okuturlar et al., 2016).  
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Finally, the analyses of the ROC curve demonstrated that PON-1 may differentiate cats with FIP 
from cats without FIP. The value on PON-1 that maximizes the diagnostic power of the test is 
equal to 51.40 U/mL (both sensitivity and specificity are 82%). However, this threshold is not 
clinically relevant, because it may include several false positive and false negative results. It is 
possible to set out a value of PON-1 activity that maximize the sensitivity (specifically: PON-1 
=78.30 U/mL; Se =100%; Sp =50.4%). The use of this threshold allows to exclude completely the 
disease. Nevertheless, this value fell inside the reference interval for PON-1 activity in the healthy 
population (57.8 – 157.3 U/mL). This means that there will be a certain number of healthy cats 
which can be mistaken for false positive. Conversely, due to the poor prognosis of a FIP diagnosis, 
it is desirable to decrease the number of false positive results, that could be obtained increasing 
the specificity of the test. A value of PON-1 equal to 24.90 U/mL could be more useful in a clinical 
setting (LR+ =18.38; Sp =97.6%; Se =44.1%). Indeed, a cat with a value of PON-1 lower than this 
threshold had 18 time the probability to be affected by FIP than not to be affected. However, even 
using this threshold, there were some false positive results. As already stated in literature, the result 
of a single test is not sufficient to confirm a diagnosis of FIP (Stranieri et al., 2018). The results of 
this study state how PON-1 measurement is not an exception. However, the association of more 
than one test could increase the suspicion of FIP (even if, in the end, it is always desirable to 
confirm the diagnosis through IHC on biopsies). Moreover, the method used in this study to 
measure PON-1 activity, based on the paraoxon as substrate, compared to other substrates is quite 
more analytically sensitive, allowing the evaluation on a wide range of values, thus permitting to 
differentiate cut-off values based on the purpose of the investigation (screening vs confirmatory 
studies). 
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IV.  DIAGNOSTIC PERFORMANCE OF RT-PCR COMPARED 
TO IMMUNOHISTOCHEMISTRY FOR THE DIAGNOSIS OF 
FELINE INFECTIOUS PERITONITIS 
 
MATERIAL AND METHODS 
Animals/Caseload 
Tissue samples were collected, post-mortem, at the Veterinary Teaching Hospital of Milan from 
cats deceased or euthanized with a suspicion of FIP or due to other systemic diseases or serious 
injuries and subjected to necropsy for diagnostic purposes. All the samplings were performed 
within routine diagnostic procedures and the owners signed an informed consent about the use of 
tissues and samples for research. Therefore, according to the Ethical Committee of the University 
of Milan (decision n° 2, 2016), residual aliquots of tissues can be used for research purposes 
without any additional formal request of authorization to the Ethical Committee. 
The inclusion criteria were: (1) tissues sampling within six hours from death; (2) availability of 
signalment, history and clinical information (physical examination, clinical pathology, diagnostic 
imaging depending on the clinical presentation).  
This information, along with the results of necropsy and histology, were used classify the cats in 
FIP or NON FIP. Specifically, FIP group included cats suspected for FIP based on history and/or 
laboratory alterations, on which diseases other than FIP were excluded, showing gross and 
histological lesions consistent with FIP in at least one tissue, including tissues sampled for 
diagnostic purposes and not included in this study (e.g. brain or cerebellum). The NON FIP group 
included cats on which, despite a clinical presentation potentially consistent with FIP, diseases 
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other than FIP were already diagnosed on a clinical basis (e.g. based on results of diagnostic 
imaging or cytology) and/or without any histological lesion consistent with FIP.  
 
Tissues sampling 
Samples from spleen, liver, mesenteric lymph node, kidney, large intestine, small intestine and 
lung, collected from the necropsied cats, were included in this study. Moreover, tissues from 
organs different from those listed above, with macroscopic lesions, as well as organs not visibly 
affected but likely involved (based on the patient history, e.g. brain and cerebellum from cats with 
neurological signs) were also collected during necropsy to perform routine histology and 
immunohistochemistry for diagnostic purposes. The information about these organs were used to 
achieve a correct classification as FIP or NON FIP.  
From each sampled organ, a fragment was taken and sectioned, with a sterile scalpel, in two 
adjacent halves of approximately one-centimetre of diameter each. If macroscopic lesions were 
present, the two halves were obtained sectioning the sample approximately in the centre of the 
lesion (Figure 4.1). One half of the fragment was immediately frozen at -20°C in plain tubes for 
molecular biology, while the other half was collected into 10% neutral-buffered formalin to 
perform histology and immunohistochemistry.  
 
Figure 4.1. Representation of sampling obtained from organs with macroscopic lesions. The kidney in figure was 
divided in two section splitting in two halves the lesion (dashed line). The A section was used for 
immunohistochemistry, while the B section was used for molecular biology test.  
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Histology and immunohistochemistry 
Formalin fixed samples were sent to the Department of Comparative Biomedicine and Food 
Science of the University of Padova. Sections (5 μm) obtained from formalin-fixed paraffin-
embedded samples were stained with haematoxylin-eosin for histology with an automated stainer 
(Autostainer XL, Leica Biosystems, Wetzlar, Germany). For immunohistochemistry (IHC) 3 μm 
paraffin sections were placed on surface-coated slides (Superfrost Plus). Slides were then 
incubated at 37°C for 30 minutes before the immunostaining performed with an automatic 
immunostainer (Ventana Benchmark XT, Roche-Diagnostics), which uses a kit with a secondary 
antibody with a horseradish peroxidase (HRP)-conjugated polymer, that binds mouse and rabbit 
primary antibodies (ultraViews Universal DAB, Ventana Medical System). All reagents were 
dispensed automatically except for the primary antibody, which was manually dispensed. As 
primary antibody, a mouse monoclonal antibody against the feline coronavirus was used (clone 
FIPV3-70 Serotec, Oxford, UK). FIP positive tissues were used as positive controls. For negative 
controls, the antibody diluent (Ventana Medical Systems) was applied instead of the primary 
monoclonal antibodies. Immunohistochemistry was considered positive if FCoV antigen was 
detected within typical histological lesions above described (Pedersen, 2009; Kipar and Meli, 
2014). In fact, the detection of FCoV antigen in scattered macrophages or epithelial cells (e.g. 
intestinal columnar cells, likely infected by FECV) only, was not considered as a positive result 
(Kipar et al., 2010).  
Histological examination was performed under light microscopy and a detailed description was 
provided for each organ.  For each organ, lesions were categorized as consistent with FIP when 
showing one or more typical lesions such as pyogranulomas on one or more serosal surfaces; 
granulomas with or without necrotic areas; lymphocytic and plasmacytic focal and perivascular 
infiltrates; granulomatous to necrotizing phlebitis and fibrinous serositis (Pedersen, 2009; Kipar 
et Meli, 2014). Conversely, if there are lesion consistent with diseases other than FIP, they were 
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considered as NON FIP. In addition, tissues were categorized as susplpected, when there are results 
from laboratory data or histology on other organs, which could be consistent with FIP.  
 
FCoV RT-nPCR 
From frozen-thawed samples, RNA was obtained using a NucleoSpin RNA kit (Macherey-Nagel, 
Bethlehem, PA). Twenty mg of tissues were thinly shredded on sterile plates using sterile scalpels 
and vigorously vortexed in RA1 lysis buffer until completely dissolved. All the further steps were 
performed according to the manufacturer’s instructions. RNA samples were then frozen at -80°C 
or immediately used for PCR. A reverse transcription nested PCR (RT-nPCR) targeting a 177 bp 
product of the highly conserved 3′ untranslated region (3′ UTR) of the FCoV genome was used 
(Herrewegh et al., 1995). FCoV RT-nPCR positive RNA was used as positive control and RNAse-
free water as negative control. PCR products were visualized under UV transilluminator on a 1.5 
% agarose gel stained with ethidium bromide. PCR was considered positive if showing a 177bp 
band on agarose gel electrophoresis (Herrewegh et al., 1995). 
 
Analyses of results 
For IHC and RT-PCR, true-positive (results consistent with FIP in cats with FIP) and false-positive 
results (results consistent with FIP in cats without FIP) as well as true-negative (results not 
consistent with FIP in cats without FIP) and false-negative results (results not consistent with FIP 
in cats with FIP) were recorded. Sensitivity, specificity, accuracy, positive and negative predictive 
values as well as positive and negative likelihood ratios (LR+ and LR−, respectively) were then 
calculated for IHC and/or PCR. 
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The concordance between IHC and PCR was assessed using Cohen’s k coefficient (Landis et 
Koch, 1977). Concordance was classified as none (k < 0); minimal (0 < k < 0.20); weak (0.21 < k 
< 0.40); moderate (0.41 < k < 0.60); strong (0.61 < k < 0.80) and almost perfect (0.81 < k < 1). 
This test was performed both on the totality of the samples and considering the two groups (FIP 
and non FIP) separately to evaluate concordance in the diagnosis of FIP. Additionally, it was 
performed also on the results recorded for type of organ, to evaluate which organ might give a 
substantial number of concordant results and, consequently, might provide the same information 
independently on the used test.  
 
RESULTS 
A total of 26 cats were included in the study. Specifically, 14 cats were included in the FIP group, 
and 12 in the non FIP group (Table 4.1).  
 I
D 
Breed Age Sex Clinical 
suspicion 
Final diagnosis Tissues not collected 
FIP 
1 DSH 8 MM F FIP Non-effusive FIP Lu 
2 DSH 6 MM M FIP Non-effusive FIP  
3 DSH 10 MM FS FIP Non-effusive FIP SI 
4 DSH 1,5 YY FS FIP Non-effusive FIP  
5 DSH Nd F FIP/Neoplasia Non-effusive FIP  
6 MC 9 YY MN FIP Effusive FIP  
7 ES 6 MM M FIP Effusive FIP  
8 DSH 5 YY FS FIP Effusive FIP SI and LI 
9 R 1 YY MN FIP Effusive FIP  
10 DSH 1 YY FS FIP Effusive FIP  
11 DSH 1 YY MN FIP Effusive FIP  
12 DSH 2 YY MN FIP/Septic Effusive FIP Ly 
13 DSH Nd MN FIP Effusive FIP  
14 MC 1 YY F FIP/Septic Effusive FIP  
Non 
FIP 
15 DSH 15 DD F Trauma Bite wounds  
16 DSH 15 YY FS Neoplasia Chronic pneumonia  
17 DSH 1,5 
MM 
FS Poisoning Rodenticide poisoning  
18 DSH 5 y F FIP Diabetes mellitus Ly 
19 DSH Nd M Trauma Multiple wounds  
20 DSH Nd MN FIP/Neoplasia Pulmonary 
adenocarcinoma 
 
21 DSH 2 MM F FPV FPV  
22 DSH Nd F Trauma Multiple wounds  
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23 DSH 2 y M FIP Heart failure  
24 DSH 1,5 YY FS Heart failure Heart failure  
25 DSH 7 YY MN Heart failure Heart failure  
26 DSH 9 YY MN FIP/Neoplasia Thymic carcinoma  
Table 4.1. Signalment, clinical suspicion, final diagnosis and not collected tissues for the cats enrolled. DD: days; 
DSH: domestic shorthair; F: female; FPV: feline panleukopenia virus; FS: female spayed; LI: large intestine; Lu: lung; 
Ly: mesenteric lymph node; MM: months; M: male; MN: male neutered; nd: not determined; SI: small intestine; YY: 
years 
As regards for the FIP group, five cats showed non-effusive forms of the disease, with primarily 
neurological (n°2, 3, 5) and ocular symptoms (n°1, 4), along with fever, lethargy and anorexia. 
The remaining nine cats exhibited effusive forms of FIP, with abdominal (n°6, 7, 8, 10, 12, 13, 14) 
and/or thoracic (n°9, 11, 12) effusions. When present, the effusion displayed typical features of 
FIP. The exceptions were represented by cats n° 12 and 14, whose effusions were initially 
consistent with FIP, while at necropsy had a purulent appearance, confirmed by cytologic 
evaluation, which revealed a septic component too.  
Regarding the non FIP group, in four cases, FIP was considered as a possible differential diagnosis 
because of the presence of hyphaema (n°18), body cavity effusion and jaundice (n°20), anisocoria 
ad tremors (n°23), neurological symptoms and thoracic effusion (n°26). Laboratory findings, 
diagnostic imaging and post mortem analyses subsequently led to the diagnoses of unrestrained 
diabetes mellitus, pulmonary adenocarcinoma, end stage heart failure and thymic carcinoma 
respectively. In eight cats, FIP was not suspected and, specifically, death occurred for severe 
injuries (n°15, 19 and 22), rodenticide poisoning (n°17), inflammatory (n°16), infectious (n°21) 
and cardiac (n°24, 25) diseases, diagnosed based on history, laboratory and histological analyses.  
Table 4.2 and 4.3 resume the results of histology, immunohistochemistry and RT-PCR that are 
discussed in detail in the next sections. 
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  Spleen  Liver  Lymph Node  Kidney  Small intestine  Large Intestine  Lung  
  ID H I P H I P H I P H I P H I P H I P H I P 
F 
I 
P 
1 - - + - - - - + + + + + - - - - - - NC NC NC 
2 - - - - - - - - + - - - - - - - - + - - - 
3 - - + + + + + + + + + + NC NC NC + + + + + + 
4 + + + - - - + + + + - + + + + + + + + + + 
5 + + + + + + + + + - - + + + + + + + + + + 
6 - - - - - - - - - + + + - - - - - - + - - 
7 + + + + + + + + + - - - - + + + + + - + + 
8 + + + + + + + + + + + + NC NC NC NC NC NC + + + 
9 - + + + + + + + + + + + - - + - - + + + + 
10 + - ND + + + - + + + + + + + + + + + + + + 
11 - - - - - - - - - + + + - - - - - - + + - 
12 + + + + + + NC NC NC - - + - - + - - + + + + 
13 + + + + + + - + + - - + + + + + + + - + + 
14 + + + - - + - - + + + + + + + + - + - - + 
N 
O 
N  
 
F 
I 
P  
15 - - - - - - - - - - - - - - - - - - - - - 
16 - - - - - - - - - - - - - - - - - - - - - 
17 - - - - - - - - - - - - - - - - - - - - - 
18 - - - - - - NC NC NC - - - - - - - - - - - - 
19 - - - - - - - - - - - + - - - - - - - - - 
20 - - + - - - - - + + - - - - - - - - - - - 
21 - - - - - - - - + - - - - - - - - - - - - 
22 - - - - - - - - - + - - - - - - - - - - - 
23 - - + - - - - - - - - - - - - - - - - - - 
24 - - - - - - - - - - - - - - + - - - - - - 
25 + - - + - - + - - - - - - - - - - - + - - 
26 - - - - - - - - - - - - - - - - - - - - - 
Table 4.2. Results of histological examination, immunohistochemistry and PCR obtained on each collected sample.  
H: histology; I: immunohistochemistry; NC: not collected; ND: not determined; P: PCR 
 FIP Non FIP 
 Histology IHC PCR Histology IHC PCR 
Spleen 8/14 (57.1%) 8/14 (57.1%) 10/13 (76.9%) 1/12 (8.3%) 0/12 (0.0%) 2/12 (16.7%) 
Liver 8/14 (57.1%) 8/14 (57.1%) 9/14 (64.3%) 1/12 (8.3%) 0/12 (0.0%) 0/0 (0.0%) 
Lymph node 6/13 (46.2%) 9/13 (69.2%) 11/13 (84.6%) 1/11 (9.1%) 0/11 (0.0%) 2/11 (18.2%) 
Kidney 9/14 (54.3%) 8/14 (57.1%) 12/14 (85.7%) 2/12 (16.7%) 0/12 (0.0%) 1/12 (8.3%) 
Small intestine 5/12 (41.7%) 6/12 (50.0%) 8/12 (66.7%) 0/12 (0.0%) 0/12 (0.0%) 1/12 (8.3%) 
Large intestine 7/13 (53.8%) 6/13 (46.2%) 10/13 (76.9%) 0/12 (0.0%) 0/12 (0.0%) 0/12 (0.0%) 
Lung 9/13 (69.2%) 10/13 (76.9%) 10/13 (76.9%) 1/12 (8.3%) 0/12 (0.0%) 0/12 (0.0%) 
Table 4.3. Number and percentages of positive results at histology, IHC and PCR for each tissue collected from the 
FIP and non FIP groups.  
 
Histology  
Histological examination was performed on 93 tissue samples obtained from FIP cats and 83 
obtained from NON FIP cats (Table 4.2). Overall, 52/93 tissues (55.9%) from FIP cats exhibited 
histological features consistent with the disease. Specifically, the most common findings were 
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pyogranulomatous and/or granulomatous inflammation, fibrinous inflammation, 
lymphoplasmacytic inflammation, necrosis, and perivascular and vascular inflammation. Those 
lesions were often simultaneously detected in the same animal and even within the same organ. It 
was not uncommon (41/93 tissues, 44.1%) that examined histological sections did not show either 
relevant lesions or lesions not consistent with FIP. In the FIP group, the tissues that most often 
showed the typical FIP histological lesions (table 3) were the lung (9/13, 69.2%),  the liver and the 
spleen (8/14, 57.1%) followed by the kidney (9/14, 54.3%) and  the large intestine (7/13, 53.8%), 
while the small intestine was the organ that less frequently showed lesions imputable to FIP (Table 
3). In all the cases, except in cat n° 2, which presented neurological signs in vivo, FIP lesions were 
found at least in one of the examined organs. In cat n°2 histological findings of the CNS showed 
the presence of lesions consistent with FIP. 
As regards for the NON FIP group, histological examination did not show lesions consistent with 
FIP in 78/84 samples (92.9%) and therefore lesions potentially consistent with FIP were found, at 
least in one tissue, only in 6/84 tissues (7.1%), collected from 3/12 cats (25.0%). The organs that 
most frequently showed lesions possibly consistent with FIP (Table 4.3) were kidney, lymph node, 
spleen and liver. Lesions consistent with FIP were never detected in the small and large intestine.  
 
Immunohistochemistry 
All the 12 cats (100%) assigned to the non FIP group had a negative IHC for FCoV antigen in all 
the examined organs, while 13/14 cats (92.8%) assigned to the FIP group showed positive results 
in at least one of the examined organs. The only cat with negative IHC in all the examined organs 
was the cat n°2 with lesions restricted on the SNC (which were either morphologically consistent 
with FIP and immunohistochemically positive). FCoV immunodetection was more frequent in 
76 
 
lung and lymph node, followed by spleen, liver and kidney, while small and large intestine were 
less often found positive (Table 4.3). 
 
RT-PCR 
As regards for the FIP group, all the cats showed a positive result in at least one of the examined 
tissues, and 70/92 samples (76.1%) resulted positive, conversely 22/92 tissues (23.9%) resulted 
negative. The organs which more often tested positive were kidney and mesenteric lymph node, 
followed by spleen, lung and large intestine, while liver and small intestine gave less frequently 
positive results (Table 4.3).  
Considering the non FIP group, 5/13 cats (38.5%) exhibited a positive result in at least one tissue, 
and overall 6/83 samples (7.2%) were positive, while FCoV PCR was negative in 77/83 samples 
(92.8%). The organs displaying the most frequent detection of viral RNA resulted mesenteric 
lymph node and spleen. Kidney and small intestine were positive in only one case, while large 
intestine, liver and lung never tested positive (Table 4.3). 
 
Agreement among histology, immunohistochemistry and PCR 
The percentage of agreement (i.e. the percentage of cases on which both the methods classified as 
negative or positive the same sample) and the concordance expressed as Cohen’s kappa 
coefficient, are reported in Table 4.4. 
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 Histo vs IHC IHC vs PCR Histo vs PCR  
All tissues 90.3% 
0.78 (0.68-0.88) 
86.9% 
0.72 (0.62-0.83) 
80.0% 
0.58 (0.46-0.70) 
Spleen 88.5% 
0.74 (0.46-1.00) 
84.0% 
0.68 (0.40-0.95) 
76.0% 
0.51 (0.19-0.83) 
Liver 96.2% 
0.91 (0.75-1.00) 
96.2% 
0.91 (0.75-1.00) 
92.3% 
0.83 (0.60-1.00) 
Lymph node 83.3% 
0.63 (0.30-0.95) 
83.3% 
0.67 (0.40-0.95) 
66.7% 
0.36 (0.03-0.68) 
Kidney 88.5% 
0.75 (0.50-1.00) 
80.8% 
0.62 (0.34-0.90) 
76.9% 
0.54 (0.22-0.86) 
Small intestine 95.8% 
0.88 (0.66-1.00) 
87.5% 
0.71 (0.42-1.00) 
83.3% 
0.61 (0.29-0.93) 
Large intestine 96.0% 
0.90 (0.70-1.00) 
84.0% 
0.64 (0.34-0.94) 
88.0% 
0.74 (0.47-1.00) 
Lung 84.0% 
0.67 (0.37-0.97) 
92.0% 
0.83 (0.61-1.00) 
76.0% 
0.50 (0.15-0.85) 
Table 4.4. Percentage of agreement and concordance, expressed as Cohen’s kappa coefficient, for all tissues 
considered together and for the single type of tissues.  
The highest rate of agreement and concordance was found between histology and IHC either on 
the whole set of tissues and on each specific tissue. However, in the lung, the highest rate of 
agreement and concordance was found between IHC and PCR; while in liver and lymph nodes, 
IHC and PCR had the same rate of agreement and concordance than histology and IHC.  
For what concern histology and IHC, tissues with the highest rate of agreement (close to or higher 
than 90%) and concordance (almost perfect, i.e. >0.8) were liver, small and large intestine, 
followed by spleen and kidney, while lung and lymph node had the lowest agreement (80-90%) 
and concordance (between 0.6 and 0.8, i.e. strong). The highest rate of agreement was found in 
tissues with a high prevalence of double negative results (i.e. where lesions were not commonly 
found). About the discordant results, the analyses of individual results (Table 2) revealed that the 
occurrence of negative IHC in tissues with lesions potentially consistent with FIP was more 
frequent than the contrary. More specifically, IHC was negative in all the 6 samples from the non 
FIP group and in 4 samples from the FIP group that were histologically consistent with FIP. 
Conversely, in the FIP group, immunohistochemistry was positive in 7 samples on which no 
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lesions histologically consistent with FIP were found. Among these, in 2 cases (spleen of cat n° 9 
and small intestine of cat n° 7) no lesions at all were histologically detected in the section used for 
histology, while in the other 5 cases histology revealed lesions not consistent with FIP. It is 
important to highlight, that the presence of negative histology and positive immunohistochemistry 
was noted in cats on which almost all the other organs resulted positive for histology and 
immunohistochemistry, except for one case (cat n°1) in which only the kidney was positive for 
histology and immunohistochemistry. 
As stated above, with the exception of liver, that had an almost absolute agreement and an almost 
perfect concordance, in all the other organs the agreement varied between 70 and 90% and 
concordance was strong (0.60-0.80) only for small and large intestine and moderate (0.40-0.60) 
for kidney and spleen. Lymph nodes had the lower rate of agreement and concordance was weak 
(<0.40). As regards the discordant results, positive PCR in tissues without lesions consistent with 
FIP, occurred more frequently than negative PCR in tissues with lesions consistent with FIP. 
Specifically, PCR was negative in all the 6 samples from the non FIP group and in 1 sample from 
the FIP group that had lesions histologically consistent with FIP. Conversely, PCR was positive in 
21 tissues from FIP cats and in 6 tissues from the NON FIP group on which no lesions consistent 
with FIP were histologically found. 3/6 cases from the non FIP group did not have histological 
lesions at all, while in 3/6 cases lymphoid hyperplasia was found. In samples without lesions 
consistent with FIP, bur PCR-positive, in the FIP group, no lesions at all were detected in 9 cases, 
while 6 cases had lymphocytic hyperplasia, 2 cases had histiocytic infiltrates and 4 cases had 
lesions not consistent with FIP. 
Finally, agreement between IHC and PCR was higher than 90% and concordance was almost 
perfect only for liver and lung. In all the other organs, agreement varied between 80 and 90% and 
concordance could be classified as strong (0.6-0.8). Overall double negative results (negative 
result in both RT-PCR and IHC) were more common than double positive results (positive result 
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in both RT-PCR and IHC). The discordant results highlighted how, in most of the cases, PCR was 
positive in tissues with negative IHC, with one exception (lung of cat n° 11). In particular, this 
occurred in the same 6 cats from the NON FIP group and in 14/21 tissues on which histology was 
negative and PCR was positive. Additionally, IHC was negative, with positive PCR in the kidney 
of cat n° 4 and in the large intestine of cat n° 14, that however, had histological lesions consistent 
with FIP. 
 
Diagnostic accuracy of immunohistochemistry and RT-PCR 
 
IHC PCR 
  Spec Sens PPV NPV  LR+ LR- Spec Sens PPV NPV LR+ LR- 
Spleen 100,0 57,1 100,0 66,7 n.c. 0,43 83,3 76,9 83,3 76,9 4,62 0,28 
Liver 100,0 57,1 100,0 66,7 n.c. 0,43 100,0 64,3 100,0 70,6 n.c. 0,36 
Lymph node 100,0 69,2 100,0 73,3 n.c. 0,31 81,8 84,6 84,6 81,8 4,65 0,19 
Kidney 100,0 57,1 100,0 66,7 n.c. 0,43 91,7 85,7 92,3 84,6 10,29 0,16 
Small intestine 100,0 50,0 100,0 66,7 n.c. 0,50 91,7 66,7 88,9 73,3 8,00 0,36 
Large intestine 100,0 46,2 100,0 63,2 n.c. 0,54 100,0 76,9 100,0 80,0 n.c. 0,23 
Lung 100,0 76,9 100,0 80,0 n.c. 0,23 100,0 76,9 100,0 80,0 n.c. 0,23 
Table 4.5. Specificity (Spec); sensitivity (Sens); positive predictive value (PPV), negative predictive value (NPV); 
positive likelihood ratio (LR+) and negative likelihood ratio (LR-) for IHC and PCR on each tissue used in the study. 
Immunohistochemistry showed absolute specificity in all tissues and consequently a high positive 
predictive value. Conversely, the sensitivity was low, as well as the negative predictive value and 
the negative likelihood ratio, except for lung and lymph node for which, nevertheless, all the values 
were not satisfactory indicating that a negative immunohistochemistry does not exclude FIP. 
Conversely, specificity and positive predictive value of PCR was absolute only for liver, lung and 
large intestine, although also for kidney and small intestine were very high. Only for spleen and 
lymph node specificity and PPV are not extremely high but the positive LR is still acceptable for 
clinical purposes. However, sensitivity and negative predictive values of PCR, although not 
absolute and probably not relevant for diagnostic purposes, are higher than for IHC. (Table 4.5) 
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DISCUSSION  
The histological lesions most frequently detected in the FIP group agreed with the ones described 
in literature (Kipar et Meli, 2014). The absence of lesions in many histological sections is not 
unexpected and can be explained with the patchy distribution of FCoV lesions. The dissemination 
of lesions, in fact, is described to vary among different organs according to the clinical presentation 
(Kipar et al., 1998). The organs in which the typical histological lesions were less often observed 
resulted large and small intestine. This finding could be explained also by the rapid occurrence of 
autolytic changes. However, this occurrence, limited a proper histological evaluation only in three 
cases. Another possible explanation concerning two cats with exclusively thoracic effusion (n°9, 
11), is that a greater number of lesions affected the organs of the thoracic, rather than abdominal, 
cavity, as demonstrated also by the histological examination of the lung. As regards the NON FIP 
group, in two cats, granulomatous inflammation potentially consistent with FIP was detected. In 
one case (kidney of cat n°21), this finding can be related with the onset of an inflammatory process 
secondary to ischaemic necrosis, caused by disruption of blood flow related with a pulmonary 
malignancy (Sykes, 2003). In the second case (spleen, liver and mesenteric lymph node of cat 
n°26), the finding could be caused by a reactive inflammation in response to the chronic formation 
of large amount of chylous effusion (Padrid, 2000). The presence of lymphoplasmacytic infiltrate 
was reported in many cases, especially in the kidney. This histological finding is frequently 
observed and regarded as consistent with FIP, but in order to be considered typical of FIP, it should 
be accompanied by granulomatous lesions, both macroscopically and microscopically. The 
presence of lymphoplasmacytic infiltrate in the kidney could be explained by the onset of 
inflammatory and degenerative changes typical of chronic kidney disease, histologically 
characterized by lymphoplasmacytic tubulointerstitial nephritis in the cat (Brown et al., 2016). 
Indeed, cats exhibiting this feature were adult or senior cats (n°17, 19, 23, 26) and in cat n°17 this 
finding was likely related with amyloid deposition. Moreover, the advanced age, as well as the 
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absence of suggestive lesions in other organs, make the diagnosis of FIP unlikely (Tasker, 2018). 
The detection of predominant lymphoplasmacytic infiltrate in small intestine of cat n°15 was due 
to Mycobacterium avium infection, although the aetiological agent had been observed only in 
histological sections from liver. Even if it is not possible to rule out the simultaneous presence of 
FIP and mycobacteriosis, the prompt recovery after specific mycobacteriosis treatment, along with 
a follow up period longer than a year, decrease the probability of FIP. In the remaining cases, the 
lymphoplasmacytic infiltrate could be due to the presence of centrilobular necrosis for liver of cat 
n°27, and of abdominal chylous effusion for kidney, small and large intestine of cat n°26. The less 
frequent immunohistochemical FCoV detection were in small and large intestine, in concordance 
with the less frequency of histological lesions. It is quite surprising given the predominantly enteric 
localisation of FCoV. Since FIP-related lesions tend to follow the course of cranial mesenteric 
artery and thus to locate mainly on the serosal surfaces of the abdominal organs, it would be logical 
to expect a higher frequency of immunohistochemical positivity in these organs (Pedersen, 2009). 
The only cat that did not show any immunohistochemical positivity in the examined organs (n°2) 
was affected by a non-effusive form of FIP and exhibited exclusively neurological symptoms and 
a positive immunohistochemistry in brain and cerebellum. A positive immunohistochemical result 
was interestingly recorded in the large intestine of cat n°22 from the NON FIP group, even if it 
was restricted to superficial epithelial cells. The presence of FCoV antigen within intestinal 
epithelial cells from asymptomatic carriers has already been described. Indeed, in healthy infected 
cats, colonic enterocytes are thought to be the main site of viral persistence in the gut (Kipar et al., 
2010). However, since FCoV antigen was not found within a lesion, this finding was recorded as 
a negative result.  
Considering diagnostic accuracy, regardless of the examined organ, the detection of 
immunohistochemical positivity is always diagnostic for FIP, since specificity and positive 
predictive value reached 100%. Therefore, the positive predictive value was not measurable. On 
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the contrary, a negative result does not always allow to exclude FIP.  Nevertheless, it should be 
considered that performing immunohistochemistry on a wide range of organs, increases the 
probabilities to diagnose FIP. Indeed, considering as ‘positive’ those animals from which at least 
one of the sampled organs resulted positive, sensitivity and positive predictive value rise to almost 
100%, and negative likelihood ratio almost reaches zero. When diagnostic accuracy was assessed 
considering as positives only samples which, together with immunohistochemical positivity, 
exhibited also histological lesions typical of FIP, results were unchanged considering the presence 
of at least one positive tissue, while a decreased sensitivity was recorded for spleen, small intestine 
and lung. This means that a positive immunohistochemical result is often, but not always, 
accompanied by the presence of typical histological lesions, possibly due to the variable 
distribution of the lesions, as already mentioned. In light of these observations, clearly FIP can not 
be rule out based only on negative histology and in case of a strong clinical suspicion it is advisable 
to obtain many sections of the same tissue and perform immunohistochemistry, especially when 
the targeted organs are spleen, small intestine and lung.  
As previously reported, RT-PCR showed an overall higher sensitivity, but lower specificity 
compared to IHC (Barker et al., 2017). In the FIP group, RT-PCR resulted less frequently positive 
in liver, in which, however, numerous histological lesions consistent with FIP and 
immunohistochemical positivity were found. A possible explanation to this discrepancy could be 
that the viral load present in the tissue section subjected to RT-PCR was too low to be amplified, 
due to the eneve distribution of lesions and, in turn, of the virus within, as explained above. The 
detection of viral RNA in NON FIP cats was a predictable finding and has already been described 
in literature. Indeed, it has been demonstrated that FECV is able to cross the intestinal tract, causing 
recurrent viremia, and persist in different sites of the organism without causing a disease 
(Herrewegh et al., 1995; Kipar et al., 2010). In particular, the common evidence of FCoV RNA in 
mesenteric lymph node and spleen is in line with what previously described in literature about 
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naturally and experimentally infected cats, which seem to harbour high viral loads in these organs, 
without developing FIP. Conversely, the absence of RT-PCR positivity in liver and lung of NON 
FIP cats is partly surprising and in disagreement with those studies which identified these organs 
as probable FCoV persistence sites in healthy cats. Indeed, liver drains blood coming from the gut 
and lung can be considered as a ‘filter’ organ, and both harbour resident macrophages which can 
guarantee viral persistence (Kipar et al., 2010). 
Considering the diagnostic accuracy results, regardless of the examined organ, a positive RT-PCR 
result cannot be considered diagnostic of FIP. The only two organs which exhibited absolute 
specificity were liver and lung, for which the positive likelihood ratio was not measurable. At the 
same time, liver showed the lowest sensitivity, with a negative likelihood ratio too high to rule out 
FIP in presence in case of a negative result. Conversely, diagnostic accuracy of the kidney was the 
highest, as demonstrated by the high positive likelihood ratio. Surprisingly, large intestine showed 
low sensitivity (recorded also with immunohistochemistry) and high specificity. RT-PCR low 
sensitivity on large intestine can be explained by a decreased viral faecal excretion, which has been 
demonstrated to occur in FIP affected cats, maybe due to the impaired tropism of mutated FCoV 
for intestinal epithelial cells (Chang et al., 2012). The organs which showed the lowest specificity 
resulted mesenteric lymph node (81.8%) and spleen (83.3%). This is a remarkable data, since those 
organs are frequently sampled for diagnostic purposes. These results demonstrate that a RT-PCR 
positivity in spleen and lymph node aspirates cannot be considered as diagnostic for FIP. Overall, 
a low specificity was recorded for RT-PCR in the diagnosis of FIP. This means that it is mandatory 
to confirm the diagnosis through histology and IHC However, based on results obtained in this 
work, RT-PCR positivity on liver and lung seems to be highly specific for FIP, and the 
simultaneous sampling from many organs led to an absolute sensitivity.  
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As regards of the concordance, in all cases except one, discordant samples resulted negative to 
immunohistochemistry and positive to RT-PCR. This is not a surprising finding, since RT-PCR 
has a higher sensitivity than the immunohistochemistry (Kipar et al., 2010; Barker et al., 2017).  
Compared to the total, concordant positive samples were obviously more numerous within the FIP 
group. This does not seem to have affected the concordance between the examined methods, 
confirming that level of concordance should not be dependent on the composition of groups. As 
regards of the NON FIP group, the presence of viral RNA in those organs which more commonly 
gave discordant results is not surprising and agrees with what previously described. In spleen and 
mesenteric lymph node, indeed, is likely to detect viral RNA in absence of a positive 
immunohistochemistry. Finally, concordance rate between different organs emerged similar. 
Conversely, considering the concordance on positive or negative results separately, concordance 
rate resulted very variable depending on the examined organ. This point out a higher probability 
to diagnose FIP when information obtained by sampling several organs are combined, or, in 
alternative, when those organs which revealed a higher concordance are individually sampled. In 
particular, these organs are firstly liver and lung and then spleen and mesenteric lymph node. 
Provided that it is always advisable to confirm possible positive or negative RT-PCR results with 
immunohistochemical examination, data concerning concordance suggest that, when both tests 
cannot be performed, it would be preferable to examine one of these organs. In fact, the probability 
to obtain accurate information, even using a single diagnostic method, results good. Instead, when 
kidney or intestine are sampled, it is always advisable to perform immunohistochemistry, since 
the concordance of the two methods is not sufficiently high.   
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V. CANINE GUT MICROBIOTA COMPOSITION IN 
ASSOCIATION WITH LEISHMANIA INFANTUM 
 
MATERIALS AND METHODS 
Animals/Caseload 
Dogs enrolled for this study were selected among those referred both to the Veterinary Teaching 
Hospital of our Institution or to external clinic for routine or diagnostic purpose. Therefore, 
according to the decision of the Ethical Committee of the University of Milan, residual aliquots of 
samples or tissues collected under informed consent of the owners can be used for research 
purposes without any additional formal request of authorization to the Ethical Committee (EC 
decision 29 Oct 2012, renewed with the protocol n° 02-2016).  
Inclusion criteria were: (1) the absence of any antibiotic treatment for a period of at least three 
months, (2) no probiotic assumption for a period of at least three months, (3) absence of any 
gastroenteric clinical signs for at least two weeks, (4) negative result at the microscopic fecal exam, 
(5) negative result for the serologic rapid test 4Dx (evaluating Dirofilaria immitis antigen and 
antibodies against Anaplasma phagocytophilium, Anaplasma platys, Borrelia burgdoferi, Erlichia 
canis and Erlichia ewingii).  
Based on the screening analyses, dogs were divided into three groups: healthy, asymptomatic but 
exposed to Leishmania and infected symptomatic for canine leishmaniasis. The healthy group (H) 
included clinically healthy dogs with any clinicopathological alteration, negative IFAT and PCR 
for Leishmania. Exposed asymptomatic group (E_A) was composed by dogs with no clinical signs 
consistent with both leishmaniasis or other diseases, nor clinicopathological abnormalities. IFAT 
in this case could be negative or low positive. The history of these animals must include an 
endemic zone living origin or a past history of IFAT high positive or clinical manifestation of 
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canine leishmaniosis with a positive outcome. Finally, the infected symptomatic group (S) 
included sick dogs with clinical signs and clinicopathological abnormalities consistent with 
Leishmania, positive result for IFAT and for one direct test for the evaluation of the presence of 
the parasite (PCR or cytology). 
 
Sample collection 
At admission, 2 mL of whole blood was collected from each dog by venipuncture of the jugular, 
cephalic od saphenous vein: 1 mL was transferred into an EDTA tube and 1 mL into a plain tube 
(Venoject, Terumo Italia Srl, Rome, Italy). According to the standard operating procedures of our 
laboratory whole blood in EDTA was analyzed for a complete blood cell count within 12-18 hours 
from the sampling. Of the leftover, 200 L were stored into a 1.5 mL Eppendorf at -20° for 
subsequent PCR analyses. The blood placed in a plain tube was centrifuged at 2500 x g for 5 
minutes and the serum was subsequently separated into a 1.5 mL Eppendorf. From each animal, a 
fresh fecal sample (at least 15 g) was collected and divided into two aliquots: one to use fresh for 
microscopic fecal examination and one immediately stored frozen at -20° for the microbiota 
analyses. Finally, a urine sample, taken by cystocentesis or spontaneous micturition, following the 
good veterinary procedures, and the sample was placed into a 5 mL plain tubes and centrifuged at 
1250 x g for 5 minutes. Subsequently, the supernatant was separated into a 1.5 mL Eppendorf.  
 
Screening analyses 
Screening analyses had the aim to correctly classify the dogs. In cases in which not already 
available, a complete blood cell count was performed using the automated haematology analyser 
Sysmex XT-2000iV (Sysmex corporation, Kobe, Japan). On the serum samples a routine basic 
panel, including at least glucose, creatinine, urea, total protein, albumin, alanine aminotransferase, 
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and alkaline phosphatase was performed using the automated spectrophotometer BT3500 
(Biotecnica instruments S.p.a, Roma, Italia). On urine supernatant, using the same instrument, the 
urinary protein / urinary creatinine ratio was assessed. An agarose gel serum protein 
electrophoresis was performed using the semiautomated instrument Hydrasis (Sebia Italia S.r.l., 
Bagno a Ripoli, Florence, Italy) as described in literature (Giordano et Paltrinieri, 2010). The 
antibody titer against Leishmania was measured through IFAT using the commercial kit 
MegaFLUO® Leish (Diagnostik Megacor, Hörbranz, Austria). Finally, on whole blood a qPCR 
for the identification of Leishmania infantum was performed. The extraction was done using a 
commercial kit (NucleoSpin® Blood, Macherey-Nagel, Germania) and following the instruction 
of the manufacturer. The qPCR was a modified protocol of what reported in literature for mix 
containing SYBR Green (Francino et al., 2006) using the instrument QuantStudio3 (Applied 
Biosystem). The positive control was represented by a sample of a dogs previously resulted 
positive for Leishmania infantum, while the negative control was water. Serology for  Dirofilaria 
immitis antigen and antibodies against Anaplasma phagocytophilium, Anaplasma platys, Borrelia 
burgdoferi, Erlichia canis and Erlichia ewingii was performed using  a rapid 
immunochromatographic test (SNAP 4Dx, IDEXX laboratories). 
 
Microbiota analyses 
All the microbiota analyses were performed in an external laboratory. Investigation of microbial 
communities (Metabarcoding analyses) by amplicon sequencing using hypervariable genomic 
region (V3-V4 region 16SrRNA gene amplification), was performed with an NGS approach on 
Illumina Platform. Total DNA was extracted for 180-220 mg of each stool sample using the 
QIAamp DNA Stool Mini Kit (QIAGEN S.r.l., Milan, Italy) following the manufacturer 
instruction. Indexed NGS libraries were set up following the Illumina 16srRNA protocol (Figure 
5.1). 
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Figure 5.1. 16S library preparation workflow  
The first step used PCR to amplify template out of a DNA sample using specific denaturated 
primers targeting the 16S V3 and V4 region with overhang adapters attached. 1 μL of the PCR 
product was used on a Bioanalyzer DNA 1000 chip (2100 Bioanalyzer with DNA 1000 Kit, 
Agilent, Santa Clara, CA, USA) to verify the size (expected size ~550 bp). After the first step of 
AMPure XP bead clean-up from free primers and primers dimers (A63880I; Beckman Coulter 
Inc., Brea, CA, USA) a second PCR was performed to attach dual index and Illumina sequencing 
adapters using the Nextera XT Index kit (Illumina, San Diego, CA, USA). A second AMPure XP 
bead clean-up step was performed in order to clean up the final library before quantification. 1 μL 
of a 1:50 dilution of the final library was run on the same Bioanalyzer DNA 1000 chip named 
above to verify the sample size (expected size ~630 bp). Calculate DNA concentration in nM, 
based on the size of DNA amplicons, was used to pool the obtained 60 libraries in equimolar 
concentration. Pooled library was sequenced using the Illumina Miseq technology in 2x300bp run 
with 20% of PhiX library as control.  
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Statistical Analyses 
Previous standard workflows depended on clustering all 16s rRNA sequences (generated by next 
generation amplicon sequencing) that occur within a 97% similarity and then assigning these to 
‘OTUs’ from reference trees. These approaches did not incorporate all the data, specifically, 
sequence quality and statistical information were not incorporated into the results. In contrast, the 
de novo read counts used here have been constructed through the incorporation of both the quality 
scores and sequence frequencies in a probabilistic noise model for nucleotide transitions. After 
filtering the sequences and removing the chimerae, the data were compared to a standard database 
of bacteria and labeled. The key step in the sequence analysis is the manner in which reads were 
denoised and assembled into groups called RSVs (Ribosomal Sequence Variants) instead of the 
traditional OTUs (Operational Taxonomic Units). The workflow was based on software packages 
from the open-source Bioconductor project (Callahan et al., 2016). The first step included filtering 
out low-quality sequencing reads and trimming the reads to a consistent length. Then, sequence 
variants were inferred and a sequence table that is a higher-resolution analogue of the common 
“OTU table” was produced. These steps were performed using the DADA2 method that relies on 
a parameterized model of substitution errors to distinguish sequencing errors from real biological 
variation. A naive Bayesian classifier method was used to assign taxonomy. This classifier 
compares sequence variants to a training set of classified sequences (GreenGenes V13 
gg_13_8_train_set_97). Alpha diversity was assessed using Observed and Shannon metrics. 
Rarefaction Species curve was produce using “rarecurve” function of Vegan Package (vegan: 
Community Ecology Package. R package version 2.5-4.). The extent of alpha diversity considering 
the three groups was evaluated using Analyse-it for Microsoft excel. Specifically, a Kruskal-Wallis 
test was performed to evaluate the presence of possible differences, followed by a post hoc test in 
case of significant results. Beta diversity (between sample diversity comparison) was assessed with 
Non-metric multidimensional scaling (NMDS), principal coordinate decomposition (also called 
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classical scaling) of a distance matrix (PCOA) chosen to represent the dissimilarity between 
samples in a low-dimensional space based on Bray-Curtis dissimilarity matrix and Jaccard 
dissimilarity matrix. The phyloseq-format microbiome data was converted into a DESeqDataSet 
for Differential Abundance OTU call (McMurdie et Holmes, 2014).  DESeq2 performs for each 
OTU a hypothesis test to see whether evidence is sufficient to decide against the null hypothesis 
that there is no effect of the A and that the observed difference between A and B was merely 
caused by experimental variability. Significance level was set at P <0.05.  
 
RESULTS 
Screening analyses 
A total of 54 dogs were firstly enrolled. After the screening analyses 15 dogs were rejected because 
they do not comply with inclusion criteria. So, 39 dogs were finally included in this study. Of this, 
25 were male and 16 female. 12 dogs were younger than 3 years, while the remaining 28 were 
older (spans from 3 to 14 years). The most represented breed was the half-breed (26 dogs), while 
the other 13 were of different breeds (Table 5.1). 
According to clinical examination and screening analyses results, these dogs were grouped as 
healthy (14 dogs), exposed asymptomatic (13 dogs) and infected symptomatic (12 dogs). 
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ID GROUP BREED AGE GENDER 
1 Healthy Half-breed 1 YY 10 MM MN 
2 Healthy Medium Schnautzer 1YY 3 MM FS 
3 Healthy Poodle 1,5 YY MN 
4 Healthy Half-breed 7 YY FS 
5 Healthy Half-breed 1 YY MN 
6 Healthy CKCS 11 YY MN 
7 Healthy Golden Retriever 5,5 YY MN 
8 Healthy Half-breed 1,5 YY FS 
9 Healthy Australia shepherd 7 YY FS 
10 Healthy Half-breed 14 YY FS 
11 Healthy Border Collie 5,5 YY FS 
12 Healthy Half-breed 2YY 6 MM MN 
13 Healthy West Highland White terrier 4YY 11MM FS 
14 Healthy Border Collie 9YY FS 
15 Asymptomatic Half-breed 8 YY MN 
16 Asymptomatic Half-breed 6 YY MN 
17 Asymptomatic Half-breed 6 YY MN 
18 Asymptomatic Half-breed 4 YY MN 
19 Asymptomatic Half-breed 14 YY MN 
20 Asymptomatic Half-breed 4 YY MN 
21 Asymptomatic Half-breed 1 YY MN 
22 Asymptomatic Half-breed 1 YY FS 
23 Asymptomatic Half-breed 1 YY FS 
24 Asymptomatic Half-breed 1 YY FS 
25 Asymptomatic Half-breed 10 YY 6 MM MN 
26 Asymptomatic Rhodesian Ridgeback 10 YY MN 
27 Asymptomatic Half-breed 8 YY MN 
28 Symptomatic Beagle 6 YY FS 
29 Symptomatic Half-breed 6 YY FS 
30 Symptomatic Half-breed 7 YY FS 
31 Symptomatic Golden Retriever 11 YY M 
32 Symptomatic Breton  4 YY M 
33 Symptomatic  English Setter  3 YY M 
34 Symptomatic Half-breed 3,6 YY F 
35 Symptomatic Bloodhound  7 YY 8 MM M 
36 Symptomatic Labrador  7 YY M 
37 Symptomatic Half-breed 8 YY F 
38 Symptomatic Half-breed 2 YY M 
39 Symptomatic Half-breed 7 YY M 
Table 5.1. Signalment and groups of the dogs enrolled in this study. YY: years, MM: months, F: female, FS: female 
spayed, M: male, MN: male neutered. 
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All the dogs included in the infected symptomatic group had clinical signs consistent with 
leishmaniasis and one of the direct tests (namely PCR or cytology) resulted positive (Table 5.2) 
ID CLINICAL SIGNS SPE IFAT DIRECT TESTS LAB DATA 
28 periocular bilateral 
alopecia, pinnae bilateral 
crust 
> α2 1:1280 PCR  mild leukopenia with LGL, ↓alb, 
↓A/G, 
29 alopecia > γ 1:1280 PCR, CYTOLOGY 
(spleen, BM) 
Severe anaemia normocytic 
normochromic and 
thrombocytopenia, mild 
leukocytosis with mature 
neutrophilia, ↓alb, ↓A/G, 
30 Lymph node enlargment N 1:160 PCR, CYTOLOGY 
(BM) 
N 
31 PU/PD, depression > α2, 
β2, γ 
1:640 PCR, CYTOLOGY 
(BM) 
Mild normocytic normochromic 
anaemia, severe proteinuria 
32 hyperthermia, lymph nodes 
enlargment, weight loss 
> γ >1:1280 CYTOLOGY (LN) Mild macrocytic hypochromic 
anaemia, LGL, ↑PT, ↓A/G, 
33 lymph nodes enlargment, 
hyperthermia, polyarthritis 
> β2, 
γ 
>1:1280 PCR Moderate macrocytic 
hypochromic anaemia, 
lymphopenia, ↑PT, ↓alb, ↓A/G 
34 Lameness and poliarthritis > γ 1:5120 PCR Severe hypochromic anemia, 
↑↑PT, ↓alb, ↓A/G, severe 
proteinuria 
35 Lymph node enlargment 
anorexia, chachexia, pale 
mucous membranes.  
> β2, 
γ 
1:320 PCR, CYTOLOGY 
(LN) 
Severe normocytic normochromic 
anaemia, leukopenia, neutropenia, 
↓alb, ↓A/G, ↑UREA, ↑CREA 
36 Monolateral epistaxis > α2, 
β2, γ 
1:640 PCR ↑PT, ↓A/G 
37 mild depression > α2, 
β2, γ 
1:160 PCR, CYTOLOGY 
(LN) 
Mild normocytic normochromic 
anemia, ↑PT, ↓A/G, mild 
proteinuria 
38 Convulsion, bilateral 
nephropaty, urinary and 
bladder sediment.  
> α2, 
γ 
1:1280 PCR Severe thrombocytopenia, 
↑↑UREA, ↑↑CREA, ↑PT, ↓alb, 
↓A/G, ↑ALT 
39 dermathitis, PU/PD >β2, 
γ 
1:160 PCR leukocytosis with eosinophilia, 
LGL, ↑PT, ↓A/G, 
Table 5.2. Clinical signs and laboratory results of the infected symptomatic dogs. N: normal, BM: bone marrow. 
 
Microbiota analysis 
A total of 10,137,881 sequences, with an average of 259,946 sequences/sample (median 273,190, 
range 69,776 - 273,190) were of adequate quality and were subsequently analysed. 
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Figure 5.1. Alpha – diversity for the entire caseload. Each line represents one sample: in blue those belonging to S 
group, in red the H, in black the E_A. The green line represents one sample that was subsequently discarded. On the 
x-axis the number of sequences is found, while on the y-axis the number of different species is represented. 
The alpha-diversity rarefaction curves confirmed the good quality of the caseload, since most of 
the sample curves grew very quickly and some of them reached a proper plateau, showing a high 
richness of bacterial species in each of the sample, even in those from which a lower number of 
sequences was extracted (Figure 5.1). In the beta-diversity graph (Figure 5.2), the group of 
symptomatic dogs (in red), seemed to be clustered differently with respect of the other two groups. 
Indeed, blue and light blue, referred to E_A and H respectively were apparently closer to each 
other, and this could mean that the microbial communities were similar in composition.  
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Figure 5.2. Beta-diversity of the whole caseload. Each dot represents one sample, in blue the exposed asymptomatic, 
in light blue the healthy dogs, in red the symptomatic dogs. The green dot is referred to a sample excluded from the 
study (N=null). On each axis is reported the variance.  
For what concern phyla, Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria and 
Cyanobacteria were the most represented phyla in all the caseload (Figure 5.3). The statistical 
analysis highlighted some significant differences. Firmicutes resulted more represented in the 
healthy (H) group, compared to the both the asymptomatic (E_A) and symptomatic (S) group (P 
=0.007 and =0.046 respectively). Proteobacteria was more abundant in S, compared to the H (P 
=0.004). Moreover, some differences were found also in less abundant phyla: [Thermi] was present 
in lower proportion in asymptomatic dogs than in healthy (P =0.049); Spirochaetes were less 
abundant in symptomatic dogs compared to both the other two groups (P =0.02 vs H and =0.001 
vs E_A). Finally, Deferribacteres and Tenericutes were less abundant in symptomatic dogs 
compared to the asymptomatic ones (P =0.016 and =0.02 respectively). 
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Figure 5.3. Bar plot representation of phylum relative abundance in the three groups.  
For what concern class comparison, Clostridia was present in higher abundance in the healthy 
group, compared to the asymptomatic dogs (P =0.03), as well as Erysipelotrichi, compared to the 
symptomatic dogs (P =0.048). On the contrary, Gammaproteobacteria was less represented in H, 
compared to both the other groups (P =0.043 in E_A and =0.0003 in S). Again, even for rarest 
classes, significant differences were highlighted. Deinococci was less represented in asymptomatic 
than in healthy dogs (P =0.045), while [Brachyspirae], Deferribacteres and Mollicutes were more 
abundant in asymptomatic than in symptomatic dogs (P =0.007, =0.02 and =0.044 respectively) 
(Figure 5.4).  
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Figure 5.4. Microbiota composition of the group of healthy (H), exposed asymptomatic (E_A) and symptomatic (S) 
dogs represented through a Krona chart that illustrate phyla and classes of the bacteria sequenced.  
Moreover, significant differences were reported when the analysis was extended to order, family 
and genus (Table 5.3 - Table 5.5) 
ORDER H E_A S 
[Brachyspirales] 0,019 0,020a* 0,003a* 
Aeromonadales 0,844a* 0,959b* 0,114a*,b* 
Anaeroplasmatales 0,042 0,0245a 0,010a 
Bifidobacteriales 0,026a** 0,007 0,011a** 
Deferribacterales 0,044a* 0,034b 0,074a*,b 
Enterobacteriales 2,722a**,b** 6,668a** 11,243b** 
Erysipelotrichales 2,423 3,388a 1,704a 
Lactobacillales 2,362a 4,897a 4,825 
Pasteurellales 0,006a 0,030 0,021a 
Streptophyta 0,010a 0,092a 0,018 
Table 5.3. Relative abundances of the classes that resulted significantly different among the three groups. For each 
class, the paired letters mean that a significant difference was found between groups. When no other symbol is present 
P <0.05, * = P <0.01 and ** = P <0.001. 
 
FAMILY H E_A S 
[o__Streptophyta]  0,010a* 0,092a* 0,018 
[o__Bacteroidales]  0,042 0,037a 0,023a 
[Tissierellaceae] 0,127a 0,155 0,143a 
Actinomycetaceae 0,006a 0,016b 0,072a,b 
Bifidobacteriaceae 0,026a* 0,007 0,011a* 
Brachyspiraceae 0,019 0,020a* 0,003a* 
Clostridiaceae 14,061a** 2,688a**,b* 6,974a* 
Deferribacteraceae 0,044a* 0,034b 0,074a*,b 
Enterobacteriaceae 2,722a**,b** 6,668a** 11,243b** 
Enterococcaceae 0,021a* 1,091 0,874a* 
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Erysipelotrichaceae 2,423 3,388a 1,704a 
Flavobacteriaceae 0,030a 0,067a 0,0324 
Hyphomicrobiaceae 0,171 0,209a 0,130a 
Micrococcaceae 0,024a 0,015 0,006a 
Pasteurellaceae 0,006a 0,030a 0,0210 
Porphyromonadaceae 0,114a**,b** 0,684a** 1,613b** 
Prevotellaceae 5,403a 10,224b* 0,557a,b* 
Succinivibrionaceae 0,844a* 0,959b 0,114a*,b 
Turicibacteraceae 2,846a 2,433 0,657a 
Veillonellaceae 2,810a* 1,961b* 0,809a*,b* 
Table 5.4. Relative abundances of the families that resulted significantly different among the three groups. For each 
family, the paired letters mean that a significant difference was found between groups. When no other symbol is 
present P <0.05, * = P <0.01 and ** = P <0.001. 
 
GENUS H E_A S 
Actinomyces 0.006a* 0.016b 0.068a*,b 
Adlercreutzia 0.058a 0.136b** 0.0243a,b** 
Allobaculum 0.414 1.067a 0.276a 
Anaerobiospirillum 0.732 0.924a 0.103a 
Anaerofilum 0.009a 0.009 0.109a 
Brachyspira 0.019 0.020a* 0.003a* 
Catenibacterium 0.628a* 0.680b* 0.0618a*,b* 
Clostridium 13.549a,b** 2.414a,c* 6.603b**,c* 
Dorea 1.624a* 2.034b* 3.659a*,b* 
Enterococcus 0.020a**,b* 1.091a** 0.874b* 
Escherichia 2.674a,b* 6.6285a 10.142b* 
Fusobacterium 2.4635a 3.454 5.584a 
Holdemania 0.023a 0.024 0.001a 
Megamonas 2.214a** 1.222b* 0.189a**,b* 
Mesorhizobium 0a* 0.006a* 0.002 
Mucispirillum 0.044a* 0.034b 0.074a*,b 
Parabacteroides 0.096a** 0.557a** 0.115 
Peptostreptococcus 0.001a* 0.006 0.024a* 
Phenylobacterium 0.011a 0.001a 0.003 
Porphyromonas 0.0005a,b** 0.108a 1.48b** 
Prevotella 5.403a 10.224b* 0.557a,b* 
Proteus 0.0002a* 0.001b 1.078a*,b 
Roseburia 0.086a 0.029b** 0.276a,b** 
Ruminococcus 0.103 0.096a 0.202a 
Streptococcus 2.12 3.6228a 3.512a 
Turicibacter 2.846a* 2.433 0.657a* 
Table 5.5. Relative abundances of the genus that resulted significantly different among the three groups. For each 
genus, the paired letters mean that a significant difference was found between groups. When no other symbol is present 
P <0.05, * = P <0.01 and ** = P <0.001. 
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DISCUSSION 
The study of microbiota composition aroused a lot of interest in human medicine and it is a new 
research field in veterinary medicine too. The most represented phyla reported in previous studies 
in healthy dogs were Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria, and this was 
confirmed also by the results of this thesis (Handl et al., 2011). The lower abundance of Firmicutes 
in the diseased animals, found in this study, is in agreement with what reported in literature, where 
this phylum is usually more represented in healthy animals (Suchodolski, 2016). The same 
consideration could be applied on Clostridia and Erysipelotrichi classes, which resulted more 
abundant in the microbiota of healthy dogs. Proteobacteria phylum is of particular concern in 
veterinary medicine, since it includes several gastrointestinal pathogens such as, for example, 
Escherichia coli. It is interesting to note that this phylum was more represented in symptomatic 
dogs, compared to the healthy ones. This finding has already been reported in literature (Zheng et 
al., 2018; Suchodolski et al., 2012b) and it could suggest the presence of dysbiosis, even in absence 
of overt gastrointestinal signs of disease. Considering the main class belonging to Proteobacteria 
phylum, meaning the Gammaproteobacteria, a significant higher abundance was found not only in 
the symptomatic, but also in the asymptomatic dogs, compared to the healthy ones and the same 
significant differences were maintained when the analyses were deepened until the genus level 
(Enterococcus and Proteus). 
For what concerns results at genus level, a lower proportion of Mucispirillum (Fam. 
Deferribacteraceae) was found in symptomatic dogs compared to both the other two groups. 
Mucispirillum has been reported in mice gut microbiota and one study highlighted its protective 
role against Salmonella infection (Herp et al., 2019). Even though the same protective mechanism 
has not been proven in dogs, the lower proportion recorded in symptomatic dogs could be a sign 
of dysbiosis or of increase susceptibility to gastrointestinal disorder. 
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Interestingly, most of the family and genus less represented in symptomatic dogs (Veillonellaceae, 
Megamonas, Prevotella, Catenibacterium and Clostridium) belong to the phyla Firmicutes and 
Bacteroidetes and had a role in the production of short chain fatty acids (SCFAs). These 
metabolites (namely acetate, propionate and butyrate) derived from the fermentation of simple 
charbohydrates had a pivotal role in the nutrition of enterocytes, but also some immunomodulatory 
effects. Indeed, it is described the stimulation of anti-inflammatory cytokines production (e.g. IL-
10 and TGFβ) and the decrease of proinflammatory cytokines (e.g. IL-6, IL-8 and TNFα) 
(Minamoto et al., 2019; Macfarlane et Macfarlane, 2012). Even though a metabolomic approach 
was not the aim of this study, it could be interesting to evaluate a possible decrease of SCFAs in 
symptomatic dogs that could possibly be in relationship with the presence of clinical disease.  
Differences in symptomatic and asymptomatic compared to the healthy dogs were expected, since 
it is already reported the presence of an altered microbiota composition in dogs with disease other 
than gastrointestinal ones (e.g. multicentric lymphoma, diabetes mellitus) (Jergens et al, 2019; 
Gavazza et al., 2018). However, results in literature about microbiota composition in healthy or 
diseased dogs are not always concordant. Moreover, it should not be forgotten that factors other 
than the presence of disease could alter microbiota composition. In literature, even if several 
studies have been reported about canine gut microbiota, there is still a lack of investigation on a 
large caseload of healthy animals, which have been deeply investigated in people. This fact could 
possibly prevent reliable consideration about differences in gut microbiota composition between 
healthy and sick animals. All the dogs enrolled in this study were fed only on commercial food in 
order to reduce at least this possible confounding factor. However, the type of commercial food 
was not the same for every dog, hence it is not known the extent of the diet influence on our 
caseload. Moreover, environment, age and body condition score could affect the microbiota 
composition, not mentioning the individual variability also present in the healthy population. Thus, 
a larger caseload could increase the probability that significant difference found in this study were 
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specifically linked to the presence or absence of a clinical disease or infection.  Hence further 
studies, possibly on a higher number of animals, are needed to better define the extent of changes 
in microbiota composition and possibly their correlation with the immune response evaluated also 
by the measurement of cytokine expression, both local and systemic. 
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VI. CORRELATION BETWEEN CANINE GUT MICROBIOTA 
COMPOSITION AND LEUKOCYTES CLASSES ASSESSED 
THROUGH FLOW CYTOMETRY IN ASSOCIATION WITH 
LEISHMANIA INFANTUM INFECTION 
 
MATERIALS AND METHODS 
Animal/Caseload and Microbiota Analyses 
Inclusion criteria and sampling methods were the same as in study V. Results from screening and 
microbiota analyses of study V were used in this further study. 
 
Flow Cytometry Analyses 
Whole blood collected into an EDTA tube was analysed in a maximum of 48 hours, according to 
the standard operating procedures of our laboratory. Flow cytometry was used to access the 
leukocytes population of CD4+, CD8+, CD5+, CD14+, CD11b, CD21 and CD4+/CD8+ using the 
flow cytometer BryCyte E6 (Mindray, Schengen, China) and the results were analysed through a 
specific software (MRFlow, Mindray, Schengen, China). Specifically, three cytoflow tubes were 
prepared for each sample, containing a whole blood volume decided based on the formula 
500/WBC, so that each tube contained exactly 500x103 cells. Then, 25 µL of RPMI solution were 
added in order to reduce the unspecific antibodies binding. In each tube 50 µL of the specific 
antibody dilution was added, following this scheme (see Table 6.1):  
• First tube: none (negative control) 
• Second tube: CD5, CD8, CD4 
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• Third tube: CD14, CD11b, CD21 
Antibody Clone Fluorocrome Specificity Producer Dilution 
CD5 YKIX322.3 FITC T lymphocytes Serotec, Oxford, 
UK 
1:400 
CD8 YCATE55.9 PE T cytotoxic 
lymphocytes 
Serotec, Oxford, 
UK 
1:35 
CD4 YKIX302.9 AF-647 T helper 
lymphocytes, 
neutrophils 
Serotec, Oxford, 
UK 
1:50 
CD14 TUK4 PE Monocyte Serotec, Oxford, 
UK 
1:25 
CD11b M1/70 PE-cy5 Neutrophils and 
monocytes 
eBioscience, San 
Diego, CA, USA 
1:500 
CD21 CA2.1D6 AF-647 B lymphocytes Serotec, Oxford, 
UK 
1:200 
Table 6.1. List of the antibodies in use and their dilution is shown. 
Each tube incubates for at least 15 minutes at room temperature. The erythrocytes were lysed using 
an 8% ammonium chloride lysant solution and then washed through centrifugation for 1250 rpm 
for 8 minutes. The supernatant was discarded and the remaining pellet was resuspended in 500 µL 
of PBS 1x and read by the flow cytometer. The cells were classified in a dot plot based on cellular 
size (Forward Scatter, FSC) and complexity (Side Scatter, SSC). On this graph a gate was placed 
in order to exclude platelets and cellular debris from the analyses. Subsequently, cell populations 
were analysed based on complexity and fluorescence. Then, for each sample the percentage of 
CD5, CD8, CD4 (only with low complexity, in order to include only lymphocyte), CD14, CD11b, 
CD21 positive cells was recorded. The percentage of neutrophils was obtained using the formula: 
CD11b-CD14.  
All the percentages obtained were then related to the white blood cells total number, in order to 
calculate the absolute number for each leukocyte subset.  
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Statistical Analysis 
Statistical analysis was performed using Analyse-it for Microsoft Excel (Analyse-it Software Ltd, 
Leeds, United Kingdom). Statistical significance was set at P <0.05. Specifically, differences in 
each leukocytes subset among the three different group were evaluated using Kruskal-Wallis test, 
followed, when statistically relevant results were found, by a Wilcoxon Mann-Whitney test. These 
comparisons have been performed for both the percentages and the absolute number of leukocytes 
classes. Correlation between microbiota phylum and absolute number of leukocytes classes was 
performed using the Spearmann’s test.  
 
RESULTS 
For what concern the composition of the three groups, see the results of the study V above. For 
dogs 11, 17 and 36 it was not possible to collect enough EDTA whole blood sample to perform 
the flow cytometric evaluation. On the other hand, two additional dogs, 40 and 41, belonging 
respectively to asymptomatic and symptomatic groups, have been included in this part of the study.  
For these two dogs it was not possible to collect a proper faecal sample for the microbiota 
evaluation.  
Flow cytometry evaluation was finally performed on 38 dogs. For 36 out of 38, microbiota 
composition results were available for the correlation (Table 6.2). 
ID GROUP BREED AGE GENDER MICROBIOTA  
1 Healthy Half-breed 1 YY 10 MM MN YES 
2 Healthy Medium Schnautzer 1YY 3 MM FS YES 
3 Healthy Poodle 1,5 YY MN YES 
4 Healthy Half-breed 7 YY FS YES 
5 Healthy Half-breed 1 YY MN YES 
6 Healthy CKCS 11 YY MN YES 
7 Healthy Golden Retriever 5,5 YY MN YES 
8 Healthy Half-breed 1,5 YY FS YES 
9 Healthy Australia shepherd 7 YY FS YES 
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10 Healthy Half-breed 14 YY FS YES 
12 Healthy Half-breed 2YY 6 MM MN YES 
13 Healthy West Highland White terrier 4YY 11MM FS YES 
14 Healthy Border Collie 9YY FS YES 
15 Asymptomatic Half-breed 8 YY MN YES 
16 Asymptomatic Half-breed 6 YY MN YES 
18 Asymptomatic Half-breed 4 YY MN YES 
19 Asymptomatic Half-breed 14 YY MN YES 
20 Asymptomatic Half-breed 4 YY MN YES 
21 Asymptomatic Half-breed 1 YY MN YES 
22 Asymptomatic Half-breed 1 YY FS YES 
23 Asymptomatic Half-breed 1 YY FS YES 
24 Asymptomatic Half-breed 1 YY FS YES 
25 Asymptomatic Half-breed 10 YY 6 MM MN YES 
26 Asymptomatic Rhodesian Ridgeback 10 YY MN YES 
27 Asymptomatic Half-breed 8 YY MN YES 
28 Symptomatic Beagle 6 YY FS YES 
29 Symptomatic Half-breed 6 YY FS YES 
30 Symptomatic Half-breed 7 YY FS YES 
31 Symptomatic Golden Retriever 11 YY M YES 
32 Symptomatic  Half-Breed  3 YY  M YES 
33 Symptomatic   Half-breed  5 YY  F YES 
34 Symptomatic Half-breed 3,6 YY F YES 
35 Symptomatic Bloodhound  7 YY 8 MM M YES 
37 Symptomatic Half-breed 8 YY F YES 
38 Symptomatic Half-breed 2 YY M YES 
39 Symptomatic Half-breed 7 YY M YES 
40 Asymptomatic Half-breed 1 YY 6 MM M NO 
41 Symptomatic Half-breed 6,7 YY M NO 
Table 6.2. Signalment, groups and availability of microbiota composition for the dogs enrolled in this study. YY: 
years, MM: months, F: female, FS: female spayed, M: male, MN: male neutered. 
 
Comparison of percentages of leukocytes classes among three groups 
The comparison of the percentages of leukocyte classes resulted in the absence of any statistical 
significance when considering CD14+ (corresponding with monocytes, P =0.63) and CD4:CD8 
ratio (P =0.34) (Figure 6.1).  
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Figure 6.1. Comparison of the percentage of CD14+ cells (left) and CD4:CD8 ratio (right) among the group 
ASYMPTOMATIC, HEALTHY and SYMPTOMATIC. The orange crosses represent the near outliers.  
For what concern all the other classes, a significant difference has been observed for CD11b+ (P 
=0.0015), Neutrophils (P =0.011), CD5+ (P =0.0045), CD4+ (P =0.022), CD8+ (P =0.017) and 
CD21+ (P =0.002). Specifically, CD11b and Neutrophils were lower in the HEALTHY group 
compared both to the ASYMPTOMATIC (P =0.022 and P =0.026 respectively) and 
SYMPTOMATIC group (P =0.0009 and P =0.0077 respectively). The comparison between 
SYMPTOMATIC and ASYMPTOMATIC did not result in significant differences (Table 6.3 and 
Figure 6.2).  
  Group  Median IQR 95% CI Min Max 
CD11b+  
(%) 
Asymptomatic 79,91 8,36 73,09 to 81,76 65,76 90,72 
Healthy 72,82 5,88 69,68 to 75,63 65,30 83,62 
Symptomatic 83,32 15,31 76,35 to 92,37 71,79 94,42 
Neutrophils 
(%) 
Asymptomatic 70,49 13,94 61,50 to 77,01 56,37 84,68 
Healthy 62,82 11,29 56,83 to 68,79 52,43 75,44 
Symptomatic 74,07 18,86 67,02 to 86,48 59,11 90,71 
Table 6.3. Percentages of CD11b+ cells and neutrophils in dogs belonging to ASYMPTOMATIC, HEALTHY and 
SYMPTOMATIC group. For each group median, interquartile range, 95% confidence interval and maximum and 
minimum value has been reported. 
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Figure 6.2. Comparison of the percentage of CD11b+ cells (left) and Neutrophils (right) among the group 
ASYMPTOMATIC, HEALTHY and SYMPTOMATIC.  
For what concern the lymphocytes classes, CD21+ and CD8+ cells were significantly lower in the 
SYMPTOMATIC group compared to both ASYMPTOMATIC (P =0.0019 and 0.0039 
respectively) and HEALTHY (P =0.0028 and P =0.0077), while no differences were recorded in 
the comparison between these latter two groups. On the other hand, CD4+ and CD5+ were 
significantly lower in the SYMPTOMATIC group, compared to the HEALTHY one (P =0.0055 
and P =0.0023 respectively), but not to dogs belonging to the ASYMPTOMATIC group (Table 
6.4 and Figure 6.3) 
  Group Median IQR 95% CI Min Max 
CD21+ 
(%) 
Asymptomatic 5,81 2,59 4,49 to 7,67 2,57 15,15 
Healthy 5,62 4,64 3,43 to 10,43 0,83 11,26 
Symptomatic 1,30 1,70 0,54 to 2,58 0,19 8,43 
CD8+ 
(%) 
Asymptomatic 5,77 2,80 3,61 to 6,54 2,29 7,72 
Healthy 5,61 2,92 3,84 to 7,93 3,47 9,89 
Symptomatic 3,04 3,52 1,55 to 5,13 0,64 7,27 
CD4+ 
(%) 
Asymptomatic 5,01 4,53 3,74 to 8,76 2,57 9,67 
Healthy 7,08 2,84 5,60 to 8,49 3,83 12,70 
Symptomatic 3,99 3,69 2,08 to 5,94 1,88 10,43 
CD5+ 
(%) 
Asymptomatic 13,09 5,74 8,91 to 16,96 6,68 21,64 
Healthy 14,91 5,73 13,43 to 19,71 10,24 29,50 
Symptomatic 9,35 9,34 4,26 to 13,81 3,01 17,46 
Table 6.4. Percentages of CD21+ cells and neutrophils in dogs belonging to ASYMPTOMATIC, HEALTHY and 
SYMPTOMATIC group. For each group median, interquartile range, 95% confidence interval and maximum and 
minimum value has been reported. 
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Figure 6.3. Comparison of the percentage of CD21+ cells (upper left), CD8+ cells (upper right), CD5+ cells (lower 
left) and CD4+ cells (lower right) among the group ASYMPTOMATIC, HEALTHY and SYMPTOMATIC. The 
orange crosses represent the near outliers, while the red stars represent the outliers. 
  
Comparison of the absolute number of leukocytes classes among three groups 
The comparison of the absolute number of leukocyte classes resulted in the absence of any 
statistical significance when considering CD14+ (P =0.51), CD11b+ (P =0.44) and Neutrophils (P 
=0.43) among the three groups considered (Figure 6.4).  
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Figure 6.4. Comparison of the absolute value (expressed as x10³/μL) of CD14+ cells (left), CD11b+ cells (centre) 
and neutrophils (right) among the group ASYMPTOMATIC, HEALTHY and SYMPTOMATIC. The orange crosses 
represent the near outliers.  
For what concern lymphocytes classes, a significant difference has been observed in CD5+ (P 
=0.0042), CD4+ (P =0.0018), CD8+ (P =0.0043) and CD21+ (P =0.0004) among the three 
groups (Table 6.5). 
    Median IQR 95% CI Max Min 
CD5+ (x10³/μL)  
Asymptomatic 1,37 0,61 0,91 to 1,66 2,05 0,61 
Healthy 1,68 0,98 0,90 to 1,90 2,96 0,83 
Symptomatic 0,51 0,73 0,33 to 1,09 2,03 0,31 
CD4+ (x10³/μL) 
Asymptomatic 0,63 0,30 0,35 to 0,70 0,81 0,34 
Healthy 0,70 0,46 0,39 to 0,91 1,27 0,27 
Symptomatic 0,28 0,30 0,16 to 0,52 0,63 0,13 
CD8+ (x10³/μL) 
Asymptomatic 0,50 0,32 0,30 to 0,69 1,13 0,17 
Healthy 0,49 0,45 0,30 to 0,79 0,10 0,21 
Symptomatic 0,14 0,26 0,11 to 0,46 0,75 0,07 
CD21+ (x10³/μL) 
Asymptomatic 0,66 0,38 0,34 to 0,80 1,10 0,22 
Healthy 0,55 0,67 0,28 to 1,04 1,56 0,05 
Symptomatic 0,10 0,20 0,03 to 0,27 0,66 0,01 
Table 6.5. Absolute values expressed as x10³/μL of CD5+, CD4+, CD8+ and CD21+ cells in dogs belonging to 
ASYMPTOMATIC, HEALTHY and SYMPTOMATIC group. For each group median, interquartile range, 95% 
confidence interval and maximum and minimum value has been reported. 
Specifically, in all those cases, lymphocyte belonging to classes of CD5+, CD4+, CD8+ and CD 
21+ were lower in the SYMPTOMATIC group compared to both ASYMPTOMATIC (P =0.0047, 
0.0028, 0.0039 and 0.0016 respectively) and HEALTHY (P =0.0047, 0.0028, 0.0047 and 0.0003 
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respectively). On the other hand, the comparison between HEALTHY and ASYMPTOMATIC 
did not result in significant differences, in any lymphocyte class (Figure 6.5).  
   
  
Figure 6.5. Comparison of the absolute value (expressed as x10³/μL) of CD5+ cells (upper left), CD4+ cells (upper 
right), CD8+ (lower let) and CD21+ (lower right) cells among the group ASYMPTOMATIC, HEALTHY and 
SYMPTOMATIC. The orange crosses represent the near outliers.  
 
Correlation between microbiota phyla and leukocyte classes 
The statistical analyses of correlation between different phyla found in the gut microbiota (see 
Study V) and the absolute number of leukocyte classes results in few significant results.  
Specifically, a mild positive correlation was found between Actinobacteria and CD11b (r =0.35) 
and Fusobacteria and CD4:CD8 (r =0.33). A mild negative correlation was found between 
Fusobacteria and CD11b (r =-0.35) and Neutrophils (r =-0.39) (Figure 6.6). 
Asymptomatic Healthy Symptomatic
0,25
0,75
1,25
1,75
2,25
2,75 #CD5
Asymptomatic Healthy Symptomatic
0,1
0,3
0,5
0,7
0,9
1,1
1,3
#CD4
Asymptomatic Healthy Symptomatic
0
0,2
0,4
0,6
0,8
1
1,2
#CD8
Asymptomatic Healthy Symptomatic
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
#CD21
110 
 
    
Figure 6.6. Significant correlation among Actinobacteria and CD11b (first graph), Fusobacteria and CD11b (second 
graph), neutrophils (third graph) and CD4:CD8 (fourth graph) 
 
DISCUSSION 
It has been demonstrated that the immune system plays a pivotal role in the development and 
outcome of Leishmania spp. infection in dogs. Results from the present study were in agreement 
with some studies present in the literature.  In the murine model of cutaneous leishmaniasis a Th1 
response has been correlated with resistance and a Th2 response to susceptibility to the disease. 
However, this is not true for human and murine visceral leishmaniasis, in which usually a mixed 
response has been found (Miralles et al., 1994). In canine Leishmania spp. infection, even though 
not completely understood, the Th1-like immunity seems to be protective as well (Solano-Gallego 
et al., 2000). In our study all the lymphocyte classes were significantly decreased in the 
SYMPTOMATIC group compared with both the exposed ASYMPTOMATIC and the HEALTHY 
dogs. CD21+ is a B-cells antigen and even though B-cells are involved in the subsequent 
stimulation of plasma cells and immunoglobulin production, responsible for most of the clinical 
signs of canine leishmaniasis, this process usually occurs in lymphoid organs or in bone marrow. 
For this reason, it is not surprising to find a low proportion (both in percentage and absolute 
number) of CD21+ cells in peripheral blood of dogs affected by clinical leishmaniasis, as already 
reported in literature (Bourdoiseau et al., 1997; Reis et al., 2006). The significant decrease in the 
number of CD5+, CD4+ cells in SYMPTOMATIC dogs is not surprising as well, because the lack 
of T lymphocytes and the related Th1 response is associated with the susceptibility to the disease, 
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as already stated above (Bourdoiseau et al., 1997; Reis et al., 2006). The use of CD4:CD8 ratio in 
canine leishmaniasis is still controversial. Indeed, even though our results agreed with some 
studies, others reported a decrease of that ratio in symptomatic dogs (Miranda et al., 2007; Coura-
Vital et al., 2011). In our study there is not a significant difference in CD4:CD8 among the three 
groups examined and this could be due to a lower concentration of CD8+ together with CD4+ cells 
in the SYMPTOMATIC group that lead to a lack of any change in the ratio between the two 
lymphocytes populations. The evaluation of the related box plot, even though not significant, 
suggest that, in this study, CD4:CD8 seems to be lower in the asymptomatic group. This evidence 
is in agreement with what reported in the study of Reis and colleagues (Reis et al., 2006) in which 
an increase in CD8+ determine an inversion on CD4:CD8 ratio and is associated with low parasite 
density in bone marrow. These results are reflection of the complexity of canine leishmaniasis thus 
it could be interesting to further investigate the role of Th1/Th2 response through the use of 
cytokine expression measurement. The results of correlation, even though statistically significant, 
were not high enough to be relevant. An evaluation on a higher number of animals is suggested to 
confirm this correlation. Moreover, this is the first report, to our knowledge, of this kind of 
evaluation, so there are no data to hypothesize the effective role of this phyla on the immune 
system. However, this could be a starting point for new investigation on the role of microbiota in 
shaping the immune system.   
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CONCLUSIONS 
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This PhD project was aimed to investigate the presence of possible correlations between gut 
microbiota and the presence of systemic infectious diseases in dogs and cats. Based on the peculiar 
pathogenesis, feline infectious peritonitis and canine leishmaniasis have been identified as the 
ideal disease model to investigate this correlation, since clinical presentation in both the diseases 
relies not only on the pathogenic effect of the etiologic agents but also on the type of immune 
response mounted by the host, which can be efficient in eliminating the pathogen or, on the 
contrary, in enhancing its systemic spread and/or causing multi-organic dysfunctions and 
frequently the death of affected animals. This approach in the investigation of these diseases is, in 
our knowledge, the first studies ever accomplished on this topic.  
Moreover, for FIP, due to difficulties in diagnosing the disease in vivo, that lead to a delay in the 
enrolment of clinical cases, the performances of new biomarker have been evaluated. Specifically, 
reference interval and diagnostic performance of PON-1 have been measured, as well as the 
concordance of PCR with the IHC, which is the gold standard for FIP diagnosis.  
Specifically, the most relevant findings of this thesis are the following: 
- Preliminary results about microbiota composition in cats affected by FIP and healthy 
coronavirus positive cats have been provided. The absence of significant differences 
among the three groups could be related with the low number of samples, caused mainly 
by the strict inclusion criteria that have been applied in order to reduce all the factors that 
could influence microbiota composition (for example outdoor access or contact with other 
species). Nevertheless, in our study, the cats positive to FCoV but resistant to FIP group 
showed a lower Bacteroidetes to Firmicutes ratio compared to the other groups, possibly 
indicating that the presence of the FCoV in the enterocytes. may alter microbiota stability, 
even in absence of overt clinical signs. Investigation of the causes and clinical significance 
of these microbiota changes on a larger number of animals are required to better understand 
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the pathogenesis and possibly provide some input for treatment of this fatal condition. The 
correlation of the data collected here, together with feature concerning the immune asset 
of the intestinal mucosa in these cats would represent an interesting starting point for future 
investigations.   
- Reference interval for PON-1 activity in healthy cats has been calculated and spans from 
57.8 to 153.7 U/mL. No partitioning for age of gender are required. However, it could be 
interesting the measurement of PON-1 activity in newborns, which are not included in the 
study and could have low values of PON-1 due to a liver immaturity. 
- PON-1 seems to have a usefulness as a biomarker in the diagnosis of FIP, even if the best 
results have been provided during the effusive form of the disease. The paraoxon-based 
method is a less expensive test that provide results in a short time. As already stated in 
literature, the association of PON-1 results with other tests, especially in dubious cases, 
could increase the positive predictive value of the disease. Further studies on other diseases 
with a strong inflammatory (panleukopenia, sepsis or triadis) or oxidative stress (neoplasia) 
component are required to better characterized the diagnostic potential of this negative 
acute phase reactant.  
- Even though the immunohistochemistry is considered the gold standard for the diagnosis 
of FIP, its sensitivity is not optimal, especially in those cases in which lesions are localized 
in few organs. For this reason, it is useful to associate information regarding different 
organs and, when not possible, preferring mesenteric lymph node and lung biopsies, 
instead of intestine ones. For what concern the RT-PCR, it shows a low specificity, as 
already reported in literature, but with liver and lung sample that show maximum 
specificity. On the other hand, RT-PCR on renal samples gave the highest sensitivity. 
However, it is not possible to use RT-PCR to confirm the diagnosis of FIP because of the 
high number of false positive results. The good agreement between these two methods 
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suggests the possible use of an association of both techniques in order to minimize 
diagnostic errors.  
- Results of microbiota composition among dogs with or without Leishmania (both in 
presence of clinical signs or not) highlight some significant differences, specifically in the 
Firmicutes and Proteobacteria phyla, that are in agreement with what reported in literature. 
Moreover, an interesting finding about lower abundance of Mucispirillum and SCFAs 
producing genus were found in symptomatic dogs. An evaluation on a higher number of 
cases, and eventually the chance to sample infected asymptomatic, instead of exposed ones 
(chosen for ethical reasons), could lead to different results. This is the first study that 
investigate the gut microbiota composition in dogs with leishmaniasis and gave new insight 
on this disease.   
- Results from flow cytometric evaluation are partially in agreement with what reported in 
literature. Immune response could be further investigated through the measurement of 
cytokine expression. Some correlations have been found between microbiota phyla and 
leukocyte classes. However, these preliminary results need an investigation on a higher 
number of dogs. Moreover, in literature there are no data about this correlation, so it is 
quite difficult to biologically explain it. Nevertheless, this could be a starting point for the 
researcher. 
In conclusion, the investigation of possible correlations between the intestinal microbiota 
composition and the immune asset in systemic infectious diseases of dogs and cats would require 
a big amount of data to be adequately investigated, as well as a deepen knowledge about the exact 
relationship that allows microbiota to shape immunity. However, data obtained in this PhD project 
could be a starting point to better investigate this subject and eventually highlight new aspects of 
the pathogenesis of investigated disease.  
116 
 
REFERENCES 
Abt MC, Osborne LC, Monticelli LC, Doering TA, Alenghat T, Sonnenberg GF, Paley MA, 
Antenus M, Williams KL, Erikson J., Wherry EJ., Artis D. Immunity (2012) 37(1):158-170 
Commensal Bacteria Calibrate the Activation Threshold of Innate Antiviral Immunity 
Adak A, Khan MR. Cellular and Molecolar Life Science (2019) 76(3):473-493 An insight 
into gut microbiota and its functionalities.  
Addie D, Belák S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann 
K, Hosie MJ, Lloret A, Lutz H, Marsilio F, Pennisi MG, Radford AD, Thiry E, Truyen U, 
Horzinek MC. Journal of Feline Medicine and Surgery (2009) 11(7):594-604 Feline 
infectious peritonitis. ABCD guidelines on prevention and management. 
Addie DD, Jarrett O. Veterinary Record (2001) 148(21):649-53 Use of a reverse-
transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by 
healthy cats. 
Alessandri G, Milani C, Mancabelli L, Mangifesta M, Lugli GA, Viappiani A, Duranti S, 
Turroni F, Ossiprandi MC, van Sinderen D, Ventura M. Environmental Microbiology (2019) 
21(4):1331-1343 Metagenomic dissection of the canine gut microbiota: insights into 
taxonomic, metabolic and nutritional features. 
Alkanani AK, Hara N, Gottlieb PA, Ir D, Robertson CE, Wagner BD, Frank DN, Zipris D. 
Diabetes (2015) 64(10):3510-20 Alterations in Intestinal Microbiota Correlate With 
Susceptibility to Type 1 Diabetes. 
Almeida AB, Sousa VR, Gasparetto ND, da Silva GF, Figueiredo FB, Dutra V, Nakazato L, 
Madeira MF. Diagnostic Microbiology and Infectious Disease (2013) 76(3):321-4 Canine 
visceral leishmaniasis: diagnostic approaches based on polymerase chain reaction employing 
different biological samples. 
Almeida MA, Jesus EE, Sousa-Atta ML, Alves LC, Berne ME, Atta AM. Veterinary 
Immunology and Immunopathology (2005) 106(1-2):151-8 Antileishmanial antibody profile 
in dogs naturally infected with Leishmania chagasi. 
Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Science (2005) 
307(5717):1915-20 Host-bacterial mutualism in the human intestine. 
Baneth G. Leishmaniasis. In: Greene GE, ed. Infectious Diseases of the Dog and Cat, 3rd 
edn. Philadelphia, W.B. Saunders (2005) 685–95 
Barker EN, Stranieri A, Helps CR, Porter EL, Davidson AD, Day MJ, Knowles T, Kipar A, 
Tasker S. Veterinary Research (2017) 48(1):60 Limitations of using feline coronavirus spike 
protein gene mutations to diagnose feline infectious peritonitis.  
117 
 
Bin Ali A, Zhang Q, Lim YK, Fang D, Retnam L, Lim SK. Free Radical Biology&Medicine 
(2003) 34(7):824-9 Expression of major HDL-associated antioxidant PON-1 is gender 
dependent and regulated during inflammation.  
Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, D Lieber A, Wu F, Perez-
Perez GI, Chen Y, Schweizer W, Zheng X, Contreras M, Dominguez-Bello MG, Blaser MJ. 
Science Translational Medicine (2016) 8(343):343ra82 Antibiotics, birth mode, and diet 
shape microbiome maturation during early life. 
Bosch BJ, Van der Zee R, de Haan CA, Rottier PJ. Journal of Virology (2003) 77(16):8801-
11 The coronavirus spike protein is a class I virus fusion protein: structural and functional 
characterization of the fusion core complex. 
Bourdoiseau G, Bonnefont C, Magnol JP, Saint-André I, Chabanne L. Veterinary 
Immunology and Immunopathology (1997) 56(3-4):345-51 Lymphocyte subset 
abnormalities in canine leishmaniasis. 
Brandonisio O, Panunzio M, Faliero SM, Ceci L, Fasanella A, Puccini V. Veterinary 
Immunology and Immunopathology (1996) 53(1-2):95-103 Evaluation of 
polymorphonuclear cell and monocyte functions in Leishmania infantum-infected dogs. 
Brown CA, Elliott J, Schmiedt CW, Brown SA. Veterinary pathology (2016) 53(2):309-326 
Chronic kidney disease in aged cats: clinical features, morphology, and proposed 
pathogeneses.  
Callahan BJ, Sankaran K, Fukuyama JA, McMurdie PJ, Holmes SP. F1000Research (2016) 
5:1492 Bioconductor Workflow for Microbiome Data Analysis: from raw reads to 
community analyses. 
Camps J, Marsillach J, Joven J. Critical Reviews in Clinical Laboratory Science (2009) 
46:83-106 The paraoxonases: role in human diseases and methodological difficulties in 
measurement.  
Cardoso L, Schallig HD, Cordeiro-da-Silva A, Cabral M, Alunda JM, Rodrigues M. 
Veterinary Immunology and Immunopathology (2007) 117(1-2):35-41 Anti-Leishmania 
humoral and cellular immune responses in naturally infected symptomatic and asymptomatic 
dogs. 
Chang HW, Egberink HF, Halpin R, Spiro DJ, Rottier PJM. Emerging Infectious Diseases 
(2012) 18(7):1089-1095 Spike protein fusion peptide and feline coronavirus virulence.  
Ciaramella P, Oliva G, Luna RD, Gradoni L, Ambrosio R, Cortese L, Scalone A, Persechino 
A. Veterinary Record (1997) 141(21):539-43 A retrospective clinical study of canine 
leishmaniasis in 150 dogs naturally infected by Leishmania infantum. 
118 
 
Cornelissen E, Dewerchin HL, Van Hamme E, Nauwynck HJ. Virus Research (2009) 144(1-
2):285-9. Absence of antibody-dependent, complement-mediated lysis of feline infectious 
peritonitis virus-infected cells. 
Corrêa AP, Dossi AC, de Oliveira Vasconcelos R, Munari DP, de Lima VM. Veterinary 
Parasitology (2007) 143(3-4):267-74 Evaluation of transformation growth factor beta1, 
interleukin-10, and interferon-gamma in male symptomatic and asymptomatic dogs naturally 
infected by Leishmania (Leishmania) chagasi. 
Costa M, Weese JS. The Veterinary Journal (2019) 249:10-15 Methods and basic concepts 
for microbiota assessment. 
Coura-Vital W, Marques MJ, Giunchetti RC, Teixeira-Carvalho A, Moreira ND, Vitoriano-
Souza J, Vieira PM, Carneiro CM, Corrêa-Oliveira R, Martins-Filho OA, Carneiro M, Reis 
AB. The Veterinary Journal (2011) 190(2):e43-7 Humoral and cellular immune responses in 
dogs with inapparent natural Leishmania infantum infection. 
Crawford AH, Stoll AL, Sanchez-Masian D, Shea A, Michaels J, Fraser AR, Beltran E. 
Journal of Veterinary Internal Medicine (2017) 31(5):1477-1486 Clinicopathologic Features 
and Magnetic Resonance Imaging Findings in 24 Cats With Histopathologically Confirmed 
Neurologic Feline Infectious Peritonitis. 
da Costa-Val AP, Cavalcanti RR, de Figueiredo Gontijo N, Michalick MS, Alexander B, 
Williams P, Melo MN. The Veterinary Journal (2007) 174(3):636-43 Canine visceral 
leishmaniasis: relationships between clinical status, humoral immune response, haematology 
and Lutzomyia (Lutzomyia) longipalpis infectivity. 
de Groot-Mijnes JD, van Dun JM, van der Most RG, de Groot RJ. Journal of Virology 
(2005) 79(2):1036-44 Natural history of a recurrent feline coronavirus infection and the role 
of cellular immunity in survival and disease. 
de Lima VM, Peiro JR, de Oliveira Vasconcelos R. Veterinary Immunology and 
Immunopathology (2007) 115(1-2):189-93 IL-6 and TNF-alpha production during active 
canine visceral leishmaniasis. 
de Menezes JP, Saraiva EM, da Rocha-Azevedo B. Parasites & Vectors (2016) 9: 264. The 
site of the bite: Leishmania interaction with macrophages, neutrophils and the extracellular 
matrix in the dermis. 
de Souza HSP, Fiocchi C, Iliopoulos D Nature Reviews. Gastroenterology & Hepatology 
(2017) 14(12):739-749 The IBD interactome: an integrated view of aetiology, pathogenesis 
and therapy. 
Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, Wu X, DeStefano Shields CE, 
Hechenbleikner EM, Huso DL, Anders RA, Giardiello FM, Wick EC, Wang H, Wu S, 
119 
 
Pardoll DM, Housseau F, Sears CL Science (2018) 359(6375):592-597 Patients with familial 
adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. 
Desai AR, Musil KM, Carr AP, Hill JE. Veterinary Microbiology (2009) 137 (1–2), 120–128 
Characterization and quantification of feline fecal microbiota using cpn60 sequence-based 
methods and investigation of animal-to-animal variation in microbial population structure.  
Di Muccio T, Scalone A, Bruno A, Marangi M, Grande R, Armignacco O, Gradoni L, 
Gramiccia M. PLoS One (2015) 10(6):e0129418 Epidemiology of Imported Leishmaniasis in 
Italy: Implications for a European Endemic Country. 
Draganov D, Teiber J, Watson C, Bisgaier C, Nemzek J, Remick D, Standiford T, La Du B. 
Advances in Experimental Medicine and Biology (2010) 660:89-97 PON1 and oxidative 
stress in human sepsis and an animal model of sepsis. 
Drechsler Y, Alcaraz A, Bossong FJ, Collisson EW, Diniz PP. The Veterinary Clinics of 
North America. Small Animal Practice (2011) 41(6):1133-69 Feline coronavirus in multicat 
environments. 
Duthie S, Eckersall PD, Addie DD, Lawrence CE, Jarrett O. Veterinary Record (1997) 
141(12):299-303 Value of alpha 1-acid glycoprotein in the diagnosis of feline infectious 
peritonitis. 
Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. Nature Communications (2017) 
8(1):1784 Meta-analysis of gut microbiome studies identifies disease-specific and shared 
responses. 
Engwerda CR, Ato M, Kaye PM. Trends in Parasitology (2004) 20(11):524-30 Macrophages, 
pathology and parasite persistence in experimental visceral leishmaniasis. 
Feingold KR, Memon RA, Moser AH, Grunfeld C. Atherosclerosis (1998) 139:307-315 
Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase 
response.  
Felten S, Leutenegger CM, Balzer HJ, Pantchev N, Matiasek K, Wess G, Egberink H, 
Hartmann K. BMC Veterinary Research (2017b) 13(1):228 Sensitivity and specificity of a 
real-time reverse transcriptase polymerase chain reaction detecting feline coronavirus 
mutations in effusion and serum/plasma of cats to diagnose feline infectious peritonitis. 
Felten S, Matiasek K, Gruendl S, Sangl L, Wess G, Hartmann K. Journal of Feline Medicine 
and Surgery (2017a) 19(4):410-418 Investigation into the utility of an immunocytochemical 
assay in body cavity effusions for diagnosis of feline infectious peritonitis. 
Fischer Y, Weber K, Sauter-Louis C, Hartmann K. Tierarztliche Praxis. Ausgabe K, 
Kleintiere/Heimtiere (2013) 41(5):297-303 The Rivalta's test as a diagnostic variable in 
feline effusions--evaluation of optimum reaction and storage conditions. 
120 
 
Font A, Closa JM, Mascort J. Journal of Veterinary Internal Medicine (1994) 8(3):233-5 
Monoclonal gammopathy in a dog with visceral leishmaniasis. 
Francino O, Altet L, Sánchez-Robert E, Rodriguez A, Solano-Gallego L, Alberola J, Ferrer 
L, Sánchez A, Roura X. Veterinary Parasitology (2006) 137(3-4):214-21 Advantages of real-
time PCR assay for diagnosis and monitoring of canine leishmaniosis. 
Friedrichs KR, Harr KE, Freeman KP, Szladovits B, Walton RM, Barnhart KF, Blanco-
Chavez J; American Society for Veterinary Clinical Pathology. Veterinary Clinical 
Pathology (2012) 41(4):441-53 ASVCP reference interval guidelines: determination of de 
novo reference intervals in veterinary species and other related topics. 
Furlong CE, Marsillach J, Jarvik GP, Costa L.G. Chemico-Biological Interactions (2016) 259 
(Pt B): 51–62 Paraoxonases-1, -2 and -3: What are their Functions?  
Gavazza A, Rossi G, Lubas G, Cerquetella M, Minamoto Y, Suchodolski JS. Veterinary 
Comparative Oncology (2018) 16(1):E169-E175 Faecal microbiota in dogs with multicentric 
lymphoma. 
Geffré A, Concordet D, Braun JP, Trumel C. Veterinary Clinical Pathology (2011) 
40(1):107-12 Reference Value Advisor: a new freeware set of macroinstructions to calculate 
reference intervals with Microsoft Excel.  
Giordano A, Paltrinieri S. Veterinary Clinical Pathology (2010) 39(4):464-73 Interpretation 
of capillary zone electrophoresis compared with cellulose acetate and agarose gel 
electrophoresis: reference intervals and diagnostic efficiency in dogs and cats. 
Giordano A, Stranieri A, Rossi G, Paltrinieri S. Veterinary Clinical Pathology (2015) 
44(2):295-302 High diagnostic accuracy of the Sysmex XT-2000iV delta total nucleated cells 
on effusions for feline infectious peritonitis. 
Giordano A, Veronesi MC, Rossi G, Pezzia F, Probo M, Giori L, Paltrinieri S. The 
Veterinary Journal (2013) 197:499-501 Serum paraoxonase-1 activity in neonatal calves: age 
related variations and comparison between healthy and sick animals.  
Giori L, Giordano A, Giudice C, Grieco V, Paltrinieri S. Journal of Small Animal Practice 
(2011) 52(3):152-7 Performances of different diagnostic tests for feline infectious peritonitis 
in challenging clinical cases. 
Giudice E, Passantino A. Acta Veterinaria Hungarica (2011) 59(2):205-13 Detection of 
Leishmania amastigotes in peripheral blood from four dogs--Short communication. 
Goedert J. EBioMedicine (2016) 5:14–15 Effect of HIV, immune deficiency, and 
confounding on the distal gut microbiota.  
121 
 
Gosalbes MJ, Durbán A, Pignatelli M, Abellan JJ, Jiménez-Hernández N, Pérez-Cobas AE, 
Latorre A, Moya A. PLoS One (2011) 6(3):e17447 Metatranscriptomic approach to analyze 
the functional human gut microbiota. 
Handl S, Dowd SE, Garcia-Mazcorro JF, Steiner JM, Suchodolski JS. FEMS Microbiology 
Ecology (2011) 76(2):301-10 Massive parallel 16S rRNA gene pyrosequencing reveals 
highly diverse fecal bacterial and fungal communities in healthy dogs and cats. 
Harris EK, Boyd JC. Clinical Chemistry (1990) 36(2):265-70 On dividing reference data into 
subgroups to produce separate reference ranges.  
Hayward AHS. Journal of Small Animal Practice (1968) 9:75-82 Thoracic effusion in the 
cat. 
Hazuchova K, Held S, Neiger R. Journal of Feline Medicine and Surgery (2017) 19(8):809-
816 Usefulness of acute phase proteins in differentiating between feline infectious peritonitis 
and other diseases in cats with body cavity effusions. 
Hentges DJ, Maier BR, Burton GC, Flynn MA, Tsutakawa RK Cancer Research (1977) 
37(2):568–571 Effect of a high-beef diet on the fecal bacterial flora of humans.  
Herp S, Brugiroux S, Garzetti D, Ring D, Jochum LM, Beutler M, Eberl C, Hussain S, 
Walter S, Gerlach RG, Ruscheweyh HJ, Huson D, Sellin ME, Slack E, Hanson B, Loy A, 
Baines JF, Rausch P, Basic M, Bleich A, Berry D, Stecher B. Cell Host&Microbe (2019) 
25(5):681-694.e8 Mucispirillum schaedleri Antagonizes Salmonella Virulence to Protect 
Mice against Colitis. 
Herrewegh AA, de Groot RJ, Cepica A, Egberink HF, Horzinek MC, Rottier PJ. Journal of 
Clinical Microbiology (1995) 33(3):684-9 Detection of feline coronavirus RNA in feces, 
tissues, and body fluids of naturally infected cats by reverse transcriptase PCR. 
Herrewegh AA, Smeenk I, Horzinek MC, Rottier PJ, de Groot RJ. Journal of Virology 
(1998) 72(5):4508-14 Feline coronavirus type II strains 79-1683 and 79-1146 originate from 
a double recombination between feline coronavirus type I and canine coronavirus. 
Hooda S, Minamoto Y, Suchodolski JS, Swanson KS. Animal Health Research Reviews 
(2012) 13(1):78-88 Current state of knowledge: the canine gastrointestinal microbiome. 
Ibba F, Rossi G, Meazzi S, Giordano A, Paltrinieri S. Research in Veterinary Science (2015) 
98:89-91 Serum concentration of high density lipoproteins (HDLs) in leishmaniotic dogs. 
IRIS Canine GN Study Group Diagnosis Subgroup, Littman MP, Daminet S, Grauer GF, 
Lees GE, van Dongen AM. Journal of Veterinary Internal Medicine (2013) 27 Suppl 1:S19-
26 Consensus recommendations for the diagnostic investigation of dogs with suspected 
glomerular disease. 
122 
 
Ito Y, Nisiyama Y, Shimokata K, Kimura Y, Nagata I (1976) Infection and Immunity 13(2): 
332-336 Interferon producing capacity of germfree mice 
Ives EJ, Vanhaesebrouck AE, Cian F. Journal of Feline Medicine and Surgery (2013) 
15(12):1149-53 Immunocytochemical demonstration of feline infectious peritonitis virus 
within cerebrospinal fluid macrophages. 
Jacob F, Polzin DJ, Osborne CA, Neaton JD, Kirk CA, Allen TA, Swanson LL. Journal of 
American Veterinary Medicine Association (2005) 226(3):393-400 Evaluation of the 
association between initial proteinuria and morbidity rate or death in dogs with naturally 
occurring chronic renal failure. 
Jakobsson HE, Rodríguez-Piñeiro AM, Schütte A, Ermund A, Boysen P, Bemark M, 
Sommer F, Bäckhed F, Hansson GC, Johansson ME. EMBO Reports (2015) 16(2):164-77 
The composition of the gut microbiota shapes the colon mucus barrier. 
Jergens AE, Guard BC, Redfern A, Rossi G, Mochel JP, Pilla R, Chandra L, Seo YJ, Steiner 
JM, Lidbury J, Allenspach K, Suchodolski J. Frontiers in Veterinary Science (2019) 6:199 
Microbiota-Related Changes in Unconjugated Fecal Bile Acids Are Associated With 
Naturally Occurring, Insulin-Dependent Diabetes Mellitus in Dogs. 
Kaakoush NO, Day AS, Huinao KD, Leach ST, Lemberg DA, Dowd SE, Mitchell HM. 
Journal of Clinical Microbiology (2012) 50 (10), 3258–3266 Microbial dysbiosis in pediatric 
patients with Crohn’s disease.  
Kamada N, Seo SU, Chen GY, Núñez G. Natural Reviews. Immunology (2013) 13(5):321-
35 Role of the gut microbiota in immunity and inflammatory disease.  
Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld 
C. Journal of Lipid Research (2004) 45: 1169-1196 Effects of infection and inflammation on 
lipid and lipoprotein metabolism: mechanisms and consequences to the host. 
Kipar A, Baptiste K, Barth A, Reinacher M. Journal of Feline Medicine and Surgery (2006a) 
8(1):69-72 Natural FCoV infection: cats with FIP exhibit significantly higher viral loads than 
healthy infected cats. 
Kipar A, Bellmann S, Kremendahl J, Köhler K, Reinacher M. Veterinary Immunology and 
Immunopathology (1998) 65:243-257 Cellular composition, coronavirus antigen expression 
and production of specific antibodies in lesions in feline infectious peritonitis.  
Kipar A, May H, Menger S, Weber M, Leukert W, Reinacher M. Veterinary Pathology 
(2005) 42(3):321-30 Morphologic features and development of granulomatous vasculitis in 
feline infectious peritonitis. 
Kipar A, Meli ML, Baptiste KE, Bowker LJ, Lutz H. Journal of General Virology (2010) 
91(Pt 7):1698-707 Sites of feline coronavirus persistence in healthy cats. 
123 
 
Kipar A, Meli ML, Failing K, Euler T, Gomes-Keller MA, Schwartz D, Lutz H, Reinacher 
M. Veterinary Immunology and Immunopathology (2006b) 112(3-4):141-55 Natural feline 
coronavirus infection: differences in cytokine patterns in association with the outcome of 
infection. 
Kipar A, Meli ML. Veterinary Pathology (2014) 51(2):505-26 Feline infectious peritonitis: 
still an enigma? 
Koh H, Kim M, Lee J, Kim H, Park S. Microbes Environment (2015) 30 (3), 284–287 
Changes in the swine gut microbiota in response to porcine epidemic Diarrhea infection.  
Kostic AD, Gevers D, Siljander H, Vatanen T, Hyötyläinen T, Hämäläinen AM, Peet A, 
Tillmann V, Pöhö P, Mattila I, Lähdesmäki H, Franzosa EA, Vaarala O, de Goffau M, 
Harmsen H, Ilonen J, Virtanen SM, Clish CB, Orešič M, Huttenhower C, Knip M; 
DIABIMMUNE Study Group, Xavier RJ Cell Host & Microbe (2015) 17(2):260-73 The 
dynamics of the human infant gut microbiome in development and in progression toward 
type 1 diabetes. 
Koutinas AF, Koutinas CK. Veterinary Pathology (2014) 51(2):527-38 Pathologic 
mechanisms underlying the clinical findings in canine leishmaniasis due to Leishmania 
infantum/chagasi. 
Kristensen K, Henriksen L Journal of Allergy and Clinical Immunology (2016) 137(2):587-
90 Cesarean section and disease associated with immune function. 
Lahti A, Petersen PH, Boyd JC, Rustad P, Laake P, Solberg HE. Clinical Chemistry (2004) 
50 (5):891–900 Partitioning of nongaussian-distributed.  
Landis JR, Koch GG. Biometrics (1997) 33(1):159-74 The measurement of observer 
agreement for categorical data.  
Lee YK, Mazmanian SK. Science (2010) 330(6012):1768-73 Has the microbiota played a 
critical role in the evolution of the adaptive immune system? 
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Nature (2006) 444(7122):1022-3 Microbial 
ecology: human gut microbes associated with obesity. 
Liu S, Zhao L, Zhai Z, Zhao W, Ding J, Dai R, Sun T, Meng H, Current in Microbiology 
(2015) 71 (6), 643–649 Porcine epidemic Diarrhea virus infection induced the unbalance of 
gut microbiota in piglets. 
Locksley RM, Heinzel FP, Sadick MD, Holaday BJ, Gardner KD Jr. Annales de l’Institut 
Pasteur. Immunology (1987) 138(5):744-9 Murine cutaneous leishmaniasis: susceptibility 
correlates with differential expansion of helper T-cell subsets. 
Lopes M, Carneiro M, Dos Santos L, Vieira L. Parasite immunology (2016 38(1):37-44 
Indigenous microbiota and Leishmaniasis.  
124 
 
Lopez R, Lucena R, Novales M, Ginel PJ, Martin E, Molleda JM. Zentralblatt fur 
Veterinarmedizin. Reihe B. (1996) 43(8):469-74 Circulating immune complexes and renal 
function in canine leishmaniasis. 
Macfarlane GT, Macfarlane S. Journal of AOAC International (2012) 95(1):50-60 Bacteria, 
colonic fermentation, and gastrointestinal health. 
Mackness M, Mackness B. Gene (2015) 567:12-21 Human paraoxonase-1 (PON1): Gene 
structure and expression, promiscuous activities and multiple physiological roles.  
Manna L, Reale S, Viola E, Vitale F, Foglia Manzillo V, Pavone LM, Caracappa S, Gravino 
AE. Veterinary Parasitology (2006) 142(3-4):271-80 Leishmania DNA load and cytokine 
expression levels in asymptomatic naturally infected dogs. 
Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, 
Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A. Gut (2016) 65(2):330-9 
The gut microbiota and host health: a new clinical frontier. 
Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. Medical and Veterinary 
Entomology (2013) 27(2):123-47 Phlebotomine sandflies and the spreading of leishmaniases 
and other diseases of public health concern. 
Martínez-Moreno A, Martínez-Cruz MS, Blanco A, Hernández-Rodríguez S. Veterinary 
Parasitology (1993) 51(1-2):49-59 Immunological and histological study of T- and B-
lymphocyte activity in canine visceral leishmaniosis. 
Martínez-Subiela S1, Tecles F, Eckersall PD, Cerón JJ. Veterinary Record (2002) 
150(8):241-4 Serum concentrations of acute phase proteins in dogs with leishmaniasis. 
McMurdie PJ, Holmes S. PLoS One (2013) 8(4), e61217 Phyloseq: an R package for 
reproducible interactive analysis and graphics of microbiome census data.  
McMurdie PJ, Holmes S. PLoS Computational Biology (2014) 10(4):e1003531 Waste not, 
want not: why rarefying microbiome data is inadmissible. 
McNeil NI. American Journal of Clinical Nutrition (1984) 39(2):338-42 The contribution of 
the large intestine to energy supplies in man. 
Meli M, Kipar A, Müller C, Jenal K, Gönczi E, Borel N, Gunn-Moore D, Chalmers S, Lin F, 
Reinacher M, Lutz H. Journal of Feline Medicine and Surgery (2004) 6(2), 69-81 High viral 
loads despite absence of clinical and pathological findings in cats experimentally infected 
with feline coronavirus (FCoV) type I and in naturally FCoV-infected cats.  
Metzker ML. Genome Research (2005) 15(12):1767-76 Emerging technologies in DNA 
sequencing. 
125 
 
Minamoto Y, Minamoto T, Isaiah A, Sattasathuchana P, Buono A, Rangachari VR, McNeely 
IH, Lidbury J, Steiner JM, Suchodolski JS. Journal of Veterinary Internal Medicine (2019) 
33(4):1608-1618 Fecal short-chain fatty acid concentrations and dysbiosis in dogs with 
chronic enteropathy. 
Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW. Infection and 
Immunity (1994) 62(3):1058-63 Th1 and Th2 cell-associated cytokines in experimental 
visceral leishmaniasis. 
Miranda S, Martorell S, Costa M, Ferrer L, Ramis A. Veterinary Parasitology (2007) 144(3-
4):251-60 Characterization of circulating lymphocyte subpopulations in canine leishmaniasis 
throughout treatment with antimonials and allopurinol. 
Modi S, Collins J, Relman D. Journal of Clinical Investigations (2014) 124 (10), 4212–4218 
Antibiotics and the gut microbiota. 
Montorfano I, Becerra A, Cerro R, Echeverria C, Saez E, Morales MG, Fernandez R, 
Cabello-Verrugio C, Simon F. Laboratory Investigation (2014) 94, 1068-1082 Oxidative 
stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-b1 and 
TGF-b2-dependent pathway.  
Murphy EA, Velazquez KT, Herbert KM. Current Opinion in Clinical Nutritional and 
Metabolic Care (2015) 18(5):515-20 Influence of high-fat diet on gut microbiota: a driving 
force for chronic disease risk. 
Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-
Ortuño MI. BMC Medicine (2013) 11:46 Gut microbiota in children with type 1 diabetes 
differs from that in healthy children: a case-control study. 
Mylonakis ME, Papaioannou N, Saridomichelakis MN, Koutinas AF, Billinis C, Kontos VI. 
Veterinary Clinical Pathology (2005) 34(3):243-7 Cytologic patterns of lymphadenopathy in 
dogs infected with Leishmania infantum. 
Neish AS. Gastroenterology (2009) 136(1):65-80 Microbes in gastrointestinal health and 
disease. 
Nicolato Rde C, de Abreu RT, Roatt BM, Aguiar-Soares RD, Reis LE, Carvalho Md, 
Carneiro CM, Giunchetti RC, Bouillet LE, Lemos DS, Coura-Vital W, Reis AB. PLoS One 
(2013) 8(12):e82947 Clinical forms of canine visceral Leishmaniasis in naturally Leishmania 
infantum-infected dogs and related myelogram and hemogram changes. 
Nie P, Li Z, Wang Y, Zhang Y, Zhao M, Luo J, Du S, Deng Z, Chen J, Wang Y, Chen S, 
Wang L. Medicinal Research Review (2019) [Epub ahead of print]. Gut microbiome 
interventions in human health and diseases. 
126 
 
Norris JM, Bosward KL, White JD, Baral RM, Catt MJ, Malik R. Australian Veterinary 
Journal (2005) 83(11):666-73 Clinicopathological findings associated with feline infectious 
peritonitis in Sydney, Australia: 42 cases (1990-2002). 
Okuturlar Y, Gedikbasi A, Akalin N, Gunaldi M, Yilmaz D, Mert M, Harmankaya O, Soylu 
A, Karakaya P, Kumbasar A. Archives of medical science (2016) 12(4):697-703 Serum 
paraoxonase 1 activity in patients with iron deficiency anemia.  
Ottenjann M, Weingart C, Arndt G, Kohn B. Journal of Veterinary Internal Medicine (2006) 
20:1143–1150 Characterization of the Anemia of Inflammatory Disease in Cats with 
Abscesses, Pyothorax, or Fat Necrosis.  
Padrid P. Veterinary Clinics: Small Animal Practice (2000) 30(6):1295-1308 Canine and 
feline pleural disease.  
Palm NW, de Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L, Degnan PH, Hu J, 
Peter I, Zhang W, Ruggiero E, Cho JH, Goodman AL, Flavell RA. Cell (2014) 158(5):1000-
1010 Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel 
disease. 
Paltrinieri S, Giordano A, Tranquillo V, Guazzetti S. Journal of Veterinary Diagnostic 
Investigation (2007) 19(3):266-72 Critical assessment of the diagnostic value of feline 
alpha1-acid glycoprotein for feline infectious peritonitis using the likelihood ratios approach. 
Paltrinieri S, Gradoni L, Roura X, Zatelli A, Zini E. Veterinary Clinical Pathology (2016) 
45(4):552-578 Laboratory tests for diagnosing and monitoring canine leishmaniasis. 
Paltrinieri S. The Veterinary Journal (2008) 177:26–35 The acute phase reaction.  
Pedersen NC, Black JW, Boyle JF, Evermann JF, McKeirnan AJ, Ott RL. Advances in 
Experimental Medicine and Biology (1984) 173:365-80 Pathogenic differences between 
various feline coronavirus isolates. 
Pedersen NC, Boyle JF. American Journal of Veterinary Research (1980) 41(6):868-76 
Immunologic phenomena in the effusive form of feline infectious peritonitis. 
Pedersen NC. Journal of Feline Medicine and Surgery (2009) 11(4):225-58 A review of 
feline infectious peritonitis virus infection: 1963-2008. 
Pedersen NC. The Veterinary Journal (2014a) 201(2):133-41 An update on feline infectious 
peritonitis: diagnostics and therapeutics. 
Pedersen NC. The Veterinary Journal (2014b) 201(2):123-32 An update on feline infectious 
peritonitis: virology and immunopathogenesis. 
Pesteanu-Somogyi LD, Radzai C, Pressler BM. Journal of Feline Medicine and Surgery 
(2006) 8(1):1-5 Prevalence of feline infectious peritonitis in specific cat breeds. 
127 
 
Pietro SD, Bosco VR, Crinò C, Francaviglia F, Giudice E. Veterinary World (2016) 
9(6):633-7. Prevalence, type, and prognosis of ocular lesions in shelter and owned-client 
dogs naturally infected by Leishmania infantum. 
Pinelli E, Boog CJ, Rutten VP, van Dijk B, Bernadina WE, Ruitenberg EJ. Tissue Antigens 
(1994) 43(3):189-92 A canine CD8+ cytotoxic T-cell line specific for Leishmania infantum-
infected macrophages. 
Pinelli E, Gonzalo RM, Boog CJ, Rutten VP, Gebhard D, del Real G, Ruitenberg EJ. 
European Journal of Immunology (1995) 25(6):1594-600 Leishmania infantum-specific T 
cell lines derived from asymptomatic dogs that lyse infected macrophages in a major 
histocompatibility complex-restricted manner. 
Płoneczka-Janeczko K, Bania J, Bierowiec K, Kiełbowicz M, Kiełbowicz Z. Biomedical 
Research International (2017) 3710404 Bacterial diversity in feline conjunctiva based on 16S 
rRNA gene sequence analysis: a pilot study.  
Ready PD. Annual Review of Entomology (2013) 58:227-50 Biology of phlebotomine sand 
flies as vectors of disease agents. 
Ready PD. Revue Scientifique et Technique (2008) 27(2):399-412 Leishmaniasis emergence 
and climate change. 
Regan AD, Cohen RD, Whittaker GR. Virology (2009) 384(1):135-43 Activation of p38 
MAPK by feline infectious peritonitis virus regulates pro-inflammatory cytokine production 
in primary blood-derived feline mononuclear cells. 
Reis AB, Teixeira-Carvalho A, Giunchetti RC, Guerra LL, Carvalho MG, Mayrink W, 
Genaro O, Corrêa-Oliveira R, Martins-Filho OA. Clinical and Experimental Immunology 
(2006) 146(2):303-11 Phenotypic features of circulating leucocytes as immunological 
markers for clinical status and bone marrow parasite density in dogs naturally infected by 
Leishmania chagasi. 
Reis LE, Coura-Vital W, Roatt BM, Bouillet LÉ, Ker HG, Fortes de Brito RC, Resende Dde 
M, Carneiro M, Giunchetti RC, Marques MJ, Carneiro CM, Reis AB. Veterinary 
Parasitology (2013) 197(3-4):498-503 Molecular diagnosis of canine visceral leishmaniasis: 
a comparative study of three methods using skin and spleen from dogs with natural 
Leishmania infantum infection. 
Riemer F, Kuehner KA, Ritz S, Sauter-Louis C, Hartmann K. Journal of Feline Medicine and 
Surgery (2016) 18(4):348-56 Clinical and laboratory features of cats with feline infectious 
peritonitis--a retrospective study of 231 confirmed cases (2000-2010). 
Robinson M, Smyth G. Biostatistics (2008) 9 (2), 321–332 Small-sample estimation of 
negative binomial dispersion, with applications to SAGE data.  
128 
 
Rossi G, Giordano A, Costarelli E, Moretti P, Paltrinieri S. ACVP and ASVCP annual 
meeting, Atlanta, Nov 8th-12th, 2014. Published in: Veterinary Clinical Pathology (2014b) 
43:E18 Analytical validation of a paraoxon based method to measure the activity of 
paraoxonase-1 in feline serum.  
Rossi G, Giordano A, Pezzia F, Kjelgaard-Hansen M, Paltrinieri S. Veterinary Clinical 
Pathology (2013) 42: 329–341 Serum paraoxonase 1 activity in dogs: preanalytical and 
analytical factors and correlation with C-reactive protein and alpha-2-globulin.  
Rossi G, Ibba F, Meazzi S, Giordano A, Paltrinieri S. The Veterinary Journal (2014a) 
199(1):143-9 Paraoxonase activity as a tool for clinical monitoring of dogs treated for canine 
leishmaniasis. 
Round JL, Mazmanian SK. Nature Reviews. Immunology (2009) 9(5):313-23 The gut 
microbiota shapes intestinal immune responses during health and disease. 
Ruggerone B, Bonelli F, Nocera I, Paltrinieri S, Giordano A, Sgorbini M. Veterinary Clinical 
Pathology (2018) 47:69-77 Validation of a paraoxon-based method for measurement of 
paraoxonase (PON-1) activity and establishment of RIs in horses.  
Santos-Gomes GM, Rosa R, Leandro C, Cortes S, Romão P, Silveira H. Veterinary 
Immunology and Immunopathology (2002) 88(1-2):21-30 Cytokine expression during the 
outcome of canine experimental infection by Leishmania infantum.   
Sarangi AN, Goel A, Aggarwal R. Journal of Clinical and Experimental Hepatology (2019) 
9(1):62-73 Methods for Studying Gut Microbiota: A Primer for Physicians. 
Saridomichelakis MN, Koutinas AF. Veterinary Dermatology (2014) 25(2):61-71 Cutaneous 
involvement in canine leishmaniosis due to Leishmania infantum (syn. L. chagasi). 
Saridomichelakis MN. Veterinary Dermatology (2009) 20(5-6):471-89 Advances in the 
pathogenesis of canine leishmaniosis: epidemiologic and diagnostic implications. 
Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, 
M., Shimizu, T., Ogihara, T., Tamura, Y., Sakurai, Y., Yamamoto, R., Mita, T., Fujitani Y, 
Fukuda H, Nomoto K, Takahashi T, Asahara T, Hirose T, Nagata S, Yamashiro Y, Watada 
H. Diabetes Care (2014) 37 (8), 2343–2350 Gut dysbiosis and detection of “live gut bacteria” 
in blood of Japanese patients with type 2 diabetes.  
Schmid SM, Suchodolski JS, Price JM, Tolbert MK. Frontiers in Veterinary Science (2018) 
16 (5), 79 Omeprazole minimally alters the Fecal microbial Community in six Cats: a pilot 
study.  
Schmidt M, Unterer S, Suchodolski JS, Honneffer JB, Guard BC, Lidbury JA, Steiner JM, 
Fritz J, Kölle P. PLoS One (2018) 13(8):e0201279 The fecal microbiome and metabolome 
differs between dogs fed Bones and Raw Food (BARF) diets and dogs fed commercial diets. 
129 
 
Shin NR, Whon TW, Bae JW. Trends in Biotechnology (2015) 33 (9), 496–503 
Proteobacteria: microbial signature of dysbiosis in gut microbiota.  
Shunmoogam N, Naidoo P, Chilton R. Vascular Health and Risk Management (2018) 14: 
137–143 Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and 
clinical relevance.  
Solano-Gallego L, Koutinas A, Miró G, Cardoso L, Pennisi MG, Ferrer L, Bourdeau P, Oliva 
G, Baneth G. Veterinary Parasitology (2009) 165(1-2):1-18 Directions for the diagnosis, 
clinical staging, treatment and prevention of canine leishmaniosis. 
Solano-Gallego L, Llull J, Ramos G, Riera C, Arboix M, Alberola J, Ferrer L. Veterinary 
Parasitology (2000) 10;90(1-2):37-45 The Ibizian hound presents a predominantly cellular 
immune response against natural Leishmania infection. 
Solano-Gallego L, Villanueva-Saz S, Carbonell M, Trotta M, Furlanello T, Natale A. 
Parasites & Vectors (2014) 7:111 Serological diagnosis of canine leishmaniosis: comparison 
of three commercial ELISA tests (Leiscan, ID Screen and Leishmania 96), a rapid test 
(Speed Leish K) and an in-house IFAT. 
Stranieri A, Giordano A, Bo S, Braghiroli C, Paltrinieri S. Journal of Feline Medicine and 
Surgery (2017) 19(8):880-887 Frequency of electrophoretic changes consistent with feline 
infectious peritonitis in two different time periods (2004-2009 vs 2013-2014). 
Stranieri A, Giordano A, Paltrinieri S, Giudice C, Cannito V, Lauzi S. Journal of Veterinary 
Diagnostic Investigation (2018) 30(3):459-463 Comparison of the performance of laboratory 
tests in the diagnosis of feline infectious peritonitis. 
Stranieri A, Paltrinieri S, Giordano A. Journal of Veterinary Diagnostic and Investigation. 
(2017b) 29(3):321-324 Diagnosing feline infectious peritonitis using the Sysmex XT-2000iV 
based on frozen supernatants from cavitary effusions. 
Suchodolski JS, Dowd SE, Wilke V, Steiner JM, Jergens AE. PLoS One. (2012b) 
7(6):e39333 16S rRNA gene pyrosequencing reveals bacterial dysbiosis in the duodenum of 
dogs with idiopathic inflammatory bowel disease. 
Suchodolski JS, Markel ME, Garcia-Mazcorro JF, Unterer S, Heilmann RM, Dowd SE, 
Kachroo P, Ivanov I, Minamoto Y, Dillman EM, Steiner JM, Cook AK, Toresson L. PLoS 
One (2012a) 7(12):e51907 The fecal microbiome in dogs with acute diarrhea and idiopathic 
inflammatory bowel disease. 
Suchodolski JS. The Veterinary Journal (2016) 215:30-7 Diagnosis and interpretation of 
intestinal dysbiosis in dogs and cats. 
130 
 
Swiatecka D, Narbad A, Ridgway KP, Kostyra H (2011) 145(1):267–272 The study on the 
impact of glycated pea proteins on human intestinal bacteria. International Journal of Food 
Microbiology  
Sykes JE. Journal of feline medicine and surgery (2003) 5(6):353-356 Ischemic 
neuromyopathy due to peripheral arterial embolization of an adenocarcinoma in a cat.  
Takano T, Azuma N, Satoh M, Toda A, Hashida Y, Satoh R, Hohdatsu T. Archive of 
Virology (2009) 154:775-781 Neutrophil survival factors (TNF-alpha, GM-CSF, and G-CSF) 
produced by macrophages in cats infected with feline infectious peritonitis virus contribute to 
the pathogenesis of granulomatous lesions.  
Tasker S. Journal of Feline Medicine and Surgery (2018) 20(3):228-243 Diagnosis of feline 
infectious peritonitis: Update on evidence supporting available tests. 
Tecles F, Caldín M, Tvarijonaviciute A, Escribano D, Martínez-Subiela S, Cerón JJ. 
Research in Veterinary Science (2015) 100:12-17 Serum biomarkers of oxidative stress in 
cats with feline infectious peritonitis.  
The Human Microbiome Project Consortium. Nature (2012) 486:207-214 Structure, function 
and diversity of the healthy human microbiome 
Tomás M, Sentí M, García-Faria F, Vila J, Torrents A, Covas M, Marrugat J. 
Arteriosclerosis, Thrombosis, and Vascular Biology (2000) 20:2113-2119 Effect of 
Simvastatin Therapy on Paraoxonase Activity and Related Lipoproteins in Familial 
Hypercholesterolemic Patients.  
Toyokuni S, Okamoto K, Yodoi J, Hiai H FEBS letters (1995) 358 1-3 Persistent oxidative 
stress in cancer.  
Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, 
Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. 
Nature (2009) 457(7228):480-4 A core gut microbiome in obese and lean twins. 
Vermeulen BL, Devriendt B, Olyslaegers DA, Dedeurwaerder A, Desmarets LM, Favoreel 
HW, Dewerchin HL, Nauwynck HJ. Veterinary Microbiology (2013) 164(1-2):46-59 
Suppression of NK cells and regulatory T lymphocytes in cats naturally infected with feline 
infectious peritonitis virus. 
Vogel L, Van der Lubben M, te Lintelo EG, Bekker CP, Geerts T, Schuijff LS, Grinwis GC, 
Egberink HF, Rottier PJ. Veterinary Research (2010) 41(5):71 Pathogenic characteristics of 
persistent feline enteric coronavirus infection in cats. 
Vouldoukis I, Drapier JC, Nüssler AK, Tselentis Y, Da Silva OA, Gentilini M, Mossalayi 
DM, Monjour L, Dugas B. Antimicrobial Agents and Chemotherapy (1996) 40(1):253-6 
131 
 
Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial 
activity via the L-arginine nitric oxide pathway. 
Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. The ISME Journal. 
(2012) 6(2):320-9 Structural segregation of gut microbiota between colorectal cancer patients 
and healthy volunteers. 
Weese J, Nichols J, Jalali M, Litster A. Veterinary Microbiology (2015) 180, 96–102 The 
rectal microbiota of cats infected with feline immunodeficiency virus infection and 
uninfected controls.  
Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong 
FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. Nature (2008) 455(7216):1109-13 
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. 
Williams A, Probert C, Stepankova R, Tlaskalova-Hogenova H, Phillips A, Bland P. 
Immunology (2006) 119(4):470-8 Effects of microflora on the neonatal development of gut 
mucosal T cells and myeloid cells in the mouse.  
Winkler ES, Thackray LB Current Opinion in Virology (2019) 37:44-51 A long-distance 
relationship: the commensal gut microbiota and systemic viruses. 
Zatelli A, Borgarelli M, Santilli R, Bonfanti U, Nigrisoli E, Zanatta R, Tarducci A, Guarraci 
A. American Journal of Veterinary Research (2003) 64(5):558-61 Glomerular lesions in dogs 
infected with Leishmania organisms. 
Zheng Y, Hao X, Lin X, Zheng Q, Zhang W, Zhou P, Li S. Microbial Pathogenesis (2018) 
121:70-76 Bacterial diversity in the feces of dogs with CPV infection. 
Zini E, Nolli S, Ferri F, Massari F, Gerardi G, Nicoli S, Romanelli G, Montinaro V, Trez D, 
Cavicchioli L, Ferro S. Veterinary Pathology (2018) 56 (3), 358–368 Pheochromocytoma in 
dogs undergoing adrenalectomy.  
  
132 
 
PUBLICATIONS 
INTERNATIONAL PEER REVIEWED PAPERS 
- Rossi G, Meazzi S, Giordano A, Paltrinieri S. Journal of Veterinary Diagnostic 
Investigation [Submitted, Under Review]. Paraoxonase-1 (PON-1) activity in cats: 
analytical validation, reference intervals and correlation with serum amyloid A and alpha-
1-acid glycoprotein 
- Groppetti D, Meazzi S, Filipe J, Colombani C, Panseri S, Palestrini C, Cannas S, Giordano 
A, Pecile A. [Manuscript in preparation] Maternal and neonatal cortisol link during 
perinatal period: preliminary results in German shepherd dogs. 
- Meazzi S, Paltrinieri S, Brentali I, Ferriani R, Giordano A. [Manuscript in preparation] 
Role of paraoxonase-1 (PON-1) as a diagnostic marker for feline infectious peritonitis 
(FIP) 
- Meazzi S, Stranieri A, Lauzi S, Bonsembiante F, Ferro S, Paltrinieri S, Giordano A. 
Research in Veterinary Science 2019. 125:272-278. Feline gut microbiota composition in 
association with feline coronavirus infection: A pilot study. 
- Stranieri A, Probo M, Pisu MC, Fioletti A, Meazzi S, Gelain ME, Bonsembiante F, Lauzi 
S, Paltrinieri S. Journal of Feline Medicine and Surgery 2019. [Epub ahead of print] 
Preliminary investigation on feline coronavirus presence in the reproductive tract of the 
tom cat as a potential route of viral transmission. 
 
ABSTRACTS 
- Groppetti D, Meazzi S, Palestrini C, Giordano A, Pizzi G, de Vera d’Aragona I, Pecile A. 
2019. Cortisol impact on reproductive and behavioral parameters throughout the perinatal 
133 
 
period: preliminary results in dogs. 22nd European Veterinary Society for Small Animal 
Reproduction (EVSSAR) Congress, June 28-29th 2019, Berlin, Germany 
- Bonsembiante F, Giordano A, Moretti P, Meazzi S, Mazzariol S, Gelain ME. 2019 Post-
mortem biochemistry: aqueous humor as an alternative matrix for biochemical analyses in 
dogs.  73th SISVET Congress, June 19-22th 2019, Olbia, Italy. 
- Meazzi S, Stranieri A, Lauzi S, Martino P, Paltrinieri S, Giordano A. 2018 Gut microbiome 
and feline infectious peritonitis. 72th SISVET Congress, June 20-22th 2018, Turin, Italy. 
- Meazzi S, Ferriani R, Paltrinieri S, Giordano A. 2018.Paraoxonase-1(PON-1) as a 
diagnostic marker for feline infectious peritonitis (FIP). 18th International Society of 
Animal Clinical Pathology (ISACP) Congress, August 5-8th 2018, Tokyo, Japan. 
 
ORAL PRESENTATION 
- Meazzi S, Ferriani R, Paltrinieri S, Giordano A. 2018.Paraoxonase-1(PON-1) as a 
diagnostic marker for feline infectious peritonitis (FIP). 18th International Society of 
Animal Clinical Pathology (ISACP) Congress, August 5-8th 2018, Tokyo, Japan. 
- Meazzi S, Ferriani R, Verde D, Rossi S, Barbè F. 2017 A dog with a gastric foreign body 
and leishmaniasis. 19th European Society of Veterinary Clinical Pathology (ESVCP) 
Annual Meeting. September 6-9th 2017, London, United Kingdom 
 
CO-SUPERVISION OF DEGREE THESIS 
- Enrico Bellini: CONFRONTO TRA DUE METODI STRUMENTALI PER LA CONTA 
CELLULARE IN VERSAMENTI DI GATTO. Thesis supervisor: Saverio Paltrinieri; 
Thesis co-supervisor: Sara Meazzi. October 2018 
134 
 
- Irene Brentali: UTILIZZO DELLA PARAOXONASI-1 (PON-1) NELLA DIAGNOSI DI 
PERITONITE INFETTIVA FELINA (FIP). Thesis supervisor: Saverio Paltrinieri; Thesis 
co-supervisor: Sara Meazzi. February 2019 
- Margherita Peri: LEISHMANIOSI CANINA: CORRELAZIONE TRA MICROBIOTA 
INTESTINALE E ASSETTO IMMUNITARIO. Thesis supervisor: Alessia Giordano; 
Thesis co-supervisor: Sara Meazzi. October 2019 
  
135 
 
ACKNOWLEDGMENTS 
Grazie a tutte le persone che mi hanno accompagnata alla fine di questo progetto, a tutti quelli che 
ogni giorno mi insegnano qualcosa e che hanno arricchito la mia vita professionale e personale.  
Ad Alessia, tutor ed amica, e con lei tutte le persone con cui ho lavorato in questi anni, ma anche 
tutti i colleghi e gli studenti che questo dottorato mi ha dato modo di conoscere. 
Ai miei genitori, che ancora cercano di ascoltarmi quando parlo di microbiota (che pazienza) ed a 
mia nonna (anche ai miei nonni che in questi anni se ne sono andati, ma so che sarebbero comunque 
molto orgogliosi di me: Ecco). A Hiro.  
Alle amiche che non vedo mai, ma che ci sono sempre.  
Al karate e a tutto il meraviglioso gruppo che è cresciuto e mi ha fatto crescere in questi vent’anni 
di pratica. Il karate si pratica tutta la vita.  
A Matteo per ogni cosa. Sei la mia Domenica. 
 
 
Una somma di piccole cose. 
